US3755560A - Nongreasy cosmetic lotions - Google Patents
Nongreasy cosmetic lotions Download PDFInfo
- Publication number
- US3755560A US3755560A US00158559A US3755560DA US3755560A US 3755560 A US3755560 A US 3755560A US 00158559 A US00158559 A US 00158559A US 3755560D A US3755560D A US 3755560DA US 3755560 A US3755560 A US 3755560A
- Authority
- US
- United States
- Prior art keywords
- lotion
- skin
- polymer
- oily
- lotions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
Definitions
- This invention relates to hand lotions and like products and particularly to formulations which after application to the skin do not have a greasy or oily feel to the touch.
- Thickening agents have also been found useful in formulations of this type and include such materials as water solutions of vegetable gums, cellulose derivatives and syntbetic polymers.
- pigmented products such as eye or body makeup are prepared polymers may be used as binders for the pigment.
- Heinrich et al. in British 1,110,- 240 propose to prepare liquid makeup lotions which are rub-proof, etc. by the addition of an emulsion polymer. This is analogous to the function of the polymer as a pigment binder in a latex paint except the total solids level is more dilute than in a paint.
- cosmetic formulations for skin care and skin protection may be formulated to contain high levels of normally greasy or oily effect agents with the addition thereto of an emulsion of a water insoluble, organo soluble film-forming vinyl polymer (latex) without the formulation feeling greasy or oily to the touch nor tacky after applying and drying same on the skin. Additionally the formulations of this invention have the desirable property of-being readily removed by washing with soap and water.
- an aqueous based lotion consisting essentially of from about 0.5 to about 8 weight percent of said vinyl polymer solids, from about 1 to 20 weight percent of an oil soluble effect agent which is a non-solvent and a non-plasticizer for said polymer, from about 2 to 10 weight percent of a compatible, cosmetically suitable emulsifying agent with the balance of the formulation to make of water.
- the Weight ratio of the effect agent to the vinyl polymer in the formulation ranges from about 2:1 to 20: 1. For heavier lotions or creams higher proportions of effect agents (emollients) up to 30 percent may be employed.
- Several optional ingredients such as humectants, thickeners and the like add desirable properties to the lotions.
- this invention provides the cosmetic formulator a means to greatly expand the range and kind of effect agents as well as the proportions thereof in a variety of cosmetic lotions for skin care and protection without diminishing the aesthetic properties thereof by adding to the lotions the previously described proportions of the vinyl polymers emulsion (latex).
- the effect of the emulsion polymer is to permit such formulations to be prepared without the oily or greasy effect after applying and drying the lotion.
- This effect of the emulsion polymer on the dry characteristics of the lotion was quite unexpected in the absence of any pigments or other inert solids in the formulation and also in view of the low polymer concentration in the formulation.
- the benefits and advantages of this invention may be found with a wide variety of cosmetic formulations designed for skin care and skin protection.
- the prevention or relief of dryness of the skin with emollient or hand lotions is an important area. Dryness or chapping of the skin results when there is insufiicient hydration from lower epidermal areas or an excessive loss of water from exposure of the skin to low humidities or both. Heavy or continuous use of soaps, etc. contribute to a dry skin condition by removal of the protective lipid layer which provides slip and flexibility as well as retards the transpiration of moisture.
- Lotions containing emollients are used to prevent or care for a dry skin condition.
- emollients are oily or greasy materials and their application to the skin leaves a greasy or oily feel, which of course is more pronounced the larger the proportion or amount of the emollient used.
- This invention permits the application of lotions containing relatively large amounts of emollients which rapidly rehydrate skin but which feel dry to the touch and not oily or greasy.
- Hand lotions containing a variety of medicants in addition to emollients may .also .be.
- One of the essential-components of the cosmetic lotions of this invention is an emulsion or aqueous dispersion of a- ,water insoluble, organo soluble; film-forming vinyl polymer.
- the emulsion is also commonly known as a latex.
- the lotion is formulated to contain from about 0.5 to 8 weight'percent of said vinyl polymer solids.'Since the lotions are designed for topical application tothe skin the vinyl polymer should also be non-toxic,'but this presents no problems with most emulsion polymers.
- film forming it is meant the ability of the vinyl polymer to form a continuous solid film by air drying of a deposited coating.
- film-formability is enhanced by a number of factors such as particle size which normally ranges from about 300 to about 2000 angstrom units. Additionally, the latex must be predominantly in the amorphous state. It is well known that such amorphous polymers may be prepared even from polymers which normally are considered to be crystalline.
- organo soluble it is meant that the vinyl polymer is soluble in a common organic solvent such as an aromatic solvent, e.g. xylene, toluene, etc., a ketone, e.g. acetone, methyl ethyl ketone, and the like.
- aromatic solvent e.g. xylene, toluene, etc.
- ketone e.g. acetone, methyl ethyl ketone, and the like.
- the vinyl emulsion polymer may be prepared from a variety of well known monomers and mixtures of monomers. It is understood that the term, vinyl emulsion polymer, includes homopolymers and polymers prepared from two or more monomers.
- monomers which may be employed are esters of vinyl carboxylic acids such as the alkyl acrylate and methacrylate esters, especially alkyl methacrylates having from 1 to about 4 carbons in the alkyl group and alkyl acrylates having from 1 to about 18, preferably 1 to about 12, carbons in the alkyl group; vinyl carboxylic acids such as acrylic acid, methacrylic acid, itaconic acid and the like; vinyl chloride and vinylidene chloride; conjugated olefins such as butadiene, isoprene and the like; nitrile monomers such as acrylonitrile and methacrylonitrile; alkenyl aromatics such as styrene, vinyl toluene and the like; and vinyl esters such as
- Typical of the many vinyl emulsion polymers are polyvinyl chloride, polyvinyl acetate, copolymers of styrene and butadiene, oopolymers of vinylidene chloride and vinylchloride, 'copolymers of vinylidene chloride and :acrylonitrile, a-terpolymer' of vinylidene chloride, acrylonitrileand butyl acrylate, a terpolymer of styrene, buta- -'diene and itaconic acid," and an interpolymer of methyl acrylate, ethyl acrylate, methyl methacrylate and methacr'ylic acidf
- a preferred group of vinyl emulsion polymers are those which are prepared from a mixture of monomers,'one of which is a vinyl carboxylic acid monomer. The presence of the carboxylic acid improves the removability of the'lotion bywashing with soap and water. The amount
- the latex may be prepared by any of the known pro- "cedures'for polymerization in aqueous emulsion.
- the monomer is added to an aqueous solution of a polymerization catalyst such as'potassium persulfate or hydrogen peroxide and a surface active agent capable of emulsifying the monomers.
- a polymerization catalyst such as'potassium persulfate or hydrogen peroxide
- a surface active agent capable of emulsifying the monomers.
- Many suitable surface active agents areknown to-the-art.
- the polymerizable mixture isr'agitated to effect emulsification and polymerization is initiated by heating the emulsified mixture usually between 35 and C.
- the surface active agent is usually employed in an amount corresponding to from 0.5 to 5 percentof-the weight of the polymerizable organic compounds.
- the polymerization catalyst is usually added in an amount corresponding'to from 0.5 to 5 percent of the monomers.
- the use of the latex polymer permits formulations to contain high levels of oily'efiect agents without imparting an oily feel .to ,the skin.
- the amount of said effect agent or mixtures of same may vary from about 1 to about 20 weight percent for light lotions and up to 30 percent or even higher for heavy lotions and creams.
- the proportions of said effect agent are adjusted in relation to the amount of emulsion polymer solids. This weight ratio of effect agent to polymer solids preferably varies from about 2:1 to 20:1.
- the effect agent is an oily material which is essentially neither a solvent nor a plasticizer for the vinyl emulsion polymer, however a slight amount of plasticization or solvency may be tolerated without detracting from the beneficial results of this invention.
- an oily efiect agent it is meant to include agents which are oils or a solution of an efiect agent in an oil such as mineral oil, for example.
- emollients which include wax esters such as lanoline, s'permaceti and the like; steroid alcohols such as cholesterol and lanolin alcohols; fatty alcohols such as stearyl, cetyl, etc.; triglyceride esters (animal and vegetable oils); phospholipids such as lecithin and cephalin; fatty alcohol ethers and vesters;,hydrocarbou oils and waxes; ethoxylated lanolin or beeswax derivatives; and silicone oils.
- wax esters such as lanoline, s'permaceti and the like
- steroid alcohols such as cholesterol and lanolin alcohols
- fatty alcohols such as stearyl, cetyl, etc.
- triglyceride esters animal and vegetable oils
- phospholipids such as lecithin and cephalin
- fatty alcohol ethers and vesters such as fatty alcohol ethers and vesters
- effect agents include bactericidal agents, topical analgesics, sunscreen agents, artificially tanning agents, insect repellants and the like. It should be understood that the invention contemplates the use of more than one effect agent in a single formulation, for example, an insect repellant in combination with a sunscreen agent. It should also be understood that an oil soluble effect agent may be dissolved and usedin an inert oil.
- Essential to the preparation of a stable lotion is the addition of about 2 to 10 weight percent of an emulsifylimit the choice of emulsifiers since the cosmetic art uses a great variety of same.
- anionic emulsifiers are the fatty acid soaps or mixtures of same with fatty acid esters such as glyceryl monostearate, sodium salts 'of sulfuric esters and the like.
- Cationic agents are not too widely used but may be used both for their emulsification properties as well as other properties such as germicidal or substantive efiects.
- Typical cationics are cetyl pyridiniumchloride and alkyl dimethyl benzyl ammonium chloride.
- nonionics are Widely used because of their compatibility features as well as emulsi-fication efiectiveness.
- examples of nonionics are polyoxyethylene fatty alcohol ethers and esters, ethoxylated sorbitan fatty acid esters, polyol fatty acid esters and the like. While many of these nonionics may also impart some emollient properties they are primarily considered to be emulsifying agents. Said textbook reference cited previously can be consulted for additional suitable emulsifiers.
- the balance of the formulation to make 100% consists essentially of Water.
- humectants which principally include polyhydric alcohols and especially include glycerol, propylene glycol and sorbitol. The proportions of humectant range from about 0.5 to 4 weight percent.
- a thickening agent which may be either inorganic or organic.
- Organic thickeners and/or stabilizing agents are usually polymeric in nature and are water soluble compounds. The amount of said water soluble polymeric compound varies from about 0.1 to 2.0 weight percent.
- Other optional ingredients include preservatives, perfumes, colorants if other than a White lotion is desired, small amounts of alcohols, and the like.
- Inorganic and organic bases are frequently used to neutralize certain of the ingredients, form a fatty acid soap in situ, etc. Sodium hydroxide, potassium hydroxide and triethanol amine are commonly used.
- oil-in-water emulsion techniques may be used to prepare the formulations of this invention. Such techniques utilize sufiicient shear in the mixing of ingredients to obtain a stable, homogeneous emulsion.
- the oil phase and the Water phase advantageously may be preheated prior to mixing together to aid in forming the emulsion.
- preheating the emulsion polymer is usually added to the emulsion after it has cooled. Those latexes which are not sensitive to heating may, of course, be present during the preheat stage.
- Example 1 Ingredient Wt. percent -'Palmitic acid 1.5 Stearic acid 1.5 Isopropyl palmitate 5 Cetyl alcohol 1 Propylene glycol 5 Triethanol amine 1.3
- the hand lotion when applied to the skin had a decided oily or greasy residual feel.
- (B) A similar formulation was prepared except that the emulsion contained 5 weight percent of a pigment and percent of Veegum T (a 5% by weight solution of a silicate dispersant).
- the pigment was composed of 15% talc and 85% titanium dioxide. This formulation when applied to the skin has a non-oily residual feel, however, it does not prevent the pigment from rubbing ofi onto clothing.
- the pigment may 'be prevented from rubbing oil by adding to the above pigmented formulation about 3.5 weight percent (polymer solids) of a latex as a binder for the pigments and the non-oily residual feel is maintained.
- (E) The acrylic latex' polymer employed in parts (C) and (D) above was prepared by astandard emulsion polymerization technique. A charge of 40 grams of mixed monomers consisting of '35 parts of methyl acrylate, 20 parts of ethyl acrylate, 20 parts of methyl methacrylate, and 25 parts of methacrylic acid was added to 775 g. of water and 7.8 g. of 30.8% Nornol WAQE in a 2 liter flask equipped with a nitrogen purge, a reflux condenser, and a stirrer. This mixture was heated to 70 C. at which point a solution containing 4 g. of Na S O in 25 ml. of H 0 was added and the heat was removed.
- the temperature of the reaction increased to C. and then subsided. An additional 360 grams of the mixed monomers was then pumped into the flask at the rate of g. per hour while maintaining a temperature of 70 C. After 4 hours the monomer was all in and the reaction was heated for an additional hour at 70 C. and then heated at 90- C. for 2 hours to remove traces of the monomer. The latex solution was cooled and filtered and contained about 33 weight percent of vinyl polymer solids.
- Example 2 A hand lotion with excellent skin conditioning properties and aesthetic properties was formulated to contain the following ingredients: I
- This formulation also contained preservatives, a perfume and a yellow colorant.
- An application to the-skin of this lotion imparts a pleasant, non-oilyresidual feel.
- a hand lotion which contained no humectant but which was effective as a moisturizing hand lotion and had a non-oily residual feel was formulated to contain the following:
- the acrylic latex polymer similar to Example 1 was used. Similar results are obtained if the amount of the latex polymer solids is less by one-half the amount above.
- Example 5 As indicated previously products which might appear to be quite similar may actually be very different from the standpoint of customer acceptance and aesthetic features.
- the aesthetic as well as performance characteristics of a hand lotion similar to that of Example 2 was determined in a large sample test against the largest selling commercial hand location.
- test was conducted with 800 persons, 400 of whom where supplied a sample of the commercial lotion (unidentified) and 400 given the above hand lotion and were asked to evaluate the products against their previous experience with hand lotions. Tests were made nationwide but the largest portions were located in dry regions of the country.
- the acceptability ofthe lotion of this invention on both an aesthetic and performance basis is clearly evident.
- the 'value of the latex polymer in providing a non-oily residual feel is shown by the fact that the lotion tested contained a larger quantity of oils, etcL'than the commercial lotion.
- Example 6 Employing the acrylic latex polymer of the previous examples a lotion was prepared according to Example 1 of US. 3,100,180.
- the lotion was prepared by adding 2.75 gm. of said latex (about 33% solids) to 30.25 gms. of hot water and warmed to 65 C. Then 5 gms. of USP stearic acid was melted and added with good stirring. The mixture was kept at 50-65 C. and sufiicient K CO was added to adjust the pH to 6.0. Then 12 gms. of hot melted polyethylene glycol 600 monostearate was added with good mixing. In about 10 minutes the emulsion became thick and creamy.
- a small amount of the formulation was spread over about a ten square inch area of the forearm and dried for 10-15 minutes. Then half of the treated area was washed with soap and water. Small drops of a 1% solution of Sudan II (a red dyestuff which strongly stains the skin) in a mixture of heptane and xylene were placed on the unwashed and on the washed areas. After about one minute the dyed areas were rubbed briskly with a facial tissue. Almost all the color was removed from the unwashedtreated area whereas the washed-treated area still showed marked'staining indicating the lotion had been removed from the skin by washing with soap and water.
- Sudan II a red dyestuff which strongly stains the skin
- Example 2 A formulation similar to that of Example 2 was prepared and tested as above with the same results, i.e. the lotion was readily removed by washing with soap and water.
- additional formulations were prepared by replacing the acrylic latex with the saran latex or polyvinyl acetate latex, as above. Again the lotions were found to be removable by washing with soap and water.
- a cosmetic lotion having improved holding capacity for anoily effect agent which upon drying is non-tacky and nongreasy to the touch, said lotion consisting essentially of a polymeric dispersion containing.
- the lotion of claim 1 further containing from abou 0.5 to 4 weight percent of a humectant.
- the lotion of claim 1 further containing from about 0.1 to 2 weight percent of a thickening agent.
- the lotion of claim 4 further containing a sun screen centration ranges from about 1 to 20 weight percent. agent.
- said vinyl polymer is References Cited a polymer of a vinyl carboxylic acid, an alkyl methacrylate UNITED STATES PATENTS having from 1 to about 4 carbons in the alkyl group and an alkyl acrylate having from 1 to about 12 carbon atoms 5 3100180 8/1963 smlth at 424-78 in the alkyl omups 3,406,238 10/1968 Freyermuth et a1 424-70 7.
- SAM ROSEN, Primary Examiner 8 The lotion of claim 1 wherein said vinyl polymer is 0 prepared from a mixture of monomers one of which is a US. Cl. X.R.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
AQUEOUS BASED COSMETIC LOTIONS FOR SKIN CARE AND SKIN PROTECTION MAY BE FORMULATED TO CONTAIN HIGH LEVELS OF AN OILY EFFECT AGENT, SUCH AS AN EMOLLIENT, WITHOUT IMPARTING A GREASY OR OILY FEEL TO THE TOUCH AFTER APPLYING AND DRYING SAME BY THE INCLUSION IN THE LOTION OF AN EMULSION (PATEX) OF A WATER INSOLUBLE, ORGANO SOLUBLE, FILM-FORMING VINYL POLYMER AND A COSMETICALLY SUITABLE EMULSIFYING AGENT. THE EFFECT AGENT MUST BE A NON-SOLVENT AND A NON-PLASTICIZER FOR THE VINYL POLYMER. CERTAIN DESIRABLE INGREDIENTS SUCH AS HUMECTANTS, THICKENERS, ETC. MAY BE OPTIONALLY ADDED TO THE LOTION.
Description
United States Patent M 3,755,560 N ONGREASY COSMETIC LOTIONS Yancy J. Dickert, Bruce P. Thill, and Alfred F. Steinhauer, Midland, Mich., assignors to The Dow Chemical Company, Midland, Mich.
No Drawing. Continuation-impart of abandoned applicafion Ser. No. 873,081, Oct. 31, 1969. This application June 30, 1971, Ser. No. 158,559
Int. Cl. A61k 7/00, 9/06; A611 23/00 U.S. Cl. 424-78 9 Claims ABSTRACT OF THE DISCLOSURE CROSS REFERENCE This application is a continuation-in-part of copending application Ser. No. 873,081 filed on Oct. 31, 1969, and now abandoned.
BACKGROUND OF THE INVENTION This invention relates to hand lotions and like products and particularly to formulations which after application to the skin do not have a greasy or oily feel to the touch.
Skin care products such as emollient or hand lotions have been marketed for many years. Over the years many new compounds and materials have been found suitable for inclusion in such lotions, but with each new material added there are new problems in formulating a satisfactory product. In spite of all the scientific studies which have been made, the formulator of a satisfactory product and particularly of a commercially acceptable product, is still guided as much by know-how and experience as he is by scientific principles, since the acceptability and saleability of such products is greatly dependent on aesthetic or certain subjective factors which are difficult to quantify. As a result one formulation which may differ only slightly in choice or proportions of ingredients compared to another, may in the marketplace, be aesthetically as different as night and day even though the two formulations may be quite similar on a casual inspection.
Many of the useful components in skin care products are oily or greasy in nature, for example certain emollients such as lanolin or isopropyl palmitate are prized ingredients but oily in nature. Frequently for functional reasons it would be desirable to increase the concentration of emollients in a skin care formulation but the increased greasiness or oiliness greatly diminishes the product acceptabiltiy.
Thickening agents have also been found useful in formulations of this type and include such materials as water solutions of vegetable gums, cellulose derivatives and syntbetic polymers. When pigmented products such as eye or body makeup are prepared polymers may be used as binders for the pigment. Heinrich et al. in British 1,110,- 240 propose to prepare liquid makeup lotions which are rub-proof, etc. by the addition of an emulsion polymer. This is analogous to the function of the polymer as a pigment binder in a latex paint except the total solids level is more dilute than in a paint.
3,755,560 Patented Aug. 28, 1973 "SUMMARY OF THE INVENTION Accordingly it has now been discovered that cosmetic formulations for skin care and skin protection .may be formulated to contain high levels of normally greasy or oily effect agents with the addition thereto of an emulsion of a water insoluble, organo soluble film-forming vinyl polymer (latex) without the formulation feeling greasy or oily to the touch nor tacky after applying and drying same on the skin. Additionally the formulations of this invention have the desirable property of-being readily removed by washing with soap and water.
The benefitsand advantages of this invention are obtained by preparing an aqueous based lotion consisting essentially of from about 0.5 to about 8 weight percent of said vinyl polymer solids, from about 1 to 20 weight percent of an oil soluble effect agent which is a non-solvent and a non-plasticizer for said polymer, from about 2 to 10 weight percent of a compatible, cosmetically suitable emulsifying agent with the balance of the formulation to make of water. The Weight ratio of the effect agent to the vinyl polymer in the formulation ranges from about 2:1 to 20: 1. For heavier lotions or creams higher proportions of effect agents (emollients) up to 30 percent may be employed. Several optional ingredients such as humectants, thickeners and the like add desirable properties to the lotions.
DETAILED DESCRIPTION OF THE INVENTION Adavantageously this invention provides the cosmetic formulator a means to greatly expand the range and kind of effect agents as well as the proportions thereof in a variety of cosmetic lotions for skin care and protection without diminishing the aesthetic properties thereof by adding to the lotions the previously described proportions of the vinyl polymers emulsion (latex). The effect of the emulsion polymer is to permit such formulations to be prepared without the oily or greasy effect after applying and drying the lotion. This effect of the emulsion polymer on the dry characteristics of the lotion was quite unexpected in the absence of any pigments or other inert solids in the formulation and also in view of the low polymer concentration in the formulation.
The benefits and advantages of this invention may be found with a wide variety of cosmetic formulations designed for skin care and skin protection. The prevention or relief of dryness of the skin with emollient or hand lotions is an important area. Dryness or chapping of the skin results when there is insufiicient hydration from lower epidermal areas or an excessive loss of water from exposure of the skin to low humidities or both. Heavy or continuous use of soaps, etc. contribute to a dry skin condition by removal of the protective lipid layer which provides slip and flexibility as well as retards the transpiration of moisture.
Lotions containing emollients are used to prevent or care for a dry skin condition. However, emollients are oily or greasy materials and their application to the skin leaves a greasy or oily feel, which of course is more pronounced the larger the proportion or amount of the emollient used. This invention permits the application of lotions containing relatively large amounts of emollients which rapidly rehydrate skin but which feel dry to the touch and not oily or greasy. Hand lotions containing a variety of medicants in addition to emollients may .also .be. formulated according .to .this invention: Other skin care products may be prepared which replace part or all of the emollient with sunscreen agents, analgesic agents-, insect repellants and the like. Many other useful lotions will beapparent to the formulatorof such cosmetic.products.;- a 1 The cosmetic lotion formulations of this invention have the further desirable property of being readily removable bywashing with soapand water. By readily removable it is meant that the lotion, after application, may be substantially removed by the" ordinary day-to-day cleansing process of lathering with soap and washing or showering.
One of the essential-components of the cosmetic lotions of this invention is an emulsion or aqueous dispersion of a- ,water insoluble, organo soluble; film-forming vinyl polymer. The emulsion is also commonly known as a latex. The lotion is formulated to contain from about 0.5 to 8 weight'percent of said vinyl polymer solids.'Since the lotions are designed for topical application tothe skin the vinyl polymer should also be non-toxic,'but this presents no problems with most emulsion polymers.
By film forming it is meant the ability of the vinyl polymer to form a continuous solid film by air drying of a deposited coating. In general film-formability is enhanced by a number of factors such as particle size which normally ranges from about 300 to about 2000 angstrom units. Additionally, the latex must be predominantly in the amorphous state. It is well known that such amorphous polymers may be prepared even from polymers which normally are considered to be crystalline.
By organo soluble it is meant that the vinyl polymer is soluble in a common organic solvent such as an aromatic solvent, e.g. xylene, toluene, etc., a ketone, e.g. acetone, methyl ethyl ketone, and the like.
The vinyl emulsion polymer may be prepared from a variety of well known monomers and mixtures of monomers. It is understood that the term, vinyl emulsion polymer, includes homopolymers and polymers prepared from two or more monomers. Examples of monomers which may be employed are esters of vinyl carboxylic acids such as the alkyl acrylate and methacrylate esters, especially alkyl methacrylates having from 1 to about 4 carbons in the alkyl group and alkyl acrylates having from 1 to about 18, preferably 1 to about 12, carbons in the alkyl group; vinyl carboxylic acids such as acrylic acid, methacrylic acid, itaconic acid and the like; vinyl chloride and vinylidene chloride; conjugated olefins such as butadiene, isoprene and the like; nitrile monomers such as acrylonitrile and methacrylonitrile; alkenyl aromatics such as styrene, vinyl toluene and the like; and vinyl esters such as vinyl acetate and the like. Generally the vinyl emulsion polymer-is prepared from two or more monomers.
Typical of the many vinyl emulsion polymers are polyvinyl chloride, polyvinyl acetate, copolymers of styrene and butadiene, oopolymers of vinylidene chloride and vinylchloride, 'copolymers of vinylidene chloride and :acrylonitrile, a-terpolymer' of vinylidene chloride, acrylonitrileand butyl acrylate, a terpolymer of styrene, buta- -'diene and itaconic acid," and an interpolymer of methyl acrylate, ethyl acrylate, methyl methacrylate and methacr'ylic acidf I A preferred group of vinyl emulsion polymers are those which are prepared from a mixture of monomers,'one of which is a vinyl carboxylic acid monomer. The presence of the carboxylic acid improves the removability of the'lotion bywashing with soap and water. The amount 'of the acid monomer can vary considerably depending on the other monomers employed but even quite small amounts are efiective.
The latex may be prepared by any of the known pro- "cedures'for polymerization in aqueous emulsion. Typically the monomer is added to an aqueous solution of a polymerization catalyst such as'potassium persulfate or hydrogen peroxide and a surface active agent capable of emulsifying the monomers. Many suitable surface active agents areknown to-the-art. The polymerizable mixture isr'agitated to effect emulsification and polymerization is initiated by heating the emulsified mixture usually between 35 and C. The surface active agent is usually employed in an amount corresponding to from 0.5 to 5 percentof-the weight of the polymerizable organic compounds. The polymerization catalyst is usually added in an amount corresponding'to from 0.5 to 5 percent of the monomers.
particular' feature of this invention is that'the use of the latex polymer permits formulations to contain high levels of oily'efiect agents without imparting an oily feel .to ,the skin. The amount of said effect agent or mixtures of same may vary from about 1 to about 20 weight percent for light lotions and up to 30 percent or even higher for heavy lotions and creams. Preferably, however, the proportions of said effect agent are adjusted in relation to the amount of emulsion polymer solids. This weight ratio of effect agent to polymer solids preferably varies from about 2:1 to 20:1. The effect agent is an oily material which is essentially neither a solvent nor a plasticizer for the vinyl emulsion polymer, however a slight amount of plasticization or solvency may be tolerated without detracting from the beneficial results of this invention. By an oily efiect agent it is meant to include agents which are oils or a solution of an efiect agent in an oil such as mineral oil, for example.
A variety of said effect agents are known and available to the cosmetic formulator. Especially valuable are the emollients which include wax esters such as lanoline, s'permaceti and the like; steroid alcohols such as cholesterol and lanolin alcohols; fatty alcohols such as stearyl, cetyl, etc.; triglyceride esters (animal and vegetable oils); phospholipids such as lecithin and cephalin; fatty alcohol ethers and vesters;,hydrocarbou oils and waxes; ethoxylated lanolin or beeswax derivatives; and silicone oils. (See Cosmetics Science and Technology, E. Sagarin, Interscience Publishers, Inc., New York, 1957 at page 102, for example.)
In addition to emollients other effect agents include bactericidal agents, topical analgesics, sunscreen agents, artificially tanning agents, insect repellants and the like. It should be understood that the invention contemplates the use of more than one effect agent in a single formulation, for example, an insect repellant in combination with a sunscreen agent. It should also be understood that an oil soluble effect agent may be dissolved and usedin an inert oil.
Essential to the preparation of a stable lotion is the addition of about 2 to 10 weight percent of an emulsifylimit the choice of emulsifiers since the cosmetic art uses a great variety of same. In the area of anionic emulsifiers are the fatty acid soaps or mixtures of same with fatty acid esters such as glyceryl monostearate, sodium salts 'of sulfuric esters and the like. Cationic agentsare not too widely used but may be used both for their emulsification properties as well as other properties such as germicidal or substantive efiects. Typical cationics are cetyl pyridiniumchloride and alkyl dimethyl benzyl ammonium chloride. The nonionics are Widely used because of their compatibility features as well as emulsi-fication efiectiveness. Examples of nonionics are polyoxyethylene fatty alcohol ethers and esters, ethoxylated sorbitan fatty acid esters, polyol fatty acid esters and the like. While many of these nonionics may also impart some emollient properties they are primarily considered to be emulsifying agents. Said textbook reference cited previously can be consulted for additional suitable emulsifiers. The balance of the formulation to make 100% consists essentially of Water.
A number of optional ingredients may also be included in the formulation of this invention. Particularly desirable are humectants which principally include polyhydric alcohols and especially include glycerol, propylene glycol and sorbitol. The proportions of humectant range from about 0.5 to 4 weight percent. Another valuable ingredient is a thickening agent which may be either inorganic or organic. Organic thickeners and/or stabilizing agents are usually polymeric in nature and are water soluble compounds. The amount of said water soluble polymeric compound varies from about 0.1 to 2.0 weight percent. Other optional ingredients include preservatives, perfumes, colorants if other than a White lotion is desired, small amounts of alcohols, and the like. Inorganic and organic bases are frequently used to neutralize certain of the ingredients, form a fatty acid soap in situ, etc. Sodium hydroxide, potassium hydroxide and triethanol amine are commonly used.
Conventional oil-in-water emulsion techniques may be used to prepare the formulations of this invention. Such techniques utilize sufiicient shear in the mixing of ingredients to obtain a stable, homogeneous emulsion. The oil phase and the Water phase advantageously may be preheated prior to mixing together to aid in forming the emulsion. When preheating is used the emulsion polymer is usually added to the emulsion after it has cooled. Those latexes which are not sensitive to heating may, of course, be present during the preheat stage.
The following non-limiting examples are presented to further illustrate this invention.
Example 1 Ingredient Wt. percent -'Palmitic acid 1.5 Stearic acid 1.5 Isopropyl palmitate 5 Cetyl alcohol 1 Propylene glycol 5 Triethanol amine 1.3
Water, balance to 100%.
The hand lotion when applied to the skin had a decided oily or greasy residual feel.
(B) A similar formulation was prepared except that the emulsion contained 5 weight percent of a pigment and percent of Veegum T (a 5% by weight solution of a silicate dispersant). The pigment was composed of 15% talc and 85% titanium dioxide. This formulation when applied to the skin has a non-oily residual feel, however, it does not prevent the pigment from rubbing ofi onto clothing.
(C) The pigment may 'be prevented from rubbing oil by adding to the above pigmented formulation about 3.5 weight percent (polymer solids) of a latex as a binder for the pigments and the non-oily residual feel is maintained.
(D) It was found that this non-oily residual feel is obtained when the acrylic latex polymer is present even when the pigments (and dispersant), which were previously shown to have a drying effect on the hand lotion, were omitted. A formulation was prepared as in part A above which-contained the following ingredients:
Water, balance to 100%.
This hand location on application to the skin, rubbing and drying had a pleasant non-oily residual feel. These results are even more unexpected when it is considered that the formulation only contains about 3.5% polymer solids and the ratio of oils to polymer is about 9:35 (including the fatty acids) or 6:35 (excluding said acids).
(E) The acrylic latex' polymer employed in parts (C) and (D) above was prepared by astandard emulsion polymerization technique. A charge of 40 grams of mixed monomers consisting of '35 parts of methyl acrylate, 20 parts of ethyl acrylate, 20 parts of methyl methacrylate, and 25 parts of methacrylic acid was added to 775 g. of water and 7.8 g. of 30.8% Dupanol WAQE in a 2 liter flask equipped with a nitrogen purge, a reflux condenser, and a stirrer. This mixture was heated to 70 C. at which point a solution containing 4 g. of Na S O in 25 ml. of H 0 was added and the heat was removed. The temperature of the reaction increased to C. and then subsided. An additional 360 grams of the mixed monomers was then pumped into the flask at the rate of g. per hour while maintaining a temperature of 70 C. After 4 hours the monomer was all in and the reaction was heated for an additional hour at 70 C. and then heated at 90- C. for 2 hours to remove traces of the monomer. The latex solution was cooled and filtered and contained about 33 weight percent of vinyl polymer solids.
Example 2 A hand lotion with excellent skin conditioning properties and aesthetic properties was formulated to contain the following ingredients: I
Weight Primary percent Ingredient function 5 Isopropyl palmitate Emollient.
1.0 Cetyl al ohol Do.
1.5 Lanolin (anhydrous) Do.
0.3. Water solublesilicone fluid (DO 473) D0.
1.0 Stearic acid Emulsifier.
2. Glyceryl monostearate Do.
2.5. Polyethylene glycol 400 distearate Do.
(Pegosperse 400 DS).
2.5- Glycerine Humectant.
2.0. Acrylic latex polymer solids.
0.2 Carbopol 940 solids 1 Thickener.
0.4 Triethanol amine Neutralizing agent.
Balance Water 1 This formulation also contained preservatives, a perfume and a yellow colorant. An application to the-skin of this lotion imparts a pleasant, non-oilyresidual feel.
. gExampleB Similar results to the previous examples were obtained when the acrylic latex was replaced on an equivalent solids basis with any of the following latexes:
(a) A commercially available vpolyvinyl acetate latex (Elvacet 1423).
(b) A commercially available latex containing about 63% butyl acrylate, 34%. acrylonitrile and 3% methacrylic acid. V
(c) A saran latex containing about 90% vinylidene chloride, 5% acrylonitrile and 5% butyl acrylate.
(d) Several acrylic latexes of the following compositions.
Weight percent MA EA MMA MAA Other I 30 35 w 10 (styrene). H 40 35 10 15 III 40 35 15 10 (t-bntyl styrene). IV 40 25 15 (styrene).
Norn.-MA=Methyl acrylete; EA=Ethylacrylate; MMA=Methyl methacrylate; MAA=Methacrylic acid. 6
.. Example 4 A hand lotion which contained no humectant but which was effective as a moisturizing hand lotion and had a non-oily residual feel was formulated to contain the following:
Water, balance to 100%.
The acrylic latex polymer similar to Example 1 was used. Similar results are obtained if the amount of the latex polymer solids is less by one-half the amount above.
Example 5 As indicated previously products which might appear to be quite similar may actually be very different from the standpoint of customer acceptance and aesthetic features. The aesthetic as well as performance characteristics of a hand lotion similar to that of Example 2 was determined in a large sample test against the largest selling commercial hand location.
The test was conducted with 800 persons, 400 of whom where supplied a sample of the commercial lotion (unidentified) and 400 given the above hand lotion and were asked to evaluate the products against their previous experience with hand lotions. Tests were made nationwide but the largest portions were located in dry regions of the country.
A brief summary of all the results showed that, overall, 35;% of the respondents who tested the hand lotion of this. invention rated it better than the hand lotion they normally used; 22% of those who tested the commercial lotion rated it better than the lotion they normally used. On a similar comparative rating basis the respondents evaluated the hand lotion'of this invention and the commercial producton the followingcharacteristics:
Percent ofv Adds rich moisturizing ingredients to the skin. 48 28 Relieves skin dryness and flaking 41 30 Replaces natural skin oils 31 21 Penetrates deeply 44 30 Softens and smoothes the skin 42 30 Feels soft'and creamy when applied- 43 24 Doesnt leave hands greasy or sticky.-- 38 33 NorE.-(l) Hand lotion of this invention; (2) Commercial hand lotions. 1
The acceptability ofthe lotion of this invention on both an aesthetic and performance basis is clearly evident. The 'value of the latex polymer in providing a non-oily residual feel is shown by the fact that the lotion tested contained a larger quantity of oils, etcL'than the commercial lotion.
Another factor ofimportance to cosmetic lotions of the type described and claimed herein is. removability by washing with soap and water. This is in contrast to certain special preparations which are designed to protect the skin against all manner of materials such as greases,solvents of all kinds, detergents and the like. Such preparations are known as barrier creams or lotions and are designed to produce a highly adherent barrier film on the skin.
The following tests show the differences between the lotions of this invention and a barrier film type lotion such as is described in US. 3,100,180 where a special fluorinated elastomer is employed to form the barrier film. The various examples in this patent show that the barrier film is highly resistant to common organo solvents, various oily materials and is resistant to removal by repeated washing with soap and water.
- Example 6 Employing the acrylic latex polymer of the previous examples a lotion was prepared according to Example 1 of US. 3,100,180. The lotion was prepared by adding 2.75 gm. of said latex (about 33% solids) to 30.25 gms. of hot water and warmed to 65 C. Then 5 gms. of USP stearic acid was melted and added with good stirring. The mixture was kept at 50-65 C. and sufiicient K CO was added to adjust the pH to 6.0. Then 12 gms. of hot melted polyethylene glycol 600 monostearate was added with good mixing. In about 10 minutes the emulsion became thick and creamy.
A small amount of the formulation was spread over about a ten square inch area of the forearm and dried for 10-15 minutes. Then half of the treated area was washed with soap and water. Small drops of a 1% solution of Sudan II (a red dyestuff which strongly stains the skin) in a mixture of heptane and xylene were placed on the unwashed and on the washed areas. After about one minute the dyed areas were rubbed briskly with a facial tissue. Almost all the color was removed from the unwashedtreated area whereas the washed-treated area still showed marked'staining indicating the lotion had been removed from the skin by washing with soap and water.
Similar results were found when the acrylic latex was replaced by the saran latex of the polyvinyl acetate latex of Example 3. r
A formulation similar to that of Example 2 was prepared and tested as above with the same results, i.e. the lotion was readily removed by washing with soap and water. In like manner additional formulations were prepared by replacing the acrylic latex with the saran latex or polyvinyl acetate latex, as above. Again the lotions were found to be removable by washing with soap and water.
The solvent solubility of films of the three latexes employed above were also tested. After casting and forming films by drying of each of the latexes employed above, the solubility was tested by placing drops of xylene and methyl ethyl ketone on each of the films. All three films readily dissolvedin methyl ethyl ketone. Xylene dissolved the polyvinyl acetate film, softened the saran film but did not affect the acrylic film. Thus the films of the above latexes are soluble in a common organo solvent.
What is claimed is:
1. A cosmetic lotion having improved holding capacity for anoily effect agent which upon drying is non-tacky and nongreasy to the touch, said lotion consisting essentially of a polymeric dispersion containing.
(a) from about 0.5 to 8 weight percent of a predominantly amorphous water insoluble, organo soluble, film-formingvinyl polymer; I V
(b) from about I to 30 weight percent of an oily effect agent which is a non-solvent and a non-plasticizer for said polymer wherein the weight ratio of said effect agent to said polymer varies from about 2:1 to 20: 1;
(c) from about 2 to 10 weight percent of a compatible, cosmetically suitable cationic, anionic or nonionic emulsifying agent; and I V J (d) water, to make percent. I 1
2. The lotion of claim 1 further containing from abou 0.5 to 4 weight percent of a humectant. I
3. The lotion of claim 1 further containing from about 0.1 to 2 weight percent of a thickening agent.
4. The lotion of claim 1 wherein said eifect agent is an emollient or mixtures thereof.
5. The lotion of claim 1 wherein the effect agent con- 9. The lotion of claim 4 further containing a sun screen centration ranges from about 1 to 20 weight percent. agent.
6. The lotion of claim 1 wherein said vinyl polymer is References Cited a polymer of a vinyl carboxylic acid, an alkyl methacrylate UNITED STATES PATENTS having from 1 to about 4 carbons in the alkyl group and an alkyl acrylate having from 1 to about 12 carbon atoms 5 3100180 8/1963 smlth at 424-78 in the alkyl omups 3,406,238 10/1968 Freyermuth et a1 424-70 7. The lotion of claim 6 wherein said vinyl polymer is 3301830 1/1967 Nelson et a1 424-78 a polymer of methyl methacrylate, methyl acrylate, ethyl 3608070 9/1971 Nouvel 424"78 acrylate and methacrylic acid. 1 SAM ROSEN, Primary Examiner 8. The lotion of claim 1 wherein said vinyl polymer is 0 prepared from a mixture of monomers one of which is a US. Cl. X.R.
vinyl carboxylic monomer. 42459, 60, 81
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15855971A | 1971-06-30 | 1971-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3755560A true US3755560A (en) | 1973-08-28 |
Family
ID=22568687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00158559A Expired - Lifetime US3755560A (en) | 1971-06-30 | 1971-06-30 | Nongreasy cosmetic lotions |
Country Status (1)
Country | Link |
---|---|
US (1) | US3755560A (en) |
Cited By (459)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3928261A (en) * | 1973-05-17 | 1975-12-23 | Minnesota Mining & Mfg | Water removable film-forming compositions for topical application to skin |
FR2333493A1 (en) * | 1975-12-03 | 1977-07-01 | Johnson & Johnson | COAT FORMING COMPOSITION FOR SUNSCREENS AND SIMILAR |
US4128634A (en) * | 1976-03-04 | 1978-12-05 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic emulsions containing copolymers of alkyl(meth)acrylates and mono-(N-hydroxyalkyl) or bis-(N-hydroxyalkyl) (meth)acrylamides |
US4128635A (en) * | 1976-03-04 | 1978-12-05 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic emulsions containing copolymers of alkyl (meth) acrylates and mono- or polyhydroxyalkyl (meth) acrylates |
US4128636A (en) * | 1976-03-26 | 1978-12-05 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic emulsions containing copolymers of 2-hydroxy-3-hydroxyalkyl-aminopropyl(meth)acrylates and alkyl (meth)acrylates |
FR2398496A1 (en) * | 1977-07-29 | 1979-02-23 | Minnesota Mining & Mfg | ANTI-SOLAR COMPOSITIONS, INSOLUBLE IN WATER, CONTAINING AN ACRYLATE POLYMER |
US4294852A (en) * | 1973-11-01 | 1981-10-13 | Johnson & Johnson | Skin treating compositions |
US4421769A (en) * | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
US4524061A (en) * | 1983-04-22 | 1985-06-18 | Gaf Corporation | Polymeric sunscreens |
EP0193387A2 (en) * | 1985-02-28 | 1986-09-03 | The Procter & Gamble Company | Sunscreen compositions and method of protecting skin |
US4731242A (en) * | 1986-03-21 | 1988-03-15 | Victor Palinczar | Waterproof sunscreen compositions |
US4938951A (en) * | 1980-12-30 | 1990-07-03 | Union Carbide Chemicals And Plastics Company Inc. | Potentiation of topical compositions wherein a uniform microdispersion of active agent is formed |
WO1992000723A1 (en) * | 1990-07-05 | 1992-01-23 | Dowbrands Inc. | Skin moisturizing composition and process of using |
EP0496434A2 (en) | 1987-10-22 | 1992-07-29 | The Procter & Gamble Company | Photoprotection compositions comprising chelating agents |
USRE34584E (en) * | 1984-11-09 | 1994-04-12 | The Procter & Gamble Company | Shampoo compositions |
US5399350A (en) * | 1990-04-05 | 1995-03-21 | Nurture, Inc. | Proteinaceous oil spill dispersant |
EP0734718A2 (en) | 1991-08-30 | 1996-10-02 | The Procter & Gamble Company | Use of N-acetyl-L-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
US5589195A (en) * | 1990-04-05 | 1996-12-31 | Nurture, Inc. | Film-forming proteinaceous emulsion |
US5700452A (en) * | 1993-04-16 | 1997-12-23 | The Procter & Gamble Company | Compositions for imparting an artificial tan and protecting the skin from ultra-violet radiation |
US5902591A (en) * | 1997-04-03 | 1999-05-11 | La Prairie Sa | Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid |
US20020034772A1 (en) * | 1999-06-29 | 2002-03-21 | Orlow Seth J. | Methods and compositions that affect melanogenesis |
US6372791B1 (en) | 2000-06-29 | 2002-04-16 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin cell metabolism |
US6432424B1 (en) | 2000-06-29 | 2002-08-13 | Johnson & Johnson Consumer Companies, Inc. | Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid |
US20020143049A1 (en) * | 2000-12-15 | 2002-10-03 | Miller Guy Michael | Compositions and methods for the prevention and treatment of cerebral ischemia |
US6468552B1 (en) | 2000-06-02 | 2002-10-22 | Neutrogena Corporation | Stabilized compositions containing oxygen-labile active agents |
US20020182166A1 (en) * | 2001-03-16 | 2002-12-05 | Martin Katharine M. | Composition containing feverfew extract and use thereof |
US20030035824A1 (en) * | 2001-06-29 | 2003-02-20 | The Procter & Gamble Company | Top-biased beneficial components on substrates |
US20030064049A1 (en) * | 2000-10-27 | 2003-04-03 | Miri Seiberg | Topical anti-cancer compositions and methods of use thereof |
US20030077343A1 (en) * | 2001-03-16 | 2003-04-24 | Martin Katharine M. | Composition containing feverfew extract and use thereof |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
US6576702B2 (en) | 2000-07-20 | 2003-06-10 | Noveon Ip Holdings Corp. | Plasticized waterborne polyurethane dispersions and manufacturing process |
US20030114520A1 (en) * | 2001-08-09 | 2003-06-19 | Croda, Inc. | Anti-irritants |
US20030118605A1 (en) * | 2001-03-23 | 2003-06-26 | Estell David A. | Proteins producing an altered immunogenic response and methods of making and using the same |
WO2003060046A1 (en) | 2002-01-09 | 2003-07-24 | Croda, Inc. | Mixtures of quaternary compounds |
US20030195293A1 (en) * | 2002-04-05 | 2003-10-16 | Lubnin Alexander V. | Breathable polyurethanes, blends, and articles |
US20030199593A1 (en) * | 2002-01-31 | 2003-10-23 | Pereira Abel G. | Additives and products including oligoesters |
US6649176B1 (en) | 2000-06-29 | 2003-11-18 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing mineral water |
US20030232743A1 (en) * | 2002-06-18 | 2003-12-18 | Miri Seiberg | Compositions and methods for darkening the skin |
US20040105905A1 (en) * | 1999-06-03 | 2004-06-03 | Theresa Callaghan | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US20040131648A1 (en) * | 2002-10-24 | 2004-07-08 | The Procter & Gamble Company | Nuclear hormone receptor compounds, products and methods employing same |
US20040138088A1 (en) * | 2002-01-09 | 2004-07-15 | Croda, Inc. | Immidazoline quats |
US6797697B2 (en) | 2001-05-21 | 2004-09-28 | Johnson & Johnson Consumer Companies, Inc. | Composition containing a peptide and a pigment and the use thereof in darkening the skin |
US20040204333A1 (en) * | 2003-03-10 | 2004-10-14 | The Procter And Gamble Company | Disposable nonwoven cleansing mitt |
US20040214937A1 (en) * | 2002-04-05 | 2004-10-28 | Miller Timothy D. | Hybrid polymer composition, and article therefrom |
US20040220062A1 (en) * | 2002-01-09 | 2004-11-04 | Croda, Inc. | Imidazoline quats |
US20050008602A1 (en) * | 2000-06-05 | 2005-01-13 | Sumitomo Electric Industries, Ltd. | Oligopeptides for promoting hair growth |
US20050054843A1 (en) * | 2001-12-31 | 2005-03-10 | Estell David A | Proteases producing an altered immunological response and methods of making and using the same |
US20050074474A1 (en) * | 2003-10-03 | 2005-04-07 | The Procter & Gamble Company | Topical composition |
US20050129743A1 (en) * | 2003-12-16 | 2005-06-16 | The Procter & Gamble Company | Child's cleaning implement comprising a biological extract |
US20050125877A1 (en) * | 2003-12-16 | 2005-06-16 | The Procter & Gamble Company | Disposable nonwoven mitt adapted to fit on a child's hand |
US20050148059A1 (en) * | 2001-12-31 | 2005-07-07 | Estell David A. | Protease producing an altered immunogenic response and methods of making and using the same |
US20050150784A1 (en) * | 2003-03-10 | 2005-07-14 | The Procter & Gamble Company | Child's cleansing system |
US20050152858A1 (en) * | 2003-07-11 | 2005-07-14 | Isp Investments Inc. | Solubilizing agents for active or functional organic compounds |
US20050175719A1 (en) * | 2004-02-05 | 2005-08-11 | Ying Sun | Procyanidins for treatment and prevention of enzymatic irritation to the skin |
US20050203026A1 (en) * | 2003-11-06 | 2005-09-15 | Day Anthony G. | Peptides and supported peptides for treating skin diseases |
US20050209428A1 (en) * | 2002-06-19 | 2005-09-22 | Krishnan Tamareselvy | Breathable polyurethanes, blends, and articles |
US20050239043A1 (en) * | 2002-02-26 | 2005-10-27 | Harding Fiona A | Subtilisin carlsberg proteins with reduced immunogenicity |
US20050288198A1 (en) * | 2003-04-17 | 2005-12-29 | Croda, Inc. | Personal care product containing diester quat |
US6987195B2 (en) | 2001-10-17 | 2006-01-17 | Croda, Inc. | Esters of aromatic alkoxylated alcohols and fatty carboxylic acids |
US20060110439A1 (en) * | 2004-10-22 | 2006-05-25 | Dynamis Therapeutics, Inc. | Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds |
US20060127431A1 (en) * | 2003-03-04 | 2006-06-15 | The Procter & Gamble Company | Regulation of mammalian hair growth |
US20060128601A1 (en) * | 2002-01-09 | 2006-06-15 | Croda, Inc. | Imidazoline quats |
US20060153926A1 (en) * | 2005-01-10 | 2006-07-13 | Bascom Charles C | Compositions, products and methods for controlling weight in a mammal |
US7081442B2 (en) | 2001-05-21 | 2006-07-25 | Johnson & Johnson Consumer Companies, Inc. | Composition containing a peptide and a pigment and the use thereof in darkening the skin |
WO2006081071A1 (en) | 2005-01-26 | 2006-08-03 | The Procter & Gamble Company | Low ph skin care compositions containing dehydroacetic acid |
US20060251598A1 (en) * | 2004-12-02 | 2006-11-09 | Ramirez Jose E | System for improved percutaneous absorption of skin benefiting agents |
US20060263400A1 (en) * | 2005-05-17 | 2006-11-23 | Bissett Donald L | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
US20060263309A1 (en) * | 2005-05-17 | 2006-11-23 | Bissett Donald L | Regulation of mammalian keratinous tissue using personal care compositions comprising tetrahydrocurcumin |
US20060263321A1 (en) * | 2005-05-17 | 2006-11-23 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using personal care compositions comprising diethylhexyl syringylidene malonate |
US20060286046A1 (en) * | 2005-01-05 | 2006-12-21 | Haber C Andrew | Skin care compositions |
US20070004640A1 (en) * | 2005-06-30 | 2007-01-04 | Lin Connie B | Treatment of dry eye |
US20070020220A1 (en) * | 2005-04-27 | 2007-01-25 | Procter & Gamble | Personal care compositions |
US20070020221A1 (en) * | 2005-05-17 | 2007-01-25 | Bissett Donald L | Regulation of mammalian keratinous tissue using personal care compositions comprising cetyl pyridinium chloride |
US20070025974A1 (en) * | 2003-02-26 | 2007-02-01 | Hardings Fiona A | Amylases producing an altered immunogenic response and methods of making and using the same |
US20070041917A1 (en) * | 2005-08-17 | 2007-02-22 | Isaac Thomas | Sunless tanning compositions |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
WO2007038454A1 (en) | 2005-09-26 | 2007-04-05 | L'oreal | Composition and process for treating keratinous substrates with at least two immiscible cosmetic compositions |
WO2007041627A1 (en) | 2005-10-03 | 2007-04-12 | Pinsky Mark A | Compositions and methods for improved skin care |
US20070085063A1 (en) * | 2005-04-26 | 2007-04-19 | The Board Of Regents Of The University Of Texas System | Tunable sunblock agents |
US7214655B2 (en) | 2001-05-21 | 2007-05-08 | Johnson & Johnson Consumer Companies, Inc. | Peptides and the use thereof in darkening the skin |
US7217424B2 (en) | 2001-10-17 | 2007-05-15 | Croda, Inc. | Compositions containing esters of aromatic alkoxylated alcohols and fatty carboxylic acids |
US20070128137A1 (en) * | 2005-12-02 | 2007-06-07 | Naohisa Yoshimi | Water in oil emulsion compositions containing siloxane elastomers |
US7235230B2 (en) | 2001-10-24 | 2007-06-26 | Clariant Finance (Bvi) Limited | Leave-on compositions for personal care |
US20070154502A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring microdermabrasion |
US20070154442A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring hair removal procedure |
US20070154416A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing hyaluronic acid treatment |
US20070154418A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring radiofrequency procedure |
US20070154503A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring skin cancer treatment |
US20070154421A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing collagen treatment |
US20070154419A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring chemical peel procedure |
US20070154420A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin subject to or affected by aesthetic surgical procedures |
US20070155842A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring Intense Pulse Light (IPL) procedure |
US20070154422A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing ablative treatment |
US20070154501A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin having incision from surgical procedures |
US20070154417A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring non-ablative procedure |
US20070154493A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing botulinum toxin type a treatment |
US7241731B2 (en) | 2000-06-05 | 2007-07-10 | Sumitomo Electric Industries, Ltd. | Oligopeptides for promoting hair growth |
US20070166275A1 (en) * | 2006-01-19 | 2007-07-19 | Mary Kay Inc. | Compositions comprising kakadu plum extract or acai berry extract |
US20070183993A1 (en) * | 2005-12-13 | 2007-08-09 | Binder Robert L | Personal care compositions |
US20070191368A1 (en) * | 2004-03-23 | 2007-08-16 | Bissett Donald L | Inhibition of tissue damage to skin from radiation treatment therapy |
US20070196292A1 (en) * | 2005-11-30 | 2007-08-23 | Robinson Larry R | Personal care composition comprising dehydroacetate salts |
US20070196296A1 (en) * | 2005-12-13 | 2007-08-23 | Rosemarie Osborne | Personal care compositions |
US20070202061A1 (en) * | 2005-10-31 | 2007-08-30 | Naturalnano, Inc. | Cosmetic skincare applications employing mineral-derived tubules for controlled release |
US20070203240A1 (en) * | 2006-02-27 | 2007-08-30 | The Procter & Gamble Company | Personal care compositions and methods for regulating mammalian hair growth |
US20070224208A1 (en) * | 2006-03-27 | 2007-09-27 | Globeimmune, Inc. | Ras mutation and compositions and methods related thereto |
US20070249714A1 (en) * | 2005-12-30 | 2007-10-25 | Judy Hattendorf | Method of treating skin requiring fractional resurfacing treatment |
US20070264210A1 (en) * | 2006-05-15 | 2007-11-15 | The Procter & Gamble Company | Method of enhancing penetration of water-soluble actives |
US20070269534A1 (en) * | 2006-02-02 | 2007-11-22 | Ramirez Jose E | Methods of treating skin to enhance therapeutic treatment thereof |
US20070269392A1 (en) * | 2006-05-17 | 2007-11-22 | Sunkara Hari B | Personal care compositions |
US20070274932A1 (en) * | 2006-05-15 | 2007-11-29 | The Procter & Gamble Company | Water in oil emulsion compositions containing sunscreen actives and siloxane elastomers |
US20080031833A1 (en) * | 2006-03-13 | 2008-02-07 | Oblong John E | Combined energy and topical composition application for regulating the condition of mammalian skin |
US20080038360A1 (en) * | 2006-08-11 | 2008-02-14 | Joseph Michael Zukowski | Personal care composition |
US20080050334A1 (en) * | 2006-08-24 | 2008-02-28 | L'oreal | Cosmetic composition comprising an extract of emblica officinalis, a hydroxy acid, and an N-substituted aminosulfonic acid, and methods of using same |
US20080051325A1 (en) * | 2003-05-16 | 2008-02-28 | Yohei Hirai | Oligopeptide |
US20080075678A1 (en) * | 2002-04-26 | 2008-03-27 | L'oreal | Cosmetic composition comprising an extract of emblica officinalis and methods of using same |
US7350256B2 (en) | 2003-12-16 | 2008-04-01 | The Procter & Gamble Company | Child's aromatherapy cleaning implement |
US20080095732A1 (en) * | 2005-04-27 | 2008-04-24 | Rosemarie Osborne | Personal care compositions |
WO2008046258A1 (en) | 2006-10-17 | 2008-04-24 | Hailong Wang | Cosmetic composition and preparation method and use thereof |
US20080113027A1 (en) * | 2006-11-09 | 2008-05-15 | Alcon Manufacturing Ltd. | Water insoluble polymer matrix for drug delivery |
US20080114076A1 (en) * | 2006-11-09 | 2008-05-15 | Alcon Manufacturing Ltd. | Punctal plug comprising a water-insoluble polymeric matrix |
US20080139453A1 (en) * | 2006-12-12 | 2008-06-12 | The Procter & Gamble Company | Multiple emulsion compositions |
US7401376B2 (en) | 2003-03-10 | 2008-07-22 | The Procter & Gamble Company | Disposable nonwoven cleansing mitt |
US20080175875A1 (en) * | 2006-09-25 | 2008-07-24 | Hari Babu Sunkara | Cosmetic compositions |
US20080206373A1 (en) * | 2007-02-28 | 2008-08-28 | Cheri Lynn Millikin | Personal Care Composition Comprising Botanical Extract |
US20080226706A1 (en) * | 2003-03-12 | 2008-09-18 | Manoj Kumar | Use of Repeat Sequence Protein Polymers in Personal Care Compositions |
US20090011035A1 (en) * | 2007-07-03 | 2009-01-08 | Joseph Michael Zukowski | Personal care composition |
US20090017147A1 (en) * | 2005-01-14 | 2009-01-15 | Sederma | Cosmetic or Dermopharmaceutical Composition Comprising an Euglena Extract |
US20090017080A1 (en) * | 2007-03-15 | 2009-01-15 | Paul Robert Tanner | Personal care kit having skin care compositions with a readily perceptible difference |
US7490382B2 (en) | 2003-12-16 | 2009-02-17 | The Procter & Gamble Company | Child's sized disposable article |
US20090047230A1 (en) * | 2007-07-27 | 2009-02-19 | Croda, Inc. | Phosphorous-containing surfactants as polymeric cationic compound deposition aids |
WO2009022338A2 (en) | 2007-08-16 | 2009-02-19 | Saher Hamed | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
US20090060933A1 (en) * | 2004-06-14 | 2009-03-05 | Estell David A | Proteases producing an altered immunogenic response and methods of making and using the same |
US20090092569A1 (en) * | 2007-10-09 | 2009-04-09 | Hari Babu Sunkara | Deodorant compositions |
US20090098173A1 (en) * | 2007-10-11 | 2009-04-16 | Robinson Ronni L | Topical pain relief product |
US20090099093A1 (en) * | 2007-06-27 | 2009-04-16 | The Board Of Trustees Of The Leland Stanford Junior University | Peptide Tyrosinase Inhibitors and Uses Thereof |
US20090099091A1 (en) * | 2007-06-27 | 2009-04-16 | The Board Of Trustees Of The Leland Stanford Junior University | Oligopeptide Tyrosinase Inhibitors and Uses Thereof |
US20090186826A1 (en) * | 2003-05-12 | 2009-07-23 | Sederma | Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides |
US20090196836A1 (en) * | 2007-10-25 | 2009-08-06 | Paul Robert Tanner | Multi-Functional, Multi-Phase Skin Care Product |
US20090214607A1 (en) * | 2005-05-13 | 2009-08-27 | Sederma | Topical use of teprenone |
US20090232856A1 (en) * | 2008-03-11 | 2009-09-17 | Mary Kay Inc. | Stable three-phased emulsions |
EP2105123A2 (en) | 2001-03-22 | 2009-09-30 | The Procter & Gamble Company | Skin care compositions containing a sugar amine and a vitamin B3 compound |
US20090253666A1 (en) * | 2006-08-03 | 2009-10-08 | Sederma | Composition comprising sarsasapogenin |
US20090264839A1 (en) * | 2008-04-21 | 2009-10-22 | Kriksunov Leo B | Dual spray can topical delivery device |
US20090269395A1 (en) * | 2005-09-06 | 2009-10-29 | Sederma | Use of protoberberines as an active substance regulating the pilosebaceous unit |
US20090291148A1 (en) * | 2007-12-21 | 2009-11-26 | Laurie Ellen Breyfogle | Depilatory Kit Resulting in Reduced Odor and Irritation |
EP2127698A1 (en) | 2001-02-28 | 2009-12-02 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing legume products |
US20090298868A1 (en) * | 2007-11-14 | 2009-12-03 | Orlow Seth J | Quinoline compounds as melanogenesis modifiers and uses thereof |
US20090304615A1 (en) * | 2007-11-14 | 2009-12-10 | Orlow Seth J | Tricyclic compounds as melanogenesis modifiers and uses thereof |
US20090324522A1 (en) * | 2008-06-18 | 2009-12-31 | Western Holdings, Llc | Skin protectant compositions |
US20100040568A1 (en) * | 2008-04-30 | 2010-02-18 | Skinmedica, Inc. | Steroidal compounds as melanogenesis modifiers and uses thereof |
US20100092409A1 (en) * | 2008-10-15 | 2010-04-15 | Amin Neelam S | Personal care compositions comprising modified variant bowman birk protease inhibitors |
US20100093028A1 (en) * | 2008-10-15 | 2010-04-15 | Amin Neelam S | Modified variant bowman birk protease inhibitors |
WO2010045163A2 (en) | 2008-10-14 | 2010-04-22 | The Procter & Gamble Company | Resilient personal care composition comprising polyalkyl ether containing siloxane elastomers |
US20100129301A1 (en) * | 2008-11-24 | 2010-05-27 | Shuhei Tanaka | Cosmetic compositions |
US20100143515A1 (en) * | 2007-04-19 | 2010-06-10 | Mary Kay Inc. | Magnolia extract containing compositions |
WO2010067327A1 (en) | 2008-12-11 | 2010-06-17 | Sederma | Cosmetic composition containing acetylated oligoglucuronans |
US20100173003A1 (en) * | 2007-05-24 | 2010-07-08 | Amcol International | Composition and method for encapsulating benefit agents |
WO2010082175A2 (en) | 2009-01-16 | 2010-07-22 | Sederma | New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
WO2010082177A2 (en) | 2009-01-16 | 2010-07-22 | Sederma | New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
WO2010082176A2 (en) | 2009-01-16 | 2010-07-22 | Sederma | Cosmetic composition containing kxk type peptides and uses |
US20100189669A1 (en) * | 2009-01-29 | 2010-07-29 | Tomohiro Hakozaki | Regulation of Mammalian Keratinous Tissue Using Skin and/or Hair Care Actives |
WO2010085532A2 (en) | 2009-01-22 | 2010-07-29 | The Procter & Gamble Company | Skin-care composition comprising dill extract |
EP2226063A2 (en) | 2009-03-04 | 2010-09-08 | Takasago International Corporation | High intensity fragrances |
US20100227011A1 (en) * | 2009-02-24 | 2010-09-09 | Dennis Eugene Kuhlman | Regulation of mammalian keratinous tissue using personal-care compositions comprising a turmerone compound |
US20100229966A1 (en) * | 2009-03-12 | 2010-09-16 | Ford Global Technologies, Llc | Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks |
WO2010108088A2 (en) | 2009-03-20 | 2010-09-23 | The Procter & Gamble Company | Personal-care composition comprising a hydrocarbon wax and a polar oil |
WO2010108085A2 (en) | 2009-03-20 | 2010-09-23 | The Procter & Gamble Company | Personal-care composition comprising oil-soluble solid sunscreens |
WO2010111267A2 (en) | 2009-03-23 | 2010-09-30 | The Procter & Gamble Company | Personal-care composition comprising a cationic active |
WO2010111266A2 (en) | 2009-03-23 | 2010-09-30 | The Procter & Gamble Company | Personal-care composition comprising a cationic active |
US20100247563A1 (en) * | 2009-03-30 | 2010-09-30 | Mary Kay Inc. | Topical skin care formulations |
WO2010113146A1 (en) | 2009-04-01 | 2010-10-07 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | A method of regulating proliferation and differentiation of keratinocyes |
US20100278765A1 (en) * | 2003-03-04 | 2010-11-04 | Donald Lynn Bissett | Regulation of mammalian keratinous tissue using hexamidine compositions |
WO2010136965A2 (en) | 2009-05-26 | 2010-12-02 | Sederma | Cosmetic use of tyr-arg dipeptide to combat cutaneous sa |
WO2010141683A2 (en) | 2009-06-04 | 2010-12-09 | The Procter & Gamble Company | Multiple product system for hair |
US20110033512A1 (en) * | 2009-08-10 | 2011-02-10 | Laurie Ellen Breyfogle | Personal care composition with improved spreadability |
US20110033507A1 (en) * | 2006-02-16 | 2011-02-10 | Sederma | Polypeptides KXK and Their Use |
WO2011019876A2 (en) | 2009-08-14 | 2011-02-17 | The Procter & Gamble Company | Personal cleansing compositions comprising a bacterial cellulose network and cationic polymer |
US20110045036A1 (en) * | 2006-05-05 | 2011-02-24 | Sederma | Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle |
WO2011026039A1 (en) | 2009-08-28 | 2011-03-03 | Mary Kay Inc. | Skin care formulations |
WO2011028601A2 (en) | 2009-08-26 | 2011-03-10 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
US20110086807A1 (en) * | 2008-05-01 | 2011-04-14 | Chia Soo | Fibromodulin formulation for reducing corneal scarring |
EP2338896A2 (en) | 2002-12-12 | 2011-06-29 | R.B.T. (Rakuto Bio Technologies) Ltd. | Use of lignin peroxidase in skin and hair lightening |
WO2011085053A2 (en) | 2010-01-07 | 2011-07-14 | The Gillette Company | Personal care compositions comprising a multi-active system for down regulating cytokines irritation |
WO2011088178A2 (en) | 2010-01-15 | 2011-07-21 | The Gillette Company | Personal care composition comprising a hydrophobically modified cationic polysaccharide |
WO2011088073A2 (en) | 2010-01-15 | 2011-07-21 | The Gillette Company | Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US20110190229A1 (en) * | 2010-01-28 | 2011-08-04 | Orlow Seth J | Compounds, compositions and methods for preventing skin darkening |
EP2357025A2 (en) | 2009-12-17 | 2011-08-17 | Johnson & Johnson Consumer Companies, Inc. | Mild leave-on skin care compositions |
WO2011103146A2 (en) | 2010-02-16 | 2011-08-25 | The Procter & Gamble Company | A post foaming gel composition comprising an anti-irritation agent |
WO2011103449A2 (en) | 2010-02-19 | 2011-08-25 | Mary Kay Inc. | Topical skin care formulation |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
WO2011133538A1 (en) | 2010-04-19 | 2011-10-27 | The Procter & Gamble Company | Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto |
WO2011133539A2 (en) | 2010-04-19 | 2011-10-27 | The Procter & Gamble Company | Combined energy and topical composition application for regulating the condition of mammalian skin |
WO2011140330A2 (en) | 2010-05-06 | 2011-11-10 | The Gillette Company | An aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet |
WO2011140312A2 (en) | 2010-05-06 | 2011-11-10 | The Gillette Company | Method of making an aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet |
WO2011146491A2 (en) | 2010-05-17 | 2011-11-24 | Mary Kay Inc. | Topical skin formulation |
WO2011153296A1 (en) | 2010-06-02 | 2011-12-08 | Lubrizol Advanced Materials, Inc. | Ink/dye receptive films, papers, and fabrics |
EP2397127A1 (en) | 1999-06-25 | 2011-12-21 | Enerdermics, Inc. | Use of creatine or creatine compounds for skin preservation |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
WO2012009298A2 (en) | 2010-07-16 | 2012-01-19 | The Gillette Company | Personal care compositions comprising a multi-active system for down regulating cytokines irritation |
WO2012011905A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Methods for improving the appearance of hyperpigmented spot(s) with multiple actives |
WO2012012497A2 (en) | 2010-07-23 | 2012-01-26 | The Procter & Gamble Company | Cosmetic composition |
WO2012011904A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Methods for improving the appearance of hyperpigmented spot(s) using an extract of laminaria saccharina |
WO2012011908A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Compositions and methods for inhibiting par2 activation of keratinocytes |
WO2012011907A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Laminaria saccharina extract and vitamin b3 as whitening agents |
WO2012011906A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Methods for inhibiting tyrosinase using an extract of laminaria saccharina |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
WO2012033634A2 (en) | 2010-09-09 | 2012-03-15 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
WO2012033646A2 (en) | 2010-09-10 | 2012-03-15 | Mary Kay Inc. | Topical skin care formulations comprising jaboticaba and cashew fruit pulps and extracts thereof |
WO2012033989A2 (en) | 2010-09-10 | 2012-03-15 | The Procter & Gamble Company | Cosmetic compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation |
WO2012034060A2 (en) | 2010-09-10 | 2012-03-15 | Akzo Nobel Chemicals International B.V. | Bioactive compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation |
WO2012061039A2 (en) | 2010-10-25 | 2012-05-10 | Vanderbilt University | Compositions for inhibition of insect host sensing |
WO2012068361A2 (en) | 2010-11-19 | 2012-05-24 | The Procter & Gamble Company | Compositions and methods for improving the appearance of facial texture |
WO2012068356A2 (en) | 2010-11-19 | 2012-05-24 | The Procter & Gamble Company | Compositions and methods for improving the appearance of facial pores |
WO2012068357A2 (en) | 2010-11-19 | 2012-05-24 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting or reducing trypsin activity |
WO2012092597A2 (en) | 2010-12-30 | 2012-07-05 | Mary Kay Inc. | Multi-purpose cosmetic compositions |
WO2012090205A2 (en) | 2010-12-28 | 2012-07-05 | Kamedis Ltd. | Plant extracts for the treatment and prevention of infections |
WO2012115947A2 (en) | 2011-02-22 | 2012-08-30 | Akzo Nobel Chemicals International B.V. | Composition comprising banyan tree, lotus, and clover serum fractions (aging) |
WO2012116055A2 (en) | 2011-02-22 | 2012-08-30 | The Procter & Gamble Company | Methods for improving the appearance of hyperpigmented skin using a synergistic composition comprising banyan tree, lotus, and clover serum fractions |
WO2012115949A2 (en) | 2011-02-22 | 2012-08-30 | Akzo Nobel Chemicals International B.V. | Composition comprising banyan tree, lotus, and clover serum fractions (hyperpigmentation) |
WO2012116081A2 (en) | 2011-02-22 | 2012-08-30 | The Procter & Gamble Company | Methods for identifying cosmetic agents for skin care compositions |
WO2012116077A2 (en) | 2011-02-22 | 2012-08-30 | The Procter & Gamble Company | Methods for improving the appearance of aging skin using a composition comprising banyan tree, lotus, and clover serum fractions |
EP2497481A1 (en) | 2011-03-08 | 2012-09-12 | ELC Management LLC | Use of extracts for activating caspase-14 expression in human skin |
EP2500423A2 (en) | 2003-02-26 | 2012-09-19 | Genencor International, Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
WO2012153336A2 (en) | 2011-05-12 | 2012-11-15 | Rakuto Bio Technologies Ltd. | Methods and device for lightening skin complexion |
WO2012174091A2 (en) | 2011-06-13 | 2012-12-20 | The Procter & Gamble Company | PERSONAL CARE COMPOSITIONS COMPRISING A pH TUNEABLE GELLANT AND METHODS OF USING |
WO2012174096A2 (en) | 2011-06-13 | 2012-12-20 | The Procter & Gamble Company | Personal care compositions comprising a di-amido gellant and methods of using |
EP2537513A2 (en) | 2011-03-11 | 2012-12-26 | ELC Management LLC | Use of anogeissus extract for fibrillin production in skin |
WO2012177757A2 (en) | 2011-06-20 | 2012-12-27 | The Procter & Gamble Company | Personal care compositions comprising shaped abrasive particles |
EP2540305A1 (en) | 2011-06-28 | 2013-01-02 | Johnson & Johnson Consumer Companies Inc. | Divalent cation/talc containing compositions and methods for treating and/or preventing enzymatic irritation |
EP2540291A1 (en) | 2011-06-28 | 2013-01-02 | Johnson & Johnson Consumer Companies Inc. | Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation |
EP2540303A1 (en) | 2011-06-28 | 2013-01-02 | Johnson & Johnson Consumer Companies Inc. | Divalent cation containing compositions and methods for treating and/or preventing enzymatic irritation |
WO2013006743A2 (en) | 2011-07-07 | 2013-01-10 | The Procter & Gamble Company | Personal care compositions with improved solubility of a solid cosmetic active |
WO2013006760A2 (en) | 2011-07-07 | 2013-01-10 | The Procter & Gamble Company | Personal care compositions with improved solubility of a solid uv active |
EP2559421A1 (en) | 2011-08-17 | 2013-02-20 | The Procter & Gamble Company | Method and kit for depilation |
WO2013025893A1 (en) | 2011-08-16 | 2013-02-21 | The Gillette Company | Personal care compositions comprising an anti-irritation agent |
WO2013025771A1 (en) | 2011-08-15 | 2013-02-21 | The Procter & Gamble Company | Cosmetic applicators |
WO2013025891A1 (en) | 2011-08-16 | 2013-02-21 | The Gillette Company | An aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet and an anti-irritation agent |
WO2013052647A2 (en) | 2011-10-04 | 2013-04-11 | Quretino Therapeutics, Inc. | Formulations and uses of retinoic acid receptor selective agonists |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
WO2013086518A1 (en) | 2011-12-09 | 2013-06-13 | Mary Kay Inc. | Skin care formulation |
WO2013092698A2 (en) | 2011-12-22 | 2013-06-27 | Akzo Nobel Chemicals International B.V. | Bioactive compositions having hair anti aging activity |
WO2013092699A2 (en) | 2011-12-22 | 2013-06-27 | Akzo Nobel Chemicals International B.V. | Bioactive compositions having skin anti-aging activity |
DE202011110324U1 (en) | 2010-12-13 | 2013-07-10 | Mary Kay Inc. | Lip gloss |
US8486458B2 (en) | 2009-11-04 | 2013-07-16 | E I Du Pont De Nemours And Company | Methods and compositions for extracting flavor and fragrance compounds and solubilizing essential oils |
WO2013109850A2 (en) | 2012-01-19 | 2013-07-25 | The Procter & Gamble Company | Methods for smoothing wrinkles and skin texture imperfections |
EP2620211A2 (en) | 2012-01-24 | 2013-07-31 | Takasago International Corporation | New microcapsules |
WO2013122931A2 (en) | 2012-02-14 | 2013-08-22 | The Procter & Gamble Company | Topical use of a skin-commensal prebiotic agent and compositions containing the same |
WO2013130948A2 (en) | 2012-03-01 | 2013-09-06 | The Procter & Gamble Company | Sunscreen composition comprising uv composite |
WO2013142471A2 (en) | 2012-03-19 | 2013-09-26 | The Procter & Gamble Company | Cross linked silicone copolmyer networks in a thickened aqueous phase |
WO2013142472A2 (en) | 2012-03-19 | 2013-09-26 | The Procter & Gamble Company | Superabsorbent polymers and silicone elastomer for use in skin care compositions |
WO2013148807A1 (en) | 2012-03-30 | 2013-10-03 | The Procter & Gamble Company | Method of formulating a skin-lightening composition |
WO2013158596A2 (en) | 2012-04-20 | 2013-10-24 | The Procter & Gamble Company | Compositions and methods for improving the appearance of facial pores |
WO2013158964A2 (en) | 2012-04-20 | 2013-10-24 | The Gillette Company | Personal care composition comprising metathesized unsaturated polyol esters |
WO2013184908A2 (en) | 2012-06-06 | 2013-12-12 | The Procter & Gamble Company | Systems and methods for identifying cosmetic agents for hair/scalp care compositions |
WO2013192076A1 (en) | 2012-06-18 | 2013-12-27 | The Procter & Gamble Company | Methods and models for assessing anti-aging benefits of agents |
WO2013192073A2 (en) | 2012-06-18 | 2013-12-27 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
DE202012012769U1 (en) | 2011-04-06 | 2014-01-29 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
DE202012012784U1 (en) | 2011-04-21 | 2014-01-30 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
DE202012012873U1 (en) | 2011-03-28 | 2014-02-03 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
DE202012012801U1 (en) | 2011-05-10 | 2014-02-17 | Mary Kay Inc. | cosmetic compositions |
WO2014028734A1 (en) | 2012-08-15 | 2014-02-20 | The Procter & Gamble Company | Human ex vivo skin model and use in methods of identifying modulators of skin inflammation |
DE202012012834U1 (en) | 2011-06-08 | 2014-03-31 | Mary Kay Inc. | Sunscreen formulations |
WO2014052179A2 (en) | 2012-09-28 | 2014-04-03 | Johnson & Johnson Consumer Companies, Inc. | Rinse-off skin care compositions containing alkyl amidopropyl betaine surfactants |
WO2014065934A1 (en) | 2012-10-25 | 2014-05-01 | Raytheon Company | Multi-bandpass, dual-polarization radome with embedded gridded structures |
WO2014066827A2 (en) | 2012-10-26 | 2014-05-01 | Mary Kay Inc. | Kit for personalizing the color of a topical skin composition |
WO2014070834A1 (en) | 2012-10-30 | 2014-05-08 | The Procter & Gamble Company | Personal care compositions comprising self-assembling peptides |
WO2014074581A1 (en) | 2012-11-09 | 2014-05-15 | Johnson & Johnson Consumer Companies, Inc. | Rinse-off skin care compositions containing cellulosic materials |
WO2014074578A1 (en) | 2012-11-09 | 2014-05-15 | Johnson & Johnson Consumer Companies, Inc. | Leave-on compositions containing cellulose materials |
WO2014100067A1 (en) | 2012-12-19 | 2014-06-26 | The Procter & Gamble Company | Compositions and/or articles with improved solubility of a solid active |
US8772252B2 (en) | 2011-01-27 | 2014-07-08 | New York University | Coumarin compounds as melanogenesis modifiers and uses thereof |
US8784907B2 (en) | 2011-12-22 | 2014-07-22 | The Procter & Gamble Company | Compositions and methods for improving the appearance of aging hair |
US8790720B2 (en) | 2011-12-22 | 2014-07-29 | The Procter & Gamble Company | Compositions and methods for treating skin |
US8802722B2 (en) | 2011-01-27 | 2014-08-12 | New York University | Benzopyran compounds as melanogenesis modifiers and uses thereof |
WO2014124197A1 (en) | 2013-02-08 | 2014-08-14 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
DE202012013018U1 (en) | 2011-12-19 | 2014-08-20 | Mary Kay Inc. | Combination of plant extracts to improve the skin tone |
WO2014130432A1 (en) | 2013-02-19 | 2014-08-28 | Johnson & Johnson Consumer Companies, Inc. | Methods and compositions for improving appearance and formation of scar tissue |
WO2014130434A1 (en) | 2013-02-19 | 2014-08-28 | Johnson & Johnson Consumer Companies, Inc. | Methods and compositions for improving appearance and formation of scar tissue |
WO2014143667A1 (en) | 2013-03-15 | 2014-09-18 | Croda, Inc. | Alkoxylated fatty alcohol alkyl ethers and products containing same |
WO2014149867A1 (en) | 2013-03-15 | 2014-09-25 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
WO2014150545A1 (en) | 2013-03-15 | 2014-09-25 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
WO2014159518A1 (en) | 2013-03-14 | 2014-10-02 | The Procter & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
WO2014159238A1 (en) | 2013-03-14 | 2014-10-02 | Mary Kay Inc. | Cosmetic compositions |
WO2014182993A2 (en) | 2013-05-10 | 2014-11-13 | The Procter & Gamble Company | Modular emulsion-based product differentiation |
WO2014182996A2 (en) | 2013-05-10 | 2014-11-13 | The Procter & Gamble Company | Modular emulsion-based product differentiation |
WO2014182995A2 (en) | 2013-05-10 | 2014-11-13 | The Procter & Gamble Company | Modular emulsion-based product differentiation |
WO2014191995A2 (en) | 2013-05-27 | 2014-12-04 | Rakuto Bio Technologies Ltd. | Enzymatic system-containing cosmetic compositions |
WO2015009689A2 (en) | 2013-07-15 | 2015-01-22 | The Procter & Gamble Company | Applicator for applying compositions that smooth wrinkles and skin texture imperfections |
WO2015009694A1 (en) | 2013-07-15 | 2015-01-22 | The Procter & Gamble Company | Applied films for smoothing wrinkles and skin texture imperfections |
WO2015009824A1 (en) | 2013-07-16 | 2015-01-22 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
WO2015012978A1 (en) | 2013-07-22 | 2015-01-29 | The Procter & Gamble Company | Method of protecting skin from an environmental stressor |
EP2832440A1 (en) | 2013-07-29 | 2015-02-04 | Takasago International Corporation | Microcapsules |
EP2832441A1 (en) | 2013-07-29 | 2015-02-04 | Takasago International Corporation | Microcapsules |
EP2832442A1 (en) | 2013-07-29 | 2015-02-04 | Takasago International Corporation | Microcapsules |
US8968712B2 (en) | 2010-11-18 | 2015-03-03 | The Procter & Gamble Company | Cosmetic compositions |
WO2015033344A1 (en) | 2013-09-05 | 2015-03-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs) |
US8999356B1 (en) | 2004-12-03 | 2015-04-07 | Omp, Inc. | Drug delivery system |
US9005674B1 (en) | 2013-07-01 | 2015-04-14 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
WO2015052426A1 (en) | 2013-10-07 | 2015-04-16 | S.P.C.M. Sa | Use in cosmetics of polymers obtained by low-concentration, inverse emulsion polymerisation with a low level of neutralised monomers |
WO2015061512A1 (en) | 2013-10-24 | 2015-04-30 | The Procter & Gamble Company | Skin lightening cosmetic compositions and methods |
WO2015063613A2 (en) | 2013-11-01 | 2015-05-07 | Spherium Biomed S.L. | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents |
US9050477B2 (en) | 2009-04-17 | 2015-06-09 | Sederma | Cosmetic compositions comprising oridonin and new cosmetic uses |
WO2015085421A1 (en) | 2013-12-10 | 2015-06-18 | Sussex Research Laboratories Inc. | Glycopeptide compositions and uses thereof |
WO2015100118A1 (en) | 2013-12-24 | 2015-07-02 | The Procter & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
DE202015001779U1 (en) | 2014-03-10 | 2015-07-09 | Mary Kay, Inc. | Topical skin composition |
US9084734B2 (en) | 2005-05-05 | 2015-07-21 | Danisco Us Inc. | Peptide personal care compositions and methods for their use |
WO2015108949A1 (en) | 2014-01-14 | 2015-07-23 | The Procter & Gamble Company | A multi-step product for improving the appearance and feel of human skin |
WO2015108946A1 (en) | 2014-01-14 | 2015-07-23 | The Procter & Gamble Company | A multi-step product for improving the appearance and feel of human skin |
WO2015108950A1 (en) | 2014-01-14 | 2015-07-23 | The Procter & Gamble Company | A multi-step regimen for improving the appearance and feel of human skin |
WO2015108947A1 (en) | 2014-01-14 | 2015-07-23 | The Procter & Gamble Company | A multi-step product for improving the appearance and feel of human skin |
US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
US9161531B2 (en) | 2011-02-23 | 2015-10-20 | Donald R. Korb | High alcohol content sanitizer |
WO2015164290A1 (en) | 2014-04-23 | 2015-10-29 | The Procter & Gamble Company | Cosmetic compositions having reduced irritation |
WO2015164291A1 (en) | 2014-04-23 | 2015-10-29 | The Procter & Gamble Company | Cosmetic compositions for hydrating skin |
US9205284B2 (en) | 2010-08-09 | 2015-12-08 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
DE202015004866U1 (en) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | Topical skin composition and its use |
DE202015004867U1 (en) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | lipstick composition |
DE202015004868U1 (en) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | Topical skin composition and its use |
DE202015004872U1 (en) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | Topical skin composition and its use |
WO2016003505A1 (en) | 2014-07-02 | 2016-01-07 | Geoffrey Brooks Consultants, Llc | Peptide-based compositions and methods of use |
WO2016018732A1 (en) | 2014-07-29 | 2016-02-04 | The Procter & Gamble Company | A multi-step regimen for improving the appearance and feel of human skin |
US9254276B2 (en) | 2011-01-25 | 2016-02-09 | The Procter & Gamble Company | Liposome and personal care composition comprising thereof |
US9271912B2 (en) | 2012-06-13 | 2016-03-01 | The Procter & Gamble Company | Personal care compositions comprising a pH tuneable gellant and methods of using |
EP3000459A1 (en) | 2014-09-29 | 2016-03-30 | Johnson & Johnson Consumer Inc. | Antiperspirant compositions |
WO2016049392A1 (en) | 2014-09-26 | 2016-03-31 | The Procter & Gamble Company | Methods for smoothing wrinkles and skin texture imperfections |
DE202015008361U1 (en) | 2014-12-03 | 2016-04-21 | Mary Kay Inc. | Cosmetic compositions |
EP3020410A1 (en) | 2008-04-18 | 2016-05-18 | Collplant Ltd. | Methods of generating and using procollagen |
WO2016090252A1 (en) | 2014-12-04 | 2016-06-09 | Mary Kay Inc. | Topical skin care composition comprising trifluoroacetyl tripeptide-2 |
US9370478B2 (en) | 2012-11-09 | 2016-06-21 | Johnson & Johnson Consumer Inc. | Skin care compositions containing cotton and citrus-derived materials |
EP3034131A1 (en) | 2014-12-19 | 2016-06-22 | Johnson & Johnson Consumer Inc. | Antiperspirant composition |
WO2016100477A1 (en) | 2014-12-16 | 2016-06-23 | The Procter & Gamble Company | Compositions providing delayed release of actives |
US9402794B2 (en) | 2011-12-07 | 2016-08-02 | Mary Kay Inc. | Topical skin care formulation |
US9446265B2 (en) | 2014-01-14 | 2016-09-20 | The Procter & Gamble Company | Cosmetic composition |
DE202014010806U1 (en) | 2013-10-29 | 2016-09-20 | Mary Kay Inc. | Cosmetic compositions |
WO2016178945A1 (en) | 2015-05-01 | 2016-11-10 | The Procter & Gamble Company | Method of improving the appearance of skin and compositions therefor using nicotinamide riboside |
WO2016178944A1 (en) | 2015-05-01 | 2016-11-10 | The Procter & Gamble Company | Method of improving the appearance of skin and compositions therefor using nicotinamide riboside |
WO2016191442A1 (en) | 2015-05-28 | 2016-12-01 | The Procter & Gamble Company | Multi-component products and multi-step regimens for improving the appearance or feel of human skin |
WO2017004101A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Skin care compositions comprising particles with nicotinamide riboside and methods of using the same |
WO2017004338A1 (en) | 2015-06-30 | 2017-01-05 | The Procter & Gamble Company | Compositions containing multiple populations of microcapsules |
WO2017004108A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Superabsorbent polymers and starch powders for use in skin care compositions |
WO2017004340A1 (en) | 2015-06-30 | 2017-01-05 | The Procter & Gamble Company | Methods for making compositions containing multiple populations of microcapsules |
WO2017004102A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container |
US9549891B2 (en) | 2012-03-19 | 2017-01-24 | The Procter & Gamble Company | Superabsorbent polymers and sunscreen actives for use in skin care compositions |
WO2017025963A1 (en) | 2015-08-10 | 2017-02-16 | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | Methods and pharmaceutical compositions for improving wound healing using cd24 |
US9578881B2 (en) | 2011-05-06 | 2017-02-28 | Vanderbilt University | Compositions for inhibition of insect sensing |
DE202015009366U1 (en) | 2014-07-11 | 2017-04-10 | Mary Kay Inc. | Pore minimizer |
US9616011B2 (en) | 2005-04-27 | 2017-04-11 | The Procter & Gamble Company | Personal care compositions |
EP3175888A1 (en) | 2015-12-02 | 2017-06-07 | Johnson & Johnson Consumer Inc. | Compositions containing polymeric sulfur and uses thereof |
US9687442B2 (en) | 2015-07-27 | 2017-06-27 | Mary Kay Inc. | Topical skin formulations |
WO2017115280A1 (en) | 2015-12-30 | 2017-07-06 | Mary Kay Inc. | Topical compositions |
WO2017124075A1 (en) | 2016-01-15 | 2017-07-20 | Isp Investments Llc | Bioactive compositions from ginseng plant (panax spp.) and methods for their production and use |
WO2017123512A1 (en) | 2016-01-11 | 2017-07-20 | The Procter & Gamble Company | Method of treating a skin condition and compositions therefor |
US9737472B2 (en) | 2010-08-09 | 2017-08-22 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
DE202015009461U1 (en) | 2014-12-03 | 2017-09-15 | Mary Kay Inc. | Cosmetic composition and use thereof |
WO2017180798A1 (en) | 2016-04-14 | 2017-10-19 | The Procter & Gamble Company | Products and methods for treating periorbital dyschromia |
WO2017180797A1 (en) | 2016-04-14 | 2017-10-19 | The Procter & Gamble Company | Products and methods for treating periorbital dyschromia |
US9801900B2 (en) | 2013-11-22 | 2017-10-31 | Mary Kay Inc. | Compositions for sensitive skin |
WO2017196818A1 (en) | 2016-05-09 | 2017-11-16 | The Procter & Gamble Company | Method of identifying cosmetic agents for moisturizing skin |
WO2018053188A1 (en) | 2016-09-14 | 2018-03-22 | Yong Zhu | Cosmetic tensioning composition |
US9974729B2 (en) | 2015-07-28 | 2018-05-22 | Mary Kay Inc. | Topical skin formulations |
WO2018111952A1 (en) | 2016-12-13 | 2018-06-21 | The Procter & Gamble Company | Stable personal care compositions containing a retinoid |
WO2018125743A1 (en) | 2016-12-29 | 2018-07-05 | Mary Kay Inc. | Cosmetic compositions comprising shea butter |
US10036741B2 (en) | 2012-08-15 | 2018-07-31 | The Procter & Gamble Company | Systems, models and methods for identifying and evaluating skin-active agents effective for treating an array of skin disorders |
US10072293B2 (en) | 2011-03-31 | 2018-09-11 | The Procter And Gamble Company | Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis |
WO2018170355A1 (en) | 2017-03-17 | 2018-09-20 | Mary Kay Inc. | Cosmetic compositions and methods |
WO2018170439A1 (en) | 2017-03-16 | 2018-09-20 | Coast Southwest, Inc. | Use of uv resistant active materials on hair |
DE202016008641U1 (en) | 2015-12-18 | 2018-10-15 | Mary Kay Inc. | Topical cosmetic compositions |
WO2018191106A1 (en) | 2017-04-11 | 2018-10-18 | The Procter & Gamble Company | Cosmetic compositions |
US10123966B2 (en) | 2013-05-16 | 2018-11-13 | The Procter And Gamble Company | Hair thickening compositions and methods of use |
WO2018237218A1 (en) | 2017-06-23 | 2018-12-27 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
US10206859B2 (en) | 2014-07-29 | 2019-02-19 | The Procter & Gamble Company | Cosmetic composition |
WO2019053051A1 (en) | 2017-09-12 | 2019-03-21 | Lts Lohmann Therapie-Systeme Ag | Lontophoretic microneedle device |
US10252088B2 (en) | 2004-12-02 | 2019-04-09 | Obagi Cosmeceuticals Llc | Topical compositions and methods of manufacturing them in specifically treated steel vessels |
WO2019087084A1 (en) | 2017-11-02 | 2019-05-09 | Eman Biodiscoveries Sd. Bhd. | Extract of orthosiphon stamineus, formulations, and uses thereof |
US10314770B2 (en) | 2014-06-06 | 2019-06-11 | Mary Kay Inc. | Multi-purpose cosmetic water-in-silicone emulsion |
WO2019148080A1 (en) | 2018-01-29 | 2019-08-01 | Mary Kay Inc. | Topical compositions |
US10407649B2 (en) | 2014-08-06 | 2019-09-10 | S.P.C.P. Sa | Use in detergent compositions of polymers obtained by low-concentration reverse emulsion polymerization with a low content of neutralized monomers |
WO2019226722A1 (en) | 2018-05-22 | 2019-11-28 | The Procter & Gamble Company | System and method for identifying connections between perturbagens and genes associated with a skin condition |
US10493179B2 (en) | 2008-10-09 | 2019-12-03 | Trustees Of Tufts College | Modified silk films containing glycerol |
WO2019236935A1 (en) | 2018-06-08 | 2019-12-12 | The Procter & Gamble Company | Topical skincare compositions comprising centella asiatica selected triterpenes |
WO2019245944A1 (en) | 2018-06-18 | 2019-12-26 | The Procter & Gamble Company | Method for degrading bilirubin in skin |
WO2020010036A1 (en) | 2018-07-03 | 2020-01-09 | The Procter & Gamble Company | Method of treating a skin condition |
WO2020026241A1 (en) | 2018-07-31 | 2020-02-06 | Collplant Ltd. | Tobacco transgenic event and methods for detection and use thereof |
DE202018006387U1 (en) | 2017-06-13 | 2020-03-20 | Mary Kay, Inc. | Cosmetic compositions and their use to tighten the skin |
WO2020061184A1 (en) | 2018-09-18 | 2020-03-26 | Mary Kay Inc. | Plant extracts to reduce the appearance of hyperpigmented skin or to lighten skin |
WO2020074395A1 (en) | 2018-10-12 | 2020-04-16 | Laboratoires Clarins | Cosmetic composition for skin care and radiance, and method for preparing same |
US10682381B2 (en) | 2009-04-27 | 2020-06-16 | Mary Kay Inc. | Botanical formulations |
WO2020123306A1 (en) | 2018-12-14 | 2020-06-18 | Mary Kay Inc. | Cosmetic compositions |
WO2020131477A2 (en) | 2018-12-20 | 2020-06-25 | Mary Kay Inc. | Cosmetic compositions |
US10722436B2 (en) | 2015-08-10 | 2020-07-28 | Mary Kay Inc. | Topical compositions |
WO2020172101A1 (en) | 2019-02-18 | 2020-08-27 | Mary Kay Inc. | Topical skin compositions for treating rosacea and skin redness |
US10791739B2 (en) | 2015-03-25 | 2020-10-06 | Vanderbilt University | Binary compositions as disruptors of orco-mediated odorant sensing |
WO2020219478A1 (en) | 2019-04-22 | 2020-10-29 | Elc Management Llc | Topical delivery system containing cellulose nanofibers |
US10842728B2 (en) | 2010-08-09 | 2020-11-24 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
WO2020264568A1 (en) | 2019-06-28 | 2020-12-30 | The Procter & Gamble Company | Method of inhibiting par2 activation and compositions therefor |
WO2020264567A1 (en) | 2019-06-28 | 2020-12-30 | The Procter & Gamble Company | Skin care composition |
US10881598B2 (en) | 2015-05-06 | 2021-01-05 | Abs Materials, Inc. | Method of using personal and home care compositions containing a sol-gel derived material |
WO2021010953A1 (en) | 2019-07-15 | 2021-01-21 | The Procter & Gamble Company | Topical skincare compositions comprising centella asiatica |
US10912956B2 (en) | 2016-03-23 | 2021-02-09 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
WO2021026565A1 (en) | 2019-08-07 | 2021-02-11 | Mary Kay Inc. | Dissolvable vitamin c and retinol film |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
US10967031B2 (en) | 2010-12-28 | 2021-04-06 | Kamedis Ltd. | Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation |
WO2021119664A1 (en) | 2019-12-10 | 2021-06-17 | Mary Kay Inc. | Herbal cosmetic composition for treating skin |
WO2021150807A1 (en) | 2020-01-24 | 2021-07-29 | The Procter & Gamble Company | Skin care composition |
WO2021155398A1 (en) | 2020-01-28 | 2021-08-05 | Mary Kay Inc. | Lip composition |
WO2021168474A1 (en) | 2020-02-17 | 2021-08-26 | Mary Kay Inc. | Topical cosmetic compositions |
EP3871765A1 (en) | 2020-02-26 | 2021-09-01 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
EP3871766A1 (en) | 2020-02-26 | 2021-09-01 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
EP3871764A1 (en) | 2020-02-26 | 2021-09-01 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
EP3900697A1 (en) | 2020-04-21 | 2021-10-27 | Takasago International Corporation | Fragrance composition |
WO2021214625A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers |
WO2021214624A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers |
WO2021214626A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols |
WO2021217186A1 (en) | 2020-04-23 | 2021-10-28 | Mary Kay Inc. | Topical cosmetic compositions |
WO2021217176A1 (en) | 2020-04-23 | 2021-10-28 | Mary Kay Inc. | Topical cosmetic compositions |
WO2021214627A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified polymers |
WO2021214628A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified polymers |
WO2021222933A1 (en) | 2020-04-29 | 2021-11-04 | Mary Kay Inc. | Cosmetic compositions and methods comprising plumeria alba flower extract |
WO2021226632A1 (en) | 2020-05-06 | 2021-11-11 | Mary Kay Inc. | Cosmetic composition comprising gluconolactone and glycolic acid |
WO2021232040A1 (en) | 2020-05-11 | 2021-11-18 | Mary Kay Inc. | Brightening booster technology and brightening ampule |
WO2021243359A1 (en) | 2020-05-27 | 2021-12-02 | Mary Kay Inc. | Topical compositions and methods |
WO2021247496A1 (en) | 2020-06-01 | 2021-12-09 | The Procter & Gamble Company | Method of improving penetration of a vitamin b3 compound into skin |
WO2021253053A1 (en) | 2020-06-12 | 2021-12-16 | Mary Kay Inc. | Topical compositions and methods |
WO2021258099A1 (en) | 2020-06-16 | 2021-12-23 | Mary Kay Inc. | Cosmetic composition |
US11304987B2 (en) | 2019-03-05 | 2022-04-19 | Fre Skincare Ltd | Argan extracts for the treatment of dermatological conditions |
WO2022094595A1 (en) | 2020-10-30 | 2022-05-05 | Mary Kay Inc. | Instant effect eye cream |
WO2022132519A1 (en) | 2020-12-14 | 2022-06-23 | The Procter & Gamble Company | Cosmetic compositions comprising sucrose esters and solvents |
WO2022132518A1 (en) | 2020-12-14 | 2022-06-23 | The Procter & Gamble Company | Method of manufacturing cosmetic compositions comprising sucrose esters and solvents |
WO2022159967A1 (en) | 2021-01-22 | 2022-07-28 | The Procter & Gamble Company | Skin care composition comprising vitamin b3 combined with two peptides |
WO2022159705A1 (en) | 2021-01-22 | 2022-07-28 | Prolacta Bioscience, Inc. | Topical human milk formulations |
WO2022159968A1 (en) | 2021-01-22 | 2022-07-28 | The Procter & Gamble Company | Skin care composition comprising a combination of peptides |
WO2022192882A1 (en) | 2021-03-09 | 2022-09-15 | Mary Kay Inc. | Topical compositions for uv protection |
US11491130B2 (en) | 2021-02-05 | 2022-11-08 | Retrotope, Inc. | Methods of treating amyotrophic lateral sclerosis |
US11510889B2 (en) | 2021-02-05 | 2022-11-29 | Retrotope, Inc. | Methods for inhibiting the progression of neurodegenerative diseases |
EP4094827A1 (en) | 2021-05-27 | 2022-11-30 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
WO2022251874A1 (en) | 2021-05-28 | 2022-12-01 | Mary Kay Inc. | Barrier guard technology |
WO2022256208A1 (en) | 2021-05-30 | 2022-12-08 | The Procter & Gamble Company | Cosmetic product comprising a cosmetic composition contained in an applicator |
KR20220166842A (en) | 2020-04-09 | 2022-12-19 | 버텔러스 홀딩스 엘엘씨 | Crosslinking composition and use thereof |
WO2023279086A1 (en) | 2021-07-01 | 2023-01-05 | Mary Kay Inc. | Topical composition against fine lines and wrinkles |
US11547734B2 (en) | 2018-07-03 | 2023-01-10 | Mary Kay Inc. | Topical muscle relaxation compositions and methods |
WO2023023397A1 (en) * | 2021-08-20 | 2023-02-23 | Retrotope, Inc | Methods for inhibiting the progression of neurodegenerative diseases |
WO2023081671A1 (en) | 2021-11-03 | 2023-05-11 | The Procter & Gamble Company | Cosmetic composition comprising oil discontinuous phase |
WO2023081670A1 (en) | 2021-11-03 | 2023-05-11 | The Procter & Gamble Company | Cosmetic product comprising oil discontinuous phase and method of use thereof |
WO2023097322A2 (en) | 2021-11-29 | 2023-06-01 | The Procter & Gamble Company | Skin care composition |
WO2023097326A1 (en) | 2021-11-29 | 2023-06-01 | The Procter & Gamble Company | Method for treating post-acne marks |
WO2023097320A1 (en) | 2021-11-29 | 2023-06-01 | The Procter & Gamble Company | Method of improving the appearance of skin |
WO2023122466A2 (en) | 2021-12-21 | 2023-06-29 | The Procter & Gamble Company | Cosmetic composition comprising sucrose ester and lauroyl lysine |
WO2023122465A2 (en) | 2021-12-21 | 2023-06-29 | The Procter & Gamble Company | Cosmetic composition comprising mica and lauroyl lysine |
WO2023122467A1 (en) | 2021-12-21 | 2023-06-29 | The Procter & Gamble Company | Cosmetic composition comprising vitamin b3 compound and lauroyl lysine |
WO2023154791A1 (en) | 2022-02-10 | 2023-08-17 | The Procter & Gamble Company | Topical skin care with colloidal oatmeal |
WO2023192538A1 (en) | 2022-03-31 | 2023-10-05 | Galderma Holding SA | Personal care compositions for sensitive skin and methods of use |
WO2024081035A1 (en) | 2022-10-12 | 2024-04-18 | The Procter & Gamble Company | Cosmetic composition comprising silica and lauroyl lysine |
WO2024081034A1 (en) | 2022-10-12 | 2024-04-18 | The Procter & Gamble Company | Cosmetic composition comprising polyacrylate crosspolymer-6, and silica and/or lauroyl lysine |
US12030919B2 (en) | 2016-02-11 | 2024-07-09 | Seevix Material Sciences Ltd. | Composite materials comprising synthetic dragline spider silk |
US12036302B2 (en) | 2020-12-14 | 2024-07-16 | The Procter & Gamble Company | Method of treating oxidative stress in skin and compositions therefor |
US12097279B2 (en) | 2017-09-18 | 2024-09-24 | Mary Kay Inc. | Cosmetic compositions and methods |
US12109194B2 (en) | 2021-02-05 | 2024-10-08 | Biojiva Llc | Synergistic combination therapy for treating ALS |
-
1971
- 1971-06-30 US US00158559A patent/US3755560A/en not_active Expired - Lifetime
Cited By (749)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3928261A (en) * | 1973-05-17 | 1975-12-23 | Minnesota Mining & Mfg | Water removable film-forming compositions for topical application to skin |
US4294852A (en) * | 1973-11-01 | 1981-10-13 | Johnson & Johnson | Skin treating compositions |
FR2333493A1 (en) * | 1975-12-03 | 1977-07-01 | Johnson & Johnson | COAT FORMING COMPOSITION FOR SUNSCREENS AND SIMILAR |
US4128634A (en) * | 1976-03-04 | 1978-12-05 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic emulsions containing copolymers of alkyl(meth)acrylates and mono-(N-hydroxyalkyl) or bis-(N-hydroxyalkyl) (meth)acrylamides |
US4128635A (en) * | 1976-03-04 | 1978-12-05 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic emulsions containing copolymers of alkyl (meth) acrylates and mono- or polyhydroxyalkyl (meth) acrylates |
US4128636A (en) * | 1976-03-26 | 1978-12-05 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic emulsions containing copolymers of 2-hydroxy-3-hydroxyalkyl-aminopropyl(meth)acrylates and alkyl (meth)acrylates |
FR2398496A1 (en) * | 1977-07-29 | 1979-02-23 | Minnesota Mining & Mfg | ANTI-SOLAR COMPOSITIONS, INSOLUBLE IN WATER, CONTAINING AN ACRYLATE POLYMER |
US4938951A (en) * | 1980-12-30 | 1990-07-03 | Union Carbide Chemicals And Plastics Company Inc. | Potentiation of topical compositions wherein a uniform microdispersion of active agent is formed |
US4421769A (en) * | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
US4524061A (en) * | 1983-04-22 | 1985-06-18 | Gaf Corporation | Polymeric sunscreens |
USRE34584E (en) * | 1984-11-09 | 1994-04-12 | The Procter & Gamble Company | Shampoo compositions |
EP0193387A3 (en) * | 1985-02-28 | 1986-10-29 | The Procter & Gamble Company | Sunscreen compositions and method of protecting skin |
US4663157A (en) * | 1985-02-28 | 1987-05-05 | The Proctor & Gamble Company | Sunscreen compositions |
EP0193387A2 (en) * | 1985-02-28 | 1986-09-03 | The Procter & Gamble Company | Sunscreen compositions and method of protecting skin |
US4731242A (en) * | 1986-03-21 | 1988-03-15 | Victor Palinczar | Waterproof sunscreen compositions |
EP0496434A2 (en) | 1987-10-22 | 1992-07-29 | The Procter & Gamble Company | Photoprotection compositions comprising chelating agents |
EP0496433A2 (en) | 1987-10-22 | 1992-07-29 | The Procter & Gamble Company | Photoprotection compositions comprising chelating agents |
US5399350A (en) * | 1990-04-05 | 1995-03-21 | Nurture, Inc. | Proteinaceous oil spill dispersant |
US5589195A (en) * | 1990-04-05 | 1996-12-31 | Nurture, Inc. | Film-forming proteinaceous emulsion |
WO1992000723A1 (en) * | 1990-07-05 | 1992-01-23 | Dowbrands Inc. | Skin moisturizing composition and process of using |
EP0734718A2 (en) | 1991-08-30 | 1996-10-02 | The Procter & Gamble Company | Use of N-acetyl-L-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
US5700452A (en) * | 1993-04-16 | 1997-12-23 | The Procter & Gamble Company | Compositions for imparting an artificial tan and protecting the skin from ultra-violet radiation |
US5902591A (en) * | 1997-04-03 | 1999-05-11 | La Prairie Sa | Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US7387807B2 (en) | 1999-06-03 | 2008-06-17 | Johnson & Johnson Consumer France, Sas, Roc Division | Topical composition comprising feverfew |
US20040105905A1 (en) * | 1999-06-03 | 2004-06-03 | Theresa Callaghan | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
US7229650B2 (en) | 1999-06-03 | 2007-06-12 | Johnson & Johnson Consumer France Sas | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
US20050244525A1 (en) * | 1999-06-03 | 2005-11-03 | Theresa Callaghan | Topical composition comprising feverfew |
EP2397127A1 (en) | 1999-06-25 | 2011-12-21 | Enerdermics, Inc. | Use of creatine or creatine compounds for skin preservation |
US20060188953A1 (en) * | 1999-06-29 | 2006-08-24 | New York University | Methods and compositions that affect melanogenesis |
US7604949B2 (en) | 1999-06-29 | 2009-10-20 | New York University | Methods and compositions that affect melanogenesis |
US20020034772A1 (en) * | 1999-06-29 | 2002-03-21 | Orlow Seth J. | Methods and compositions that affect melanogenesis |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US7879823B2 (en) | 1999-11-05 | 2011-02-01 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US6468552B1 (en) | 2000-06-02 | 2002-10-22 | Neutrogena Corporation | Stabilized compositions containing oxygen-labile active agents |
US7241731B2 (en) | 2000-06-05 | 2007-07-10 | Sumitomo Electric Industries, Ltd. | Oligopeptides for promoting hair growth |
US20050008602A1 (en) * | 2000-06-05 | 2005-01-13 | Sumitomo Electric Industries, Ltd. | Oligopeptides for promoting hair growth |
US6649176B1 (en) | 2000-06-29 | 2003-11-18 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing mineral water |
US6372791B1 (en) | 2000-06-29 | 2002-04-16 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin cell metabolism |
US6432424B1 (en) | 2000-06-29 | 2002-08-13 | Johnson & Johnson Consumer Companies, Inc. | Cosmetic compositions containing creatine, carnitine, and/or pyruvic acid |
US6576702B2 (en) | 2000-07-20 | 2003-06-10 | Noveon Ip Holdings Corp. | Plasticized waterborne polyurethane dispersions and manufacturing process |
US20030064049A1 (en) * | 2000-10-27 | 2003-04-03 | Miri Seiberg | Topical anti-cancer compositions and methods of use thereof |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US7034054B2 (en) | 2000-12-15 | 2006-04-25 | Galileo Pharmaceuticals, Inc. | Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols |
US20020143049A1 (en) * | 2000-12-15 | 2002-10-03 | Miller Guy Michael | Compositions and methods for the prevention and treatment of cerebral ischemia |
EP2127698A1 (en) | 2001-02-28 | 2009-12-02 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing legume products |
US7897144B2 (en) | 2001-02-28 | 2011-03-01 | Johnson & Johnson Comsumer Companies, Inc. | Compositions containing legume products |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
US20030077343A1 (en) * | 2001-03-16 | 2003-04-24 | Martin Katharine M. | Composition containing feverfew extract and use thereof |
US20060165646A1 (en) * | 2001-03-16 | 2006-07-27 | Martin Katharine M | Method for the treatment of nucleic acid damage |
US7547456B2 (en) | 2001-03-16 | 2009-06-16 | Johnson & Johnson Consumer Companies, Inc. | Composition containing feverfew extract and use thereof |
US20020182166A1 (en) * | 2001-03-16 | 2002-12-05 | Martin Katharine M. | Composition containing feverfew extract and use thereof |
EP2105123A2 (en) | 2001-03-22 | 2009-09-30 | The Procter & Gamble Company | Skin care compositions containing a sugar amine and a vitamin B3 compound |
US20050202551A1 (en) * | 2001-03-23 | 2005-09-15 | Estell David A. | Proteins producing an altered immunogenic response and methods of making and using the same |
US6929939B2 (en) | 2001-03-23 | 2005-08-16 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US7476528B2 (en) | 2001-03-23 | 2009-01-13 | Genencor International, Inc. | Proteins producing an altered immunogenic response and methods of making and using the same |
US20030118605A1 (en) * | 2001-03-23 | 2003-06-26 | Estell David A. | Proteins producing an altered immunogenic response and methods of making and using the same |
US7081442B2 (en) | 2001-05-21 | 2006-07-25 | Johnson & Johnson Consumer Companies, Inc. | Composition containing a peptide and a pigment and the use thereof in darkening the skin |
US6797697B2 (en) | 2001-05-21 | 2004-09-28 | Johnson & Johnson Consumer Companies, Inc. | Composition containing a peptide and a pigment and the use thereof in darkening the skin |
US7214655B2 (en) | 2001-05-21 | 2007-05-08 | Johnson & Johnson Consumer Companies, Inc. | Peptides and the use thereof in darkening the skin |
US8632793B2 (en) | 2001-06-29 | 2014-01-21 | The Procter & Gamble Company | Top-biased beneficial components on substrates |
US7166292B2 (en) | 2001-06-29 | 2007-01-23 | The Procter & Gamble Company | Top-biased beneficial components on substrates |
US20030035824A1 (en) * | 2001-06-29 | 2003-02-20 | The Procter & Gamble Company | Top-biased beneficial components on substrates |
US20070116748A1 (en) * | 2001-06-29 | 2007-05-24 | Olaf Isele | Top-biased beneficial components on substrates |
US20030114520A1 (en) * | 2001-08-09 | 2003-06-19 | Croda, Inc. | Anti-irritants |
US7091243B2 (en) | 2001-08-09 | 2006-08-15 | Croda, Inc. | Anti-irritants |
US7217424B2 (en) | 2001-10-17 | 2007-05-15 | Croda, Inc. | Compositions containing esters of aromatic alkoxylated alcohols and fatty carboxylic acids |
US6987195B2 (en) | 2001-10-17 | 2006-01-17 | Croda, Inc. | Esters of aromatic alkoxylated alcohols and fatty carboxylic acids |
US7235230B2 (en) | 2001-10-24 | 2007-06-26 | Clariant Finance (Bvi) Limited | Leave-on compositions for personal care |
US20050054843A1 (en) * | 2001-12-31 | 2005-03-10 | Estell David A | Proteases producing an altered immunological response and methods of making and using the same |
US20050148059A1 (en) * | 2001-12-31 | 2005-07-07 | Estell David A. | Protease producing an altered immunogenic response and methods of making and using the same |
US7332320B2 (en) | 2001-12-31 | 2008-02-19 | Genencor International, Inc. | Protease producing an altered immunogenic response and methods of making and using the same |
US6838419B2 (en) | 2002-01-09 | 2005-01-04 | Croda, Inc. | Mixtures of quaternary compounds |
WO2003060046A1 (en) | 2002-01-09 | 2003-07-24 | Croda, Inc. | Mixtures of quaternary compounds |
US20040138088A1 (en) * | 2002-01-09 | 2004-07-15 | Croda, Inc. | Immidazoline quats |
US6953773B2 (en) | 2002-01-09 | 2005-10-11 | Croda, Inc. | Mixtures of imidazoline quaternary ammonium and alkyl quaternary ammonium compounds |
US20060128601A1 (en) * | 2002-01-09 | 2006-06-15 | Croda, Inc. | Imidazoline quats |
US20040167057A1 (en) * | 2002-01-09 | 2004-08-26 | Croda, Inc. | Mixtures of quaternary compounds |
US20040220062A1 (en) * | 2002-01-09 | 2004-11-04 | Croda, Inc. | Imidazoline quats |
US8414906B2 (en) | 2002-01-31 | 2013-04-09 | Croda, Inc. | Additives and products including oligoesters |
US7611725B2 (en) | 2002-01-31 | 2009-11-03 | Croda, Inc. | Additives and products including oligoesters |
US20100035999A1 (en) * | 2002-01-31 | 2010-02-11 | Croda, Inc. | Additives and products includings oligoesters |
US20030199593A1 (en) * | 2002-01-31 | 2003-10-23 | Pereira Abel G. | Additives and products including oligoesters |
US20050239043A1 (en) * | 2002-02-26 | 2005-10-27 | Harding Fiona A | Subtilisin carlsberg proteins with reduced immunogenicity |
US20030195293A1 (en) * | 2002-04-05 | 2003-10-16 | Lubnin Alexander V. | Breathable polyurethanes, blends, and articles |
US20040214937A1 (en) * | 2002-04-05 | 2004-10-28 | Miller Timothy D. | Hybrid polymer composition, and article therefrom |
US6897281B2 (en) | 2002-04-05 | 2005-05-24 | Noveon Ip Holdings Corp. | Breathable polyurethanes, blends, and articles |
US7358295B2 (en) | 2002-04-05 | 2008-04-15 | Lubrizol Advanced Materials, Inc. | Hybrid polymer composition, and article therefrom |
US20080075678A1 (en) * | 2002-04-26 | 2008-03-27 | L'oreal | Cosmetic composition comprising an extract of emblica officinalis and methods of using same |
US7025951B2 (en) | 2002-06-18 | 2006-04-11 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for darkening the skin |
US20030232743A1 (en) * | 2002-06-18 | 2003-12-18 | Miri Seiberg | Compositions and methods for darkening the skin |
US20090087400A1 (en) * | 2002-06-19 | 2009-04-02 | Krishnan Tamareselvy | Breathable polyurethanes, blends, and articles |
US20050209428A1 (en) * | 2002-06-19 | 2005-09-22 | Krishnan Tamareselvy | Breathable polyurethanes, blends, and articles |
US20040131648A1 (en) * | 2002-10-24 | 2004-07-08 | The Procter & Gamble Company | Nuclear hormone receptor compounds, products and methods employing same |
EP2338896A2 (en) | 2002-12-12 | 2011-06-29 | R.B.T. (Rakuto Bio Technologies) Ltd. | Use of lignin peroxidase in skin and hair lightening |
US20070025974A1 (en) * | 2003-02-26 | 2007-02-01 | Hardings Fiona A | Amylases producing an altered immunogenic response and methods of making and using the same |
EP2500423A2 (en) | 2003-02-26 | 2012-09-19 | Genencor International, Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
EP2997960A1 (en) | 2003-03-04 | 2016-03-23 | The Procter and Gamble Company | Regulation of mammalian keratinous tissue using hexamidine compositions |
US20100278765A1 (en) * | 2003-03-04 | 2010-11-04 | Donald Lynn Bissett | Regulation of mammalian keratinous tissue using hexamidine compositions |
US8591874B2 (en) | 2003-03-04 | 2013-11-26 | The Procter & Gamble Company | Inhibition of mammalian hair growth |
US20060127431A1 (en) * | 2003-03-04 | 2006-06-15 | The Procter & Gamble Company | Regulation of mammalian hair growth |
US7581273B2 (en) | 2003-03-10 | 2009-09-01 | The Procter & Gamble Company | Disposable nonwoven cleansing mitt |
US20050150784A1 (en) * | 2003-03-10 | 2005-07-14 | The Procter & Gamble Company | Child's cleansing system |
US7401376B2 (en) | 2003-03-10 | 2008-07-22 | The Procter & Gamble Company | Disposable nonwoven cleansing mitt |
US20080317798A1 (en) * | 2003-03-10 | 2008-12-25 | Joyce Marie Benjamin | Disposable Nonwoven Cleansing Mitt |
US20040204333A1 (en) * | 2003-03-10 | 2004-10-14 | The Procter And Gamble Company | Disposable nonwoven cleansing mitt |
US20080226706A1 (en) * | 2003-03-12 | 2008-09-18 | Manoj Kumar | Use of Repeat Sequence Protein Polymers in Personal Care Compositions |
US8273704B2 (en) | 2003-03-12 | 2012-09-25 | Danisco Us Inc. | Use of repeat sequence protein polymers in personal care compositions |
US7202204B2 (en) | 2003-04-17 | 2007-04-10 | Croda, Inc. | Personal care product containing diester quat |
US20050288198A1 (en) * | 2003-04-17 | 2005-12-29 | Croda, Inc. | Personal care product containing diester quat |
US20090186826A1 (en) * | 2003-05-12 | 2009-07-23 | Sederma | Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides |
US7560428B2 (en) | 2003-05-16 | 2009-07-14 | Sumitomo Electric Industries, Ltd. | Hair growth promoting oligopeptides |
US20080051325A1 (en) * | 2003-05-16 | 2008-02-28 | Yohei Hirai | Oligopeptide |
US20050152858A1 (en) * | 2003-07-11 | 2005-07-14 | Isp Investments Inc. | Solubilizing agents for active or functional organic compounds |
US20050074474A1 (en) * | 2003-10-03 | 2005-04-07 | The Procter & Gamble Company | Topical composition |
US7524816B2 (en) | 2003-11-06 | 2009-04-28 | Genencor International, Inc. | Peptides and supported peptides for treating skin diseases |
US7485618B2 (en) | 2003-11-06 | 2009-02-03 | Genencor International, Inc. | FGF-5 supported and binding peptides |
US20050203026A1 (en) * | 2003-11-06 | 2005-09-15 | Day Anthony G. | Peptides and supported peptides for treating skin diseases |
US20050238607A1 (en) * | 2003-11-06 | 2005-10-27 | Day Anthony G | FGF-5 supported and binding peptides |
US20110230405A1 (en) * | 2003-11-06 | 2011-09-22 | Day Anthony G | Peptides and Supported Peptides for Treating Skin Diseases |
US20080269139A1 (en) * | 2003-11-06 | 2008-10-30 | Day Anthony G | FGF-5 Supported and Binding Peptides |
US20080113917A1 (en) * | 2003-11-06 | 2008-05-15 | Day Anthony G | Tgfbeta Supported and Binding Peptides |
US7490382B2 (en) | 2003-12-16 | 2009-02-17 | The Procter & Gamble Company | Child's sized disposable article |
US20080149504A1 (en) * | 2003-12-16 | 2008-06-26 | Joyce Marie Benjamin | Child's Fragrant Cleaning Implement |
US20050125877A1 (en) * | 2003-12-16 | 2005-06-16 | The Procter & Gamble Company | Disposable nonwoven mitt adapted to fit on a child's hand |
US20050129743A1 (en) * | 2003-12-16 | 2005-06-16 | The Procter & Gamble Company | Child's cleaning implement comprising a biological extract |
US7647667B2 (en) | 2003-12-16 | 2010-01-19 | The Procter & Gamble Company | Child's fragrant cleaning implement |
US7665176B2 (en) | 2003-12-16 | 2010-02-23 | The Procter & Gamble Company | Child's sized disposable article |
US20090133206A1 (en) * | 2003-12-16 | 2009-05-28 | Joyce Marie Benjamin | Child's Sized Disposable Article |
US7350256B2 (en) | 2003-12-16 | 2008-04-01 | The Procter & Gamble Company | Child's aromatherapy cleaning implement |
US20050175719A1 (en) * | 2004-02-05 | 2005-08-11 | Ying Sun | Procyanidins for treatment and prevention of enzymatic irritation to the skin |
US20070191368A1 (en) * | 2004-03-23 | 2007-08-16 | Bissett Donald L | Inhibition of tissue damage to skin from radiation treatment therapy |
US20090060933A1 (en) * | 2004-06-14 | 2009-03-05 | Estell David A | Proteases producing an altered immunogenic response and methods of making and using the same |
US20110076260A1 (en) * | 2004-06-14 | 2011-03-31 | David A Estell | Proteases Producing an Altered Immunogenic Response and Methods of Making and Using the Same |
US20060110439A1 (en) * | 2004-10-22 | 2006-05-25 | Dynamis Therapeutics, Inc. | Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds |
US20060251598A1 (en) * | 2004-12-02 | 2006-11-09 | Ramirez Jose E | System for improved percutaneous absorption of skin benefiting agents |
US10252088B2 (en) | 2004-12-02 | 2019-04-09 | Obagi Cosmeceuticals Llc | Topical compositions and methods of manufacturing them in specifically treated steel vessels |
US8999356B1 (en) | 2004-12-03 | 2015-04-07 | Omp, Inc. | Drug delivery system |
US20060286046A1 (en) * | 2005-01-05 | 2006-12-21 | Haber C Andrew | Skin care compositions |
US20060153926A1 (en) * | 2005-01-10 | 2006-07-13 | Bascom Charles C | Compositions, products and methods for controlling weight in a mammal |
US20090017147A1 (en) * | 2005-01-14 | 2009-01-15 | Sederma | Cosmetic or Dermopharmaceutical Composition Comprising an Euglena Extract |
US8741357B2 (en) | 2005-01-14 | 2014-06-03 | Sederma Sas | Cosmetic or dermopharmaceutical composition comprising an euglena extract |
WO2006081071A1 (en) | 2005-01-26 | 2006-08-03 | The Procter & Gamble Company | Low ph skin care compositions containing dehydroacetic acid |
US20070085063A1 (en) * | 2005-04-26 | 2007-04-19 | The Board Of Regents Of The University Of Texas System | Tunable sunblock agents |
US20080095732A1 (en) * | 2005-04-27 | 2008-04-24 | Rosemarie Osborne | Personal care compositions |
US20070020220A1 (en) * | 2005-04-27 | 2007-01-25 | Procter & Gamble | Personal care compositions |
US9616011B2 (en) | 2005-04-27 | 2017-04-11 | The Procter & Gamble Company | Personal care compositions |
US8871717B2 (en) | 2005-04-27 | 2014-10-28 | The Procter & Gamble Company | Personal care compositions |
US10130577B2 (en) | 2005-04-27 | 2018-11-20 | The Procter & Gamble Company | Personal care compositions |
US9084734B2 (en) | 2005-05-05 | 2015-07-21 | Danisco Us Inc. | Peptide personal care compositions and methods for their use |
US20090214607A1 (en) * | 2005-05-13 | 2009-08-27 | Sederma | Topical use of teprenone |
US20070020221A1 (en) * | 2005-05-17 | 2007-01-25 | Bissett Donald L | Regulation of mammalian keratinous tissue using personal care compositions comprising cetyl pyridinium chloride |
US20060263400A1 (en) * | 2005-05-17 | 2006-11-23 | Bissett Donald L | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
US20060263321A1 (en) * | 2005-05-17 | 2006-11-23 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using personal care compositions comprising diethylhexyl syringylidene malonate |
US20060263309A1 (en) * | 2005-05-17 | 2006-11-23 | Bissett Donald L | Regulation of mammalian keratinous tissue using personal care compositions comprising tetrahydrocurcumin |
US7381707B2 (en) | 2005-06-30 | 2008-06-03 | Johnson & Johnson Consumer Companies, Inc. | Treatment of dry eye |
US20070004640A1 (en) * | 2005-06-30 | 2007-01-04 | Lin Connie B | Treatment of dry eye |
US20070041917A1 (en) * | 2005-08-17 | 2007-02-22 | Isaac Thomas | Sunless tanning compositions |
US20090269395A1 (en) * | 2005-09-06 | 2009-10-29 | Sederma | Use of protoberberines as an active substance regulating the pilosebaceous unit |
US8846019B2 (en) | 2005-09-06 | 2014-09-30 | Sederma | Use of protoberberines as an active substance regulating the pilosebaceous unit |
WO2007038454A1 (en) | 2005-09-26 | 2007-04-05 | L'oreal | Composition and process for treating keratinous substrates with at least two immiscible cosmetic compositions |
EP3015101A1 (en) | 2005-10-03 | 2016-05-04 | PINSKY, Mark A. | Non-phospholipid liposomes comprising hyaluronic acid |
WO2007041627A1 (en) | 2005-10-03 | 2007-04-12 | Pinsky Mark A | Compositions and methods for improved skin care |
US20070202061A1 (en) * | 2005-10-31 | 2007-08-30 | Naturalnano, Inc. | Cosmetic skincare applications employing mineral-derived tubules for controlled release |
US20070196292A1 (en) * | 2005-11-30 | 2007-08-23 | Robinson Larry R | Personal care composition comprising dehydroacetate salts |
US20070128137A1 (en) * | 2005-12-02 | 2007-06-07 | Naohisa Yoshimi | Water in oil emulsion compositions containing siloxane elastomers |
US20070183993A1 (en) * | 2005-12-13 | 2007-08-09 | Binder Robert L | Personal care compositions |
US20070196296A1 (en) * | 2005-12-13 | 2007-08-23 | Rosemarie Osborne | Personal care compositions |
US20070154422A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing ablative treatment |
US20070154417A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring non-ablative procedure |
US20070155842A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring Intense Pulse Light (IPL) procedure |
US20070154419A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring chemical peel procedure |
US20070154421A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing collagen treatment |
US20070154503A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring skin cancer treatment |
US7976854B2 (en) | 2005-12-30 | 2011-07-12 | Omp, Inc. | Method of treating skin requiring skin cancer treatment |
US20070249714A1 (en) * | 2005-12-30 | 2007-10-25 | Judy Hattendorf | Method of treating skin requiring fractional resurfacing treatment |
US20070154418A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring radiofrequency procedure |
US20070154416A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing hyaluronic acid treatment |
US20070154442A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring hair removal procedure |
US20070154420A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin subject to or affected by aesthetic surgical procedures |
US20070154502A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin requiring microdermabrasion |
US20070154501A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin having incision from surgical procedures |
US20070154493A1 (en) * | 2005-12-30 | 2007-07-05 | Judy Hattendorf | Method of treating skin needing botulinum toxin type a treatment |
US20070166275A1 (en) * | 2006-01-19 | 2007-07-19 | Mary Kay Inc. | Compositions comprising kakadu plum extract or acai berry extract |
US10918591B2 (en) | 2006-01-19 | 2021-02-16 | Mary Kay Inc. | Compositions comprising kakadu plum extract or acai berry extract |
EP2944313A1 (en) | 2006-01-19 | 2015-11-18 | Mary Kay, Inc. | Compositions comprising kakadu plum extract or acai berry extract |
US10130673B2 (en) | 2006-01-19 | 2018-11-20 | Mary Kay Inc. | Compositions comprising kakadu plum extract or acai berry extract |
US10668124B2 (en) | 2006-01-19 | 2020-06-02 | Mary Kay Inc. | Compositions comprising kakadu plum extract or acai berry extract |
US10675323B2 (en) | 2006-01-19 | 2020-06-09 | Mary Kay Inc. | Topical compositions comprising acai berry extract |
US20070269534A1 (en) * | 2006-02-02 | 2007-11-22 | Ramirez Jose E | Methods of treating skin to enhance therapeutic treatment thereof |
US8404648B2 (en) | 2006-02-16 | 2013-03-26 | Sederma | Polypeptides KXK and their use |
US20110033507A1 (en) * | 2006-02-16 | 2011-02-10 | Sederma | Polypeptides KXK and Their Use |
US20070203240A1 (en) * | 2006-02-27 | 2007-08-30 | The Procter & Gamble Company | Personal care compositions and methods for regulating mammalian hair growth |
US20080031833A1 (en) * | 2006-03-13 | 2008-02-07 | Oblong John E | Combined energy and topical composition application for regulating the condition of mammalian skin |
US20070224208A1 (en) * | 2006-03-27 | 2007-09-27 | Globeimmune, Inc. | Ras mutation and compositions and methods related thereto |
US8507649B2 (en) | 2006-05-05 | 2013-08-13 | Sederma | Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle |
US20110045036A1 (en) * | 2006-05-05 | 2011-02-24 | Sederma | Cosmetic Compositions Comprising at Least One Peptide with at Least One Immobilized Aromatic Cycle |
EP2510982A1 (en) | 2006-05-05 | 2012-10-17 | Sederma | Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle |
US20070274932A1 (en) * | 2006-05-15 | 2007-11-29 | The Procter & Gamble Company | Water in oil emulsion compositions containing sunscreen actives and siloxane elastomers |
US20070264210A1 (en) * | 2006-05-15 | 2007-11-15 | The Procter & Gamble Company | Method of enhancing penetration of water-soluble actives |
US20090169500A1 (en) * | 2006-05-17 | 2009-07-02 | E. I. Du Pont De Nemours And Company | Personal care compositions |
US7628999B2 (en) | 2006-05-17 | 2009-12-08 | Hari Babu Sunkara | Personal care compositions |
US20070269392A1 (en) * | 2006-05-17 | 2007-11-22 | Sunkara Hari B | Personal care compositions |
US8029812B2 (en) | 2006-05-17 | 2011-10-04 | E. I. Du Pont De Nemours And Company | Personal care compositions |
US8361516B2 (en) | 2006-08-03 | 2013-01-29 | Sederma | Composition comprising sarsasapogenin |
US20090253666A1 (en) * | 2006-08-03 | 2009-10-08 | Sederma | Composition comprising sarsasapogenin |
US20080038360A1 (en) * | 2006-08-11 | 2008-02-14 | Joseph Michael Zukowski | Personal care composition |
US20080050334A1 (en) * | 2006-08-24 | 2008-02-28 | L'oreal | Cosmetic composition comprising an extract of emblica officinalis, a hydroxy acid, and an N-substituted aminosulfonic acid, and methods of using same |
US20080175875A1 (en) * | 2006-09-25 | 2008-07-24 | Hari Babu Sunkara | Cosmetic compositions |
WO2008046258A1 (en) | 2006-10-17 | 2008-04-24 | Hailong Wang | Cosmetic composition and preparation method and use thereof |
US20080113027A1 (en) * | 2006-11-09 | 2008-05-15 | Alcon Manufacturing Ltd. | Water insoluble polymer matrix for drug delivery |
US8632809B2 (en) | 2006-11-09 | 2014-01-21 | Alcon Research, Ltd. | Water insoluble polymer matrix for drug delivery |
EP2409687A1 (en) | 2006-11-09 | 2012-01-25 | Alcon Research, Ltd. | Water insoluble polymer matrix for drug delivery |
WO2008067127A2 (en) | 2006-11-09 | 2008-06-05 | Alcon Research, Ltd. | Water insoluble polymer matrix for drug delivery |
US20080114076A1 (en) * | 2006-11-09 | 2008-05-15 | Alcon Manufacturing Ltd. | Punctal plug comprising a water-insoluble polymeric matrix |
US20080139453A1 (en) * | 2006-12-12 | 2008-06-12 | The Procter & Gamble Company | Multiple emulsion compositions |
US9358263B2 (en) | 2007-02-28 | 2016-06-07 | The Procter & Gamble Company | Personal care composition comprising botanical extract |
US20080206373A1 (en) * | 2007-02-28 | 2008-08-28 | Cheri Lynn Millikin | Personal Care Composition Comprising Botanical Extract |
US20090017080A1 (en) * | 2007-03-15 | 2009-01-15 | Paul Robert Tanner | Personal care kit having skin care compositions with a readily perceptible difference |
US10434056B2 (en) | 2007-04-19 | 2019-10-08 | Mary Kay Inc. | Magnolia extract containing compositions |
US9668964B1 (en) | 2007-04-19 | 2017-06-06 | Mary Kay Inc. | Magnolia extract containing compositions |
US9101555B1 (en) | 2007-04-19 | 2015-08-11 | Mary Kay Inc. | Magnolia extract containing compositions |
US8084066B2 (en) | 2007-04-19 | 2011-12-27 | Mary Kay Inc. | Magnolia extract containing compositions |
US8084063B2 (en) | 2007-04-19 | 2011-12-27 | Mary Kay Inc. | Magnolia extract containing compositions |
US7744932B2 (en) | 2007-04-19 | 2010-06-29 | Mary Kay Inc. | Magnolia extract containing compositions |
US8445036B2 (en) | 2007-04-19 | 2013-05-21 | Mary Kay Inc. | Magnolia extract containing compositions |
US20100143515A1 (en) * | 2007-04-19 | 2010-06-10 | Mary Kay Inc. | Magnolia extract containing compositions |
US9844503B2 (en) | 2007-04-19 | 2017-12-19 | Mary Kay Inc. | Magnolia extract containing compositions |
EP2455134A2 (en) | 2007-04-19 | 2012-05-23 | Mary Kay, Inc. | Magnolia extract containing compositions |
US11045403B2 (en) | 2007-04-19 | 2021-06-29 | Belaj Innovations Llc | Magnolia extract containing compositions |
US11660259B2 (en) | 2007-04-19 | 2023-05-30 | Mary Kay Inc. | Magnolia extract containing compositions |
US8758839B2 (en) | 2007-04-19 | 2014-06-24 | Mary Kay Inc. | Magnolia extract containing compositions |
US9622965B2 (en) | 2007-04-19 | 2017-04-18 | Mary Kay Inc. | Magnolia extract containing compositions |
US12097273B2 (en) | 2007-04-19 | 2024-09-24 | Mary Kay Inc. | Magnolia extract containing compositions |
US20100173003A1 (en) * | 2007-05-24 | 2010-07-08 | Amcol International | Composition and method for encapsulating benefit agents |
US20110091530A1 (en) * | 2007-06-27 | 2011-04-21 | The Board Of Trustees Of The Leland Stanford Junior University | Oligopeptide tyrosinase inhibitors and uses thereof |
US7902329B2 (en) | 2007-06-27 | 2011-03-08 | The Board Of Trustees Of The Leland Stanford Junior University | Oligopeptide tyrosinase inhibitors and uses thereof |
US20090099091A1 (en) * | 2007-06-27 | 2009-04-16 | The Board Of Trustees Of The Leland Stanford Junior University | Oligopeptide Tyrosinase Inhibitors and Uses Thereof |
US8338364B2 (en) | 2007-06-27 | 2012-12-25 | The Board Of Trustees Of The Leland Stanford Junior University | Peptide tyrosinase inhibitors and uses thereof |
US8193154B2 (en) | 2007-06-27 | 2012-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Oligopeptide tyrosinase inhibitors and uses thereof |
US20090099093A1 (en) * | 2007-06-27 | 2009-04-16 | The Board Of Trustees Of The Leland Stanford Junior University | Peptide Tyrosinase Inhibitors and Uses Thereof |
US8026208B2 (en) | 2007-06-27 | 2011-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Peptide tyrosinase inhibitors and uses thereof |
US20090011035A1 (en) * | 2007-07-03 | 2009-01-08 | Joseph Michael Zukowski | Personal care composition |
US20090047230A1 (en) * | 2007-07-27 | 2009-02-19 | Croda, Inc. | Phosphorous-containing surfactants as polymeric cationic compound deposition aids |
WO2009022338A2 (en) | 2007-08-16 | 2009-02-19 | Saher Hamed | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |
US20090092569A1 (en) * | 2007-10-09 | 2009-04-09 | Hari Babu Sunkara | Deodorant compositions |
US8409596B2 (en) | 2007-10-09 | 2013-04-02 | E I Du Pont De Nemours And Company | Deodorant compositions |
US8114423B2 (en) | 2007-10-09 | 2012-02-14 | E. I. Du Pont De Nemours And Company | Deodorant compositions |
US20090098173A1 (en) * | 2007-10-11 | 2009-04-16 | Robinson Ronni L | Topical pain relief product |
US20090196836A1 (en) * | 2007-10-25 | 2009-08-06 | Paul Robert Tanner | Multi-Functional, Multi-Phase Skin Care Product |
US20090304615A1 (en) * | 2007-11-14 | 2009-12-10 | Orlow Seth J | Tricyclic compounds as melanogenesis modifiers and uses thereof |
US20090298868A1 (en) * | 2007-11-14 | 2009-12-03 | Orlow Seth J | Quinoline compounds as melanogenesis modifiers and uses thereof |
US20090291148A1 (en) * | 2007-12-21 | 2009-11-26 | Laurie Ellen Breyfogle | Depilatory Kit Resulting in Reduced Odor and Irritation |
US8505730B2 (en) | 2008-01-04 | 2013-08-13 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
US8691248B2 (en) | 2008-03-11 | 2014-04-08 | Mary Kay Inc. | Stable three-phased emulsions |
US20090232856A1 (en) * | 2008-03-11 | 2009-09-17 | Mary Kay Inc. | Stable three-phased emulsions |
US9918912B2 (en) | 2008-03-11 | 2018-03-20 | Mary Kay Inc. | Stable three-phased emulsions |
EP3020410A1 (en) | 2008-04-18 | 2016-05-18 | Collplant Ltd. | Methods of generating and using procollagen |
US8298198B2 (en) | 2008-04-21 | 2012-10-30 | Mcneil-Ppc, Inc. | Dual spray can topical delivery device |
US20090264839A1 (en) * | 2008-04-21 | 2009-10-22 | Kriksunov Leo B | Dual spray can topical delivery device |
US20100040568A1 (en) * | 2008-04-30 | 2010-02-18 | Skinmedica, Inc. | Steroidal compounds as melanogenesis modifiers and uses thereof |
US10016452B2 (en) | 2008-05-01 | 2018-07-10 | The Regents Of The University Of California | Fibromodulin formulation for reducing corneal scarring |
US20110086807A1 (en) * | 2008-05-01 | 2011-04-14 | Chia Soo | Fibromodulin formulation for reducing corneal scarring |
US20090324522A1 (en) * | 2008-06-18 | 2009-12-31 | Western Holdings, Llc | Skin protectant compositions |
US10493179B2 (en) | 2008-10-09 | 2019-12-03 | Trustees Of Tufts College | Modified silk films containing glycerol |
WO2010045163A2 (en) | 2008-10-14 | 2010-04-22 | The Procter & Gamble Company | Resilient personal care composition comprising polyalkyl ether containing siloxane elastomers |
US7947475B2 (en) | 2008-10-15 | 2011-05-24 | Danisco Us Inc. | Modified variant Bowman Birk protease inhibitors |
US7803902B2 (en) | 2008-10-15 | 2010-09-28 | Danisco Us Inc. | Modified variant bowman birk protease inhibitors |
US8394941B2 (en) | 2008-10-15 | 2013-03-12 | Danisco Us Inc. | Modified variant Bowman Birk Protease Inhibitors |
US7772181B2 (en) | 2008-10-15 | 2010-08-10 | Danisco Us Inc. | Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors |
US8962796B2 (en) | 2008-10-15 | 2015-02-24 | Danisco Us Inc. | Modified variant Bowman Birk protease inhibitors |
US20100093028A1 (en) * | 2008-10-15 | 2010-04-15 | Amin Neelam S | Modified variant bowman birk protease inhibitors |
US20100092409A1 (en) * | 2008-10-15 | 2010-04-15 | Amin Neelam S | Personal care compositions comprising modified variant bowman birk protease inhibitors |
US20100221780A1 (en) * | 2008-10-15 | 2010-09-02 | Danisco Us Inc. | Modified Variant Bowman Birk Protease Inhibitors |
US20100129301A1 (en) * | 2008-11-24 | 2010-05-27 | Shuhei Tanaka | Cosmetic compositions |
WO2010067327A1 (en) | 2008-12-11 | 2010-06-17 | Sederma | Cosmetic composition containing acetylated oligoglucuronans |
US8697656B2 (en) | 2009-01-16 | 2014-04-15 | Sederma | Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses |
WO2010082175A2 (en) | 2009-01-16 | 2010-07-22 | Sederma | New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
EP3744729A1 (en) | 2009-01-16 | 2020-12-02 | Sederma | Compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
WO2010082176A2 (en) | 2009-01-16 | 2010-07-22 | Sederma | Cosmetic composition containing kxk type peptides and uses |
WO2010082177A2 (en) | 2009-01-16 | 2010-07-22 | Sederma | New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
WO2010085532A2 (en) | 2009-01-22 | 2010-07-29 | The Procter & Gamble Company | Skin-care composition comprising dill extract |
US9676696B2 (en) | 2009-01-29 | 2017-06-13 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
WO2010088225A2 (en) | 2009-01-29 | 2010-08-05 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
US20100189669A1 (en) * | 2009-01-29 | 2010-07-29 | Tomohiro Hakozaki | Regulation of Mammalian Keratinous Tissue Using Skin and/or Hair Care Actives |
US20100227011A1 (en) * | 2009-02-24 | 2010-09-09 | Dennis Eugene Kuhlman | Regulation of mammalian keratinous tissue using personal-care compositions comprising a turmerone compound |
EP2226063A2 (en) | 2009-03-04 | 2010-09-08 | Takasago International Corporation | High intensity fragrances |
US20100229966A1 (en) * | 2009-03-12 | 2010-09-16 | Ford Global Technologies, Llc | Fuel systems and methods for controlling fuel systems in a vehicle with multiple fuel tanks |
US20110020250A1 (en) * | 2009-03-20 | 2011-01-27 | Laurie Ellen Breyfogle | Personal-care composition comprising a hydrocarbon wax and a polar oil |
WO2010108085A2 (en) | 2009-03-20 | 2010-09-23 | The Procter & Gamble Company | Personal-care composition comprising oil-soluble solid sunscreens |
US20100303744A1 (en) * | 2009-03-20 | 2010-12-02 | Laurie Ellen Breyfogle | Personal-care composition comprising oil-soluble solid sunscreens |
WO2010108088A2 (en) | 2009-03-20 | 2010-09-23 | The Procter & Gamble Company | Personal-care composition comprising a hydrocarbon wax and a polar oil |
US8088364B2 (en) | 2009-03-20 | 2012-01-03 | The Procter & Gamble Company | Personal-care composition comprising oil-soluble solid sunscreens |
US9833391B2 (en) | 2009-03-20 | 2017-12-05 | The Proctor & Gamble Company | Personal-care composition comprising a hydrocarbon wax and a polar oil |
WO2010111267A2 (en) | 2009-03-23 | 2010-09-30 | The Procter & Gamble Company | Personal-care composition comprising a cationic active |
WO2010111266A2 (en) | 2009-03-23 | 2010-09-30 | The Procter & Gamble Company | Personal-care composition comprising a cationic active |
US20100305169A1 (en) * | 2009-03-23 | 2010-12-02 | Larry Rich Robinson | Personal-care composition comprising a cationic active |
US8993006B2 (en) | 2009-03-30 | 2015-03-31 | Mary Kay Inc. | Topical skin care formulations |
US20100247563A1 (en) * | 2009-03-30 | 2010-09-30 | Mary Kay Inc. | Topical skin care formulations |
US8178106B2 (en) | 2009-03-30 | 2012-05-15 | Mary Kay Inc. | Topical skin care formulations |
WO2010113146A1 (en) | 2009-04-01 | 2010-10-07 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | A method of regulating proliferation and differentiation of keratinocyes |
US9050477B2 (en) | 2009-04-17 | 2015-06-09 | Sederma | Cosmetic compositions comprising oridonin and new cosmetic uses |
US11638735B2 (en) | 2009-04-27 | 2023-05-02 | Mary Kay Inc. | Botanical formulations |
US10953058B2 (en) | 2009-04-27 | 2021-03-23 | Mary Kay Inc. | Botanical formulations |
US10682381B2 (en) | 2009-04-27 | 2020-06-16 | Mary Kay Inc. | Botanical formulations |
WO2010136965A2 (en) | 2009-05-26 | 2010-12-02 | Sederma | Cosmetic use of tyr-arg dipeptide to combat cutaneous sa |
WO2010141683A2 (en) | 2009-06-04 | 2010-12-09 | The Procter & Gamble Company | Multiple product system for hair |
WO2011019718A2 (en) | 2009-08-10 | 2011-02-17 | The Procter & Gamble Company | Personal care composition with improved spreadability |
US20110033512A1 (en) * | 2009-08-10 | 2011-02-10 | Laurie Ellen Breyfogle | Personal care composition with improved spreadability |
WO2011019876A2 (en) | 2009-08-14 | 2011-02-17 | The Procter & Gamble Company | Personal cleansing compositions comprising a bacterial cellulose network and cationic polymer |
WO2011028601A2 (en) | 2009-08-26 | 2011-03-10 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
US11596813B2 (en) | 2009-08-28 | 2023-03-07 | Mary Kay Inc. | Skin care formulations |
WO2011026039A1 (en) | 2009-08-28 | 2011-03-03 | Mary Kay Inc. | Skin care formulations |
US8691300B2 (en) | 2009-08-28 | 2014-04-08 | Mary Kay Inc. | Skin care formulations |
US12097393B2 (en) | 2009-08-28 | 2024-09-24 | Mary Kay Inc. | Skin care formulations |
US8895082B2 (en) | 2009-08-28 | 2014-11-25 | Mary Kay Inc. | Skin care formulations |
US11123578B2 (en) | 2009-08-28 | 2021-09-21 | Mary Kay Inc. | Skin care formulations |
US10434340B2 (en) | 2009-08-28 | 2019-10-08 | Mary Kay Inc. | Skin care formulations |
US11679284B2 (en) | 2009-08-28 | 2023-06-20 | Mary Kay Inc. | Skin care formulations |
US8048456B2 (en) | 2009-08-28 | 2011-11-01 | Mary Kay Inc. | Skin care formulations |
US9833642B2 (en) | 2009-08-28 | 2017-12-05 | Mary Kay Inc. | Skin care formulations |
US9051534B2 (en) | 2009-11-04 | 2015-06-09 | E I Du Pont De Nemours And Company | Compositions for extracting flavor and fragrance compounds and solubilizing essential oils |
US8486458B2 (en) | 2009-11-04 | 2013-07-16 | E I Du Pont De Nemours And Company | Methods and compositions for extracting flavor and fragrance compounds and solubilizing essential oils |
EP2357025A2 (en) | 2009-12-17 | 2011-08-17 | Johnson & Johnson Consumer Companies, Inc. | Mild leave-on skin care compositions |
WO2011085053A2 (en) | 2010-01-07 | 2011-07-14 | The Gillette Company | Personal care compositions comprising a multi-active system for down regulating cytokines irritation |
WO2011088073A2 (en) | 2010-01-15 | 2011-07-21 | The Gillette Company | Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof |
WO2011088178A2 (en) | 2010-01-15 | 2011-07-21 | The Gillette Company | Personal care composition comprising a hydrophobically modified cationic polysaccharide |
US8563754B2 (en) | 2010-01-28 | 2013-10-22 | New York University | Compounds, compositions and methods for preventing skin darkening |
US20110190229A1 (en) * | 2010-01-28 | 2011-08-04 | Orlow Seth J | Compounds, compositions and methods for preventing skin darkening |
WO2011103146A2 (en) | 2010-02-16 | 2011-08-25 | The Procter & Gamble Company | A post foaming gel composition comprising an anti-irritation agent |
WO2011103449A2 (en) | 2010-02-19 | 2011-08-25 | Mary Kay Inc. | Topical skin care formulation |
WO2011133539A2 (en) | 2010-04-19 | 2011-10-27 | The Procter & Gamble Company | Combined energy and topical composition application for regulating the condition of mammalian skin |
WO2011133538A1 (en) | 2010-04-19 | 2011-10-27 | The Procter & Gamble Company | Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto |
WO2011140312A2 (en) | 2010-05-06 | 2011-11-10 | The Gillette Company | Method of making an aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet |
WO2011140330A2 (en) | 2010-05-06 | 2011-11-10 | The Gillette Company | An aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet |
WO2011146491A2 (en) | 2010-05-17 | 2011-11-24 | Mary Kay Inc. | Topical skin formulation |
US10548821B2 (en) | 2010-05-17 | 2020-02-04 | Mary Kay Inc. | Topical skin formulation |
US11648187B2 (en) | 2010-05-17 | 2023-05-16 | Mary Kay Inc. | Topical skin formulation |
WO2011153296A1 (en) | 2010-06-02 | 2011-12-08 | Lubrizol Advanced Materials, Inc. | Ink/dye receptive films, papers, and fabrics |
WO2012009298A2 (en) | 2010-07-16 | 2012-01-19 | The Gillette Company | Personal care compositions comprising a multi-active system for down regulating cytokines irritation |
WO2012011905A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Methods for improving the appearance of hyperpigmented spot(s) with multiple actives |
WO2012011908A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Compositions and methods for inhibiting par2 activation of keratinocytes |
WO2012011907A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Laminaria saccharina extract and vitamin b3 as whitening agents |
WO2012011906A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Methods for inhibiting tyrosinase using an extract of laminaria saccharina |
WO2012011904A1 (en) | 2010-07-22 | 2012-01-26 | The Procter & Gamble Company | Methods for improving the appearance of hyperpigmented spot(s) using an extract of laminaria saccharina |
US9132290B2 (en) | 2010-07-23 | 2015-09-15 | The Procter & Gamble Company | Cosmetic composition |
WO2012012497A2 (en) | 2010-07-23 | 2012-01-26 | The Procter & Gamble Company | Cosmetic composition |
US10842728B2 (en) | 2010-08-09 | 2020-11-24 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
US9737472B2 (en) | 2010-08-09 | 2017-08-22 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
US9205284B2 (en) | 2010-08-09 | 2015-12-08 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
WO2012033634A2 (en) | 2010-09-09 | 2012-03-15 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
WO2012033989A2 (en) | 2010-09-10 | 2012-03-15 | The Procter & Gamble Company | Cosmetic compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation |
WO2012034060A2 (en) | 2010-09-10 | 2012-03-15 | Akzo Nobel Chemicals International B.V. | Bioactive compositions comprising ficus serum fraction and methods to reduce the appearance of skin hyperpigmentation |
WO2012033646A2 (en) | 2010-09-10 | 2012-03-15 | Mary Kay Inc. | Topical skin care formulations comprising jaboticaba and cashew fruit pulps and extracts thereof |
US10701938B2 (en) | 2010-10-25 | 2020-07-07 | Vanderbilt University | Composition for inhibition of insect host sensing |
WO2012061039A2 (en) | 2010-10-25 | 2012-05-10 | Vanderbilt University | Compositions for inhibition of insect host sensing |
US10091997B2 (en) | 2010-10-25 | 2018-10-09 | Vanderbilt University | Composition for inhibition of insect host sensing |
US9332757B2 (en) | 2010-10-25 | 2016-05-10 | Vanderbilt University | Composition for inhibition of insect host sensing |
US8968712B2 (en) | 2010-11-18 | 2015-03-03 | The Procter & Gamble Company | Cosmetic compositions |
US9216146B2 (en) | 2010-11-18 | 2015-12-22 | The Procter & Gamble Company | Cosmetic composition |
WO2012068357A2 (en) | 2010-11-19 | 2012-05-24 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting or reducing trypsin activity |
US8715628B1 (en) | 2010-11-19 | 2014-05-06 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting or reducing trypsin activity |
WO2012068356A2 (en) | 2010-11-19 | 2012-05-24 | The Procter & Gamble Company | Compositions and methods for improving the appearance of facial pores |
US8524204B2 (en) | 2010-11-19 | 2013-09-03 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting or reducing trypsin activity |
WO2012068361A2 (en) | 2010-11-19 | 2012-05-24 | The Procter & Gamble Company | Compositions and methods for improving the appearance of facial texture |
DE202011110324U1 (en) | 2010-12-13 | 2013-07-10 | Mary Kay Inc. | Lip gloss |
US10226499B2 (en) | 2010-12-28 | 2019-03-12 | Kamedis Ltd. | Plant extracts for the treatment and prevention of infections |
US10967031B2 (en) | 2010-12-28 | 2021-04-06 | Kamedis Ltd. | Synergistic herbal compositions with prebiotic properties for treatment of skin infections, allergies and inflammation |
WO2012090205A2 (en) | 2010-12-28 | 2012-07-05 | Kamedis Ltd. | Plant extracts for the treatment and prevention of infections |
WO2012092597A2 (en) | 2010-12-30 | 2012-07-05 | Mary Kay Inc. | Multi-purpose cosmetic compositions |
US9254276B2 (en) | 2011-01-25 | 2016-02-09 | The Procter & Gamble Company | Liposome and personal care composition comprising thereof |
US9822125B2 (en) | 2011-01-27 | 2017-11-21 | New York University | Benzopyran compounds as melanogenesis modifiers and uses thereof |
US8772252B2 (en) | 2011-01-27 | 2014-07-08 | New York University | Coumarin compounds as melanogenesis modifiers and uses thereof |
US8802722B2 (en) | 2011-01-27 | 2014-08-12 | New York University | Benzopyran compounds as melanogenesis modifiers and uses thereof |
US9434993B2 (en) | 2011-02-22 | 2016-09-06 | The Procter & Gamble Company | Systems for identifying cosmetic agents for skin care compositions |
US8486461B2 (en) | 2011-02-22 | 2013-07-16 | The Procter & Gamble Company | Methods for improving the appearance of aging skin using a composition comprising banyan tree, lotus, and clover serum fractions |
US10563258B2 (en) | 2011-02-22 | 2020-02-18 | The Procter & Gamble Company | Method of making skin care compositions |
WO2012116077A2 (en) | 2011-02-22 | 2012-08-30 | The Procter & Gamble Company | Methods for improving the appearance of aging skin using a composition comprising banyan tree, lotus, and clover serum fractions |
US8673372B2 (en) | 2011-02-22 | 2014-03-18 | The Procter & Gamble Company | Methods for improving the appearance of hyperpigmented skin using a synergistic composition comprising banyan tree, lotus, and clover serum fractions |
WO2012116081A2 (en) | 2011-02-22 | 2012-08-30 | The Procter & Gamble Company | Methods for identifying cosmetic agents for skin care compositions |
WO2012116055A2 (en) | 2011-02-22 | 2012-08-30 | The Procter & Gamble Company | Methods for improving the appearance of hyperpigmented skin using a synergistic composition comprising banyan tree, lotus, and clover serum fractions |
WO2012115949A2 (en) | 2011-02-22 | 2012-08-30 | Akzo Nobel Chemicals International B.V. | Composition comprising banyan tree, lotus, and clover serum fractions (hyperpigmentation) |
WO2012115947A2 (en) | 2011-02-22 | 2012-08-30 | Akzo Nobel Chemicals International B.V. | Composition comprising banyan tree, lotus, and clover serum fractions (aging) |
US9161531B2 (en) | 2011-02-23 | 2015-10-20 | Donald R. Korb | High alcohol content sanitizer |
US9775344B2 (en) | 2011-02-23 | 2017-10-03 | Donald R. Korb | High alcohol content sanitizer |
EP2497481A1 (en) | 2011-03-08 | 2012-09-12 | ELC Management LLC | Use of extracts for activating caspase-14 expression in human skin |
EP2537513A2 (en) | 2011-03-11 | 2012-12-26 | ELC Management LLC | Use of anogeissus extract for fibrillin production in skin |
DE202012012873U1 (en) | 2011-03-28 | 2014-02-03 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
US10072293B2 (en) | 2011-03-31 | 2018-09-11 | The Procter And Gamble Company | Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis |
DE202012012769U1 (en) | 2011-04-06 | 2014-01-29 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
DE202012012784U1 (en) | 2011-04-21 | 2014-01-30 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
EP3653054A1 (en) | 2011-05-06 | 2020-05-20 | Vanderbilt University | Composition for inhibition of insect sensing |
US10188105B2 (en) | 2011-05-06 | 2019-01-29 | Vanderbilt University | Compositions for inhibition of insect sensing |
US10813355B2 (en) | 2011-05-06 | 2020-10-27 | Vanderbilt University | Compositions for inhibition of insect sensing |
US9578881B2 (en) | 2011-05-06 | 2017-02-28 | Vanderbilt University | Compositions for inhibition of insect sensing |
US11484032B2 (en) | 2011-05-06 | 2022-11-01 | Vanderbilt University | Compositions for inhibition of insect sensing |
DE202012012801U1 (en) | 2011-05-10 | 2014-02-17 | Mary Kay Inc. | cosmetic compositions |
WO2012153336A2 (en) | 2011-05-12 | 2012-11-15 | Rakuto Bio Technologies Ltd. | Methods and device for lightening skin complexion |
DE202012012834U1 (en) | 2011-06-08 | 2014-03-31 | Mary Kay Inc. | Sunscreen formulations |
WO2012174096A2 (en) | 2011-06-13 | 2012-12-20 | The Procter & Gamble Company | Personal care compositions comprising a di-amido gellant and methods of using |
WO2012174091A2 (en) | 2011-06-13 | 2012-12-20 | The Procter & Gamble Company | PERSONAL CARE COMPOSITIONS COMPRISING A pH TUNEABLE GELLANT AND METHODS OF USING |
WO2012177757A2 (en) | 2011-06-20 | 2012-12-27 | The Procter & Gamble Company | Personal care compositions comprising shaped abrasive particles |
EP2540303A1 (en) | 2011-06-28 | 2013-01-02 | Johnson & Johnson Consumer Companies Inc. | Divalent cation containing compositions and methods for treating and/or preventing enzymatic irritation |
EP2540305A1 (en) | 2011-06-28 | 2013-01-02 | Johnson & Johnson Consumer Companies Inc. | Divalent cation/talc containing compositions and methods for treating and/or preventing enzymatic irritation |
EP2540291A1 (en) | 2011-06-28 | 2013-01-02 | Johnson & Johnson Consumer Companies Inc. | Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation |
WO2013006760A2 (en) | 2011-07-07 | 2013-01-10 | The Procter & Gamble Company | Personal care compositions with improved solubility of a solid uv active |
US9192552B2 (en) | 2011-07-07 | 2015-11-24 | The Procter & Gamble Company | Personal care compositions with improved solubility of a solid UV active |
WO2013006743A2 (en) | 2011-07-07 | 2013-01-10 | The Procter & Gamble Company | Personal care compositions with improved solubility of a solid cosmetic active |
WO2013025767A1 (en) | 2011-08-15 | 2013-02-21 | The Procter & Gamble Company | Cosmetic applicators |
WO2013025768A1 (en) | 2011-08-15 | 2013-02-21 | The Procter & Gamble Company | Cosmetic applicators |
WO2013025771A1 (en) | 2011-08-15 | 2013-02-21 | The Procter & Gamble Company | Cosmetic applicators |
US9167880B2 (en) | 2011-08-15 | 2015-10-27 | The Procter & Gamble Company | Cosmetic applicators |
WO2013025893A1 (en) | 2011-08-16 | 2013-02-21 | The Gillette Company | Personal care compositions comprising an anti-irritation agent |
WO2013025891A1 (en) | 2011-08-16 | 2013-02-21 | The Gillette Company | An aerosol shave composition comprising a hydrophobical agent forming at least one microdroplet and an anti-irritation agent |
WO2013025961A1 (en) | 2011-08-17 | 2013-02-21 | The Procter & Gamble Company | Method and kit for depilation |
EP2559421A1 (en) | 2011-08-17 | 2013-02-20 | The Procter & Gamble Company | Method and kit for depilation |
WO2013052647A2 (en) | 2011-10-04 | 2013-04-11 | Quretino Therapeutics, Inc. | Formulations and uses of retinoic acid receptor selective agonists |
US9402794B2 (en) | 2011-12-07 | 2016-08-02 | Mary Kay Inc. | Topical skin care formulation |
WO2013086518A1 (en) | 2011-12-09 | 2013-06-13 | Mary Kay Inc. | Skin care formulation |
DE202012013021U1 (en) | 2011-12-09 | 2014-11-28 | Mary Kay Inc. | Skin care formulation |
US10780041B2 (en) | 2011-12-19 | 2020-09-22 | Mary Kay Inc. | Combination of plant extracts to improve skin tone |
US11865202B2 (en) | 2011-12-19 | 2024-01-09 | Mary Kay Inc. | Combination of plant extracts to improve skin tone |
DE202012013018U1 (en) | 2011-12-19 | 2014-08-20 | Mary Kay Inc. | Combination of plant extracts to improve the skin tone |
WO2013092699A2 (en) | 2011-12-22 | 2013-06-27 | Akzo Nobel Chemicals International B.V. | Bioactive compositions having skin anti-aging activity |
US8790720B2 (en) | 2011-12-22 | 2014-07-29 | The Procter & Gamble Company | Compositions and methods for treating skin |
WO2013092698A2 (en) | 2011-12-22 | 2013-06-27 | Akzo Nobel Chemicals International B.V. | Bioactive compositions having hair anti aging activity |
US9913797B2 (en) | 2011-12-22 | 2018-03-13 | Isp Investments Llc | Bioactive compositions having hair anti aging activity |
US8784907B2 (en) | 2011-12-22 | 2014-07-22 | The Procter & Gamble Company | Compositions and methods for improving the appearance of aging hair |
US10172784B2 (en) | 2011-12-22 | 2019-01-08 | Isp Investments Llc | Bioactive compositons having skin anti aging activity |
WO2013109851A2 (en) | 2012-01-19 | 2013-07-25 | The Procter & Gamble Company | Methods for smoothing wrinkles and skin texture imperfections |
WO2013109850A2 (en) | 2012-01-19 | 2013-07-25 | The Procter & Gamble Company | Methods for smoothing wrinkles and skin texture imperfections |
EP2620211A2 (en) | 2012-01-24 | 2013-07-31 | Takasago International Corporation | New microcapsules |
WO2013111912A1 (en) | 2012-01-24 | 2013-08-01 | Takasago International Corporation | Microcapsules |
WO2013122932A2 (en) | 2012-02-14 | 2013-08-22 | The Procter & Gamble Company | Topical use of a skin-commensal prebiotic agent and compositions containing the same |
WO2013122931A2 (en) | 2012-02-14 | 2013-08-22 | The Procter & Gamble Company | Topical use of a skin-commensal prebiotic agent and compositions containing the same |
WO2013130948A2 (en) | 2012-03-01 | 2013-09-06 | The Procter & Gamble Company | Sunscreen composition comprising uv composite |
US9839598B2 (en) | 2012-03-19 | 2017-12-12 | The Procter & Gamble Company | Superabsorbent polymers and sunscreen actives for use in skin care compositions |
WO2013142471A2 (en) | 2012-03-19 | 2013-09-26 | The Procter & Gamble Company | Cross linked silicone copolmyer networks in a thickened aqueous phase |
WO2013142301A2 (en) | 2012-03-19 | 2013-09-26 | The Procter & Gamble Company | Superabsorbent polymers and silicone elastomer for use in hair care compositions |
WO2013142472A2 (en) | 2012-03-19 | 2013-09-26 | The Procter & Gamble Company | Superabsorbent polymers and silicone elastomer for use in skin care compositions |
US9549891B2 (en) | 2012-03-19 | 2017-01-24 | The Procter & Gamble Company | Superabsorbent polymers and sunscreen actives for use in skin care compositions |
US10468120B2 (en) | 2012-03-30 | 2019-11-05 | The Procter & Gamble Company | Method of generating a hyperpigmentation condition gene expression signature |
WO2013148808A1 (en) | 2012-03-30 | 2013-10-03 | The Procter & Gamble Company | Method of generating a hyperpigmentation condition gene expression signature |
US10418127B2 (en) | 2012-03-30 | 2019-09-17 | The Procter & Gamble Company | Method of formulating a skin-lightening composition |
US10282514B2 (en) | 2012-03-30 | 2019-05-07 | The Procter & Gamble Company | Method of constructing a data architecture |
WO2013148845A1 (en) | 2012-03-30 | 2013-10-03 | The Procter & Gamble Company | System for identifying connections between perturbagens and genes associated with a skin hyperpigmentation condition |
WO2013148806A1 (en) | 2012-03-30 | 2013-10-03 | The Procter & Gamble Company | Method of constructing a data architecture for use in identifying agents for skin pigmentation |
WO2013148807A1 (en) | 2012-03-30 | 2013-10-03 | The Procter & Gamble Company | Method of formulating a skin-lightening composition |
WO2013158964A2 (en) | 2012-04-20 | 2013-10-24 | The Gillette Company | Personal care composition comprising metathesized unsaturated polyol esters |
WO2013158596A2 (en) | 2012-04-20 | 2013-10-24 | The Procter & Gamble Company | Compositions and methods for improving the appearance of facial pores |
US9920357B2 (en) | 2012-06-06 | 2018-03-20 | The Procter & Gamble Company | Systems and methods for identifying cosmetic agents for hair/scalp care compositions |
WO2013184908A2 (en) | 2012-06-06 | 2013-12-12 | The Procter & Gamble Company | Systems and methods for identifying cosmetic agents for hair/scalp care compositions |
US9271912B2 (en) | 2012-06-13 | 2016-03-01 | The Procter & Gamble Company | Personal care compositions comprising a pH tuneable gellant and methods of using |
WO2013192073A2 (en) | 2012-06-18 | 2013-12-27 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
US9724292B2 (en) | 2012-06-18 | 2017-08-08 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
WO2013192076A1 (en) | 2012-06-18 | 2013-12-27 | The Procter & Gamble Company | Methods and models for assessing anti-aging benefits of agents |
US9801811B1 (en) | 2012-06-18 | 2017-10-31 | The Procter & Gamble Company | Compositions for improving the appearance of aging skin |
US9593363B2 (en) | 2012-06-18 | 2017-03-14 | The Procter & Gamble Company | Methods and models for assessing anti-aging benefits of agents |
US9486400B2 (en) | 2012-06-18 | 2016-11-08 | The Proctor & Gamble Company | Method of improving the appearance of aging skin |
US9804152B1 (en) | 2012-08-15 | 2017-10-31 | The Procter & Gamble Company | Human ex vivo skin model and its use in methods of identifying modulators of skin inflammation |
WO2014028734A1 (en) | 2012-08-15 | 2014-02-20 | The Procter & Gamble Company | Human ex vivo skin model and use in methods of identifying modulators of skin inflammation |
US10036741B2 (en) | 2012-08-15 | 2018-07-31 | The Procter & Gamble Company | Systems, models and methods for identifying and evaluating skin-active agents effective for treating an array of skin disorders |
WO2014052179A2 (en) | 2012-09-28 | 2014-04-03 | Johnson & Johnson Consumer Companies, Inc. | Rinse-off skin care compositions containing alkyl amidopropyl betaine surfactants |
WO2014065934A1 (en) | 2012-10-25 | 2014-05-01 | Raytheon Company | Multi-bandpass, dual-polarization radome with embedded gridded structures |
WO2014066827A2 (en) | 2012-10-26 | 2014-05-01 | Mary Kay Inc. | Kit for personalizing the color of a topical skin composition |
DE202013012135U1 (en) | 2012-10-26 | 2015-08-03 | Mary Kay Inc. | Kit for customizing the color of topical skin care compositions |
WO2014070834A1 (en) | 2012-10-30 | 2014-05-08 | The Procter & Gamble Company | Personal care compositions comprising self-assembling peptides |
US9364416B2 (en) | 2012-11-09 | 2016-06-14 | Johnson & Johnson Consumer Inc. | Leave-on compositions containing cellulose materials |
US9549889B2 (en) | 2012-11-09 | 2017-01-24 | Johnson & Johnson Consumer Inc. | Rinse-off skin care compositions containing cellulosic materials |
US9549890B2 (en) | 2012-11-09 | 2017-01-24 | Johnson & Johnson Consumer Inc. | Rinse-off skin care compositions containing cellulosic materials |
US9370478B2 (en) | 2012-11-09 | 2016-06-21 | Johnson & Johnson Consumer Inc. | Skin care compositions containing cotton and citrus-derived materials |
WO2014074581A1 (en) | 2012-11-09 | 2014-05-15 | Johnson & Johnson Consumer Companies, Inc. | Rinse-off skin care compositions containing cellulosic materials |
WO2014074578A1 (en) | 2012-11-09 | 2014-05-15 | Johnson & Johnson Consumer Companies, Inc. | Leave-on compositions containing cellulose materials |
US9737473B2 (en) | 2012-11-09 | 2017-08-22 | Johnson & Johnson Consumer Inc. | Leave-on compositions containing cellulose materials |
US11000592B2 (en) | 2012-12-19 | 2021-05-11 | The Procter & Gamble Company | Compositions and methods for treating non-cornified epithelial tissue of a female body |
WO2014100067A1 (en) | 2012-12-19 | 2014-06-26 | The Procter & Gamble Company | Compositions and/or articles with improved solubility of a solid active |
WO2014124197A1 (en) | 2013-02-08 | 2014-08-14 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
US9138393B2 (en) | 2013-02-08 | 2015-09-22 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
US9084740B2 (en) | 2013-02-19 | 2015-07-21 | Johnson & Johnson Consumer Companies, Inc. | Methods and compositions for improving appearance and formation of scar tissue |
WO2014130432A1 (en) | 2013-02-19 | 2014-08-28 | Johnson & Johnson Consumer Companies, Inc. | Methods and compositions for improving appearance and formation of scar tissue |
WO2014130434A1 (en) | 2013-02-19 | 2014-08-28 | Johnson & Johnson Consumer Companies, Inc. | Methods and compositions for improving appearance and formation of scar tissue |
US9333230B2 (en) | 2013-03-14 | 2016-05-10 | Mary Kay Inc. | Cosmetic compositions |
US10111919B2 (en) | 2013-03-14 | 2018-10-30 | Mary Kay Inc. | Cosmetic compositions |
KR20150127282A (en) | 2013-03-14 | 2015-11-16 | 마리 케이 인코포레이티드 | Cosmetic compositions |
KR20200138834A (en) | 2013-03-14 | 2020-12-10 | 마리 케이 인코포레이티드 | Cosmetic compositions |
WO2014159238A1 (en) | 2013-03-14 | 2014-10-02 | Mary Kay Inc. | Cosmetic compositions |
WO2014159518A1 (en) | 2013-03-14 | 2014-10-02 | The Procter & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
US10842837B2 (en) | 2013-03-14 | 2020-11-24 | Mary Kay Inc. | Cosmetic compositions |
US9511144B2 (en) | 2013-03-14 | 2016-12-06 | The Proctor & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
US11547733B2 (en) | 2013-03-14 | 2023-01-10 | Mary Kay Inc. | Cosmetic compositions |
KR20220125370A (en) | 2013-03-14 | 2022-09-14 | 마리 케이 인코포레이티드 | Cosmetic compositions |
US9463155B2 (en) | 2013-03-15 | 2016-10-11 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
US11135139B2 (en) | 2013-03-15 | 2021-10-05 | Belaj Innovations Llc | Cosmetic compositions and uses thereof |
WO2014150545A1 (en) | 2013-03-15 | 2014-09-25 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
KR20150132516A (en) | 2013-03-15 | 2015-11-25 | 마리 케이 인코포레이티드 | Cosmetic compositions and uses thereof |
US10299994B2 (en) | 2013-03-15 | 2019-05-28 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
WO2014143667A1 (en) | 2013-03-15 | 2014-09-18 | Croda, Inc. | Alkoxylated fatty alcohol alkyl ethers and products containing same |
US11723845B2 (en) | 2013-03-15 | 2023-08-15 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
WO2014149867A1 (en) | 2013-03-15 | 2014-09-25 | The Procter & Gamble Company | Cosmetic compositions and methods for inhibiting melanin synthesis |
WO2014182993A2 (en) | 2013-05-10 | 2014-11-13 | The Procter & Gamble Company | Modular emulsion-based product differentiation |
WO2014182995A2 (en) | 2013-05-10 | 2014-11-13 | The Procter & Gamble Company | Modular emulsion-based product differentiation |
EP3777820A1 (en) | 2013-05-10 | 2021-02-17 | Noxell Corporation | Modular emulsion-based product differentiation |
WO2014182996A2 (en) | 2013-05-10 | 2014-11-13 | The Procter & Gamble Company | Modular emulsion-based product differentiation |
US10123966B2 (en) | 2013-05-16 | 2018-11-13 | The Procter And Gamble Company | Hair thickening compositions and methods of use |
WO2014191995A2 (en) | 2013-05-27 | 2014-12-04 | Rakuto Bio Technologies Ltd. | Enzymatic system-containing cosmetic compositions |
EP3626310A1 (en) | 2013-05-27 | 2020-03-25 | Rakuto Bio Technologies Ltd. | Enzymatic system containing cosmetic compositions |
US9265718B2 (en) | 2013-07-01 | 2016-02-23 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
US9005674B1 (en) | 2013-07-01 | 2015-04-14 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
US10307346B2 (en) | 2013-07-15 | 2019-06-04 | The Procter & Gamble Company | Applied films for smoothing wrinkles and skin texture imperfections |
WO2015009689A2 (en) | 2013-07-15 | 2015-01-22 | The Procter & Gamble Company | Applicator for applying compositions that smooth wrinkles and skin texture imperfections |
US10682292B2 (en) | 2013-07-15 | 2020-06-16 | The Procter & Gamble Company | Applied films for smoothing wrinkles and skin texture imperfections |
WO2015009694A1 (en) | 2013-07-15 | 2015-01-22 | The Procter & Gamble Company | Applied films for smoothing wrinkles and skin texture imperfections |
US10543165B2 (en) | 2013-07-16 | 2020-01-28 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
WO2015009824A1 (en) | 2013-07-16 | 2015-01-22 | The Procter & Gamble Company | Method of improving the appearance of aging skin |
WO2015012978A1 (en) | 2013-07-22 | 2015-01-29 | The Procter & Gamble Company | Method of protecting skin from an environmental stressor |
EP2832441A1 (en) | 2013-07-29 | 2015-02-04 | Takasago International Corporation | Microcapsules |
EP2832442A1 (en) | 2013-07-29 | 2015-02-04 | Takasago International Corporation | Microcapsules |
WO2015016368A1 (en) | 2013-07-29 | 2015-02-05 | Takasago International Corporation | Microcapsules |
WO2015016369A1 (en) | 2013-07-29 | 2015-02-05 | Takasago International Corporation | Microcapsules |
EP2832440A1 (en) | 2013-07-29 | 2015-02-04 | Takasago International Corporation | Microcapsules |
WO2015016367A1 (en) | 2013-07-29 | 2015-02-05 | Takasago International Corporation | Microcapsules |
WO2015033344A1 (en) | 2013-09-05 | 2015-03-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs) |
US10561597B2 (en) | 2013-10-07 | 2020-02-18 | S.P.C.M. Sa | Use in cosmetics of polymers obtained by low-concentration, inverse emulsion polymerisation with a low level of neutralised monomers |
WO2015052426A1 (en) | 2013-10-07 | 2015-04-16 | S.P.C.M. Sa | Use in cosmetics of polymers obtained by low-concentration, inverse emulsion polymerisation with a low level of neutralised monomers |
US9597271B2 (en) | 2013-10-24 | 2017-03-21 | The Procter & Gamble Company | Cosmetic compositions and methods |
WO2015061512A1 (en) | 2013-10-24 | 2015-04-30 | The Procter & Gamble Company | Skin lightening cosmetic compositions and methods |
US9937119B2 (en) | 2013-10-29 | 2018-04-10 | Mary Kay Inc. | Cosmetic compositions |
DE202014010806U1 (en) | 2013-10-29 | 2016-09-20 | Mary Kay Inc. | Cosmetic compositions |
US10682302B2 (en) | 2013-10-29 | 2020-06-16 | Mary Kay Inc. | Cosmetic compositions |
US11253460B2 (en) | 2013-10-29 | 2022-02-22 | Mary Kay Inc. | Cosmetic compositions |
WO2015063613A2 (en) | 2013-11-01 | 2015-05-07 | Spherium Biomed S.L. | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents |
US11865204B2 (en) | 2013-11-22 | 2024-01-09 | Mary Kay Inc. | Compositions for sensitive skin |
US9801900B2 (en) | 2013-11-22 | 2017-10-31 | Mary Kay Inc. | Compositions for sensitive skin |
US11559480B2 (en) | 2013-11-22 | 2023-01-24 | Mary Kay Inc. | Compositions for sensitive skin |
US10736837B2 (en) | 2013-11-22 | 2020-08-11 | Mary Kay Inc. | Compositions for sensitive skin |
US10245282B2 (en) | 2013-11-22 | 2019-04-02 | Mary Kay Inc. | Compositions for sensitive skin |
US9856290B2 (en) | 2013-12-10 | 2018-01-02 | Sussex Research Laboratories Inc. | Glycopeptide compositions and uses thereof |
WO2015085421A1 (en) | 2013-12-10 | 2015-06-18 | Sussex Research Laboratories Inc. | Glycopeptide compositions and uses thereof |
WO2015100118A1 (en) | 2013-12-24 | 2015-07-02 | The Procter & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
US9931285B2 (en) | 2014-01-14 | 2018-04-03 | The Procter & Gamble Company | Multi-step product for improving the appearance and feel of human skin |
US10512595B2 (en) | 2014-01-14 | 2019-12-24 | The Procter & Gamble Company | Multi-step product for improving the appearance and feel of human skin |
WO2015108949A1 (en) | 2014-01-14 | 2015-07-23 | The Procter & Gamble Company | A multi-step product for improving the appearance and feel of human skin |
WO2015108946A1 (en) | 2014-01-14 | 2015-07-23 | The Procter & Gamble Company | A multi-step product for improving the appearance and feel of human skin |
WO2015108950A1 (en) | 2014-01-14 | 2015-07-23 | The Procter & Gamble Company | A multi-step regimen for improving the appearance and feel of human skin |
US9446265B2 (en) | 2014-01-14 | 2016-09-20 | The Procter & Gamble Company | Cosmetic composition |
WO2015108947A1 (en) | 2014-01-14 | 2015-07-23 | The Procter & Gamble Company | A multi-step product for improving the appearance and feel of human skin |
US10500152B2 (en) | 2014-03-10 | 2019-12-10 | Mary Kay Inc. | Skin lightening compositions |
WO2015138237A1 (en) | 2014-03-10 | 2015-09-17 | Mary Kay Inc. | Skin lightening compositions |
US9849077B2 (en) | 2014-03-10 | 2017-12-26 | Mary Kay Inc. | Skin lightening compositions |
DE202015001779U1 (en) | 2014-03-10 | 2015-07-09 | Mary Kay, Inc. | Topical skin composition |
WO2015164290A1 (en) | 2014-04-23 | 2015-10-29 | The Procter & Gamble Company | Cosmetic compositions having reduced irritation |
WO2015164291A1 (en) | 2014-04-23 | 2015-10-29 | The Procter & Gamble Company | Cosmetic compositions for hydrating skin |
US9480634B2 (en) | 2014-04-23 | 2016-11-01 | The Procter & Gamble Company | Cosmetic compositions |
US10314770B2 (en) | 2014-06-06 | 2019-06-11 | Mary Kay Inc. | Multi-purpose cosmetic water-in-silicone emulsion |
WO2016003505A1 (en) | 2014-07-02 | 2016-01-07 | Geoffrey Brooks Consultants, Llc | Peptide-based compositions and methods of use |
DE202015004866U1 (en) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | Topical skin composition and its use |
DE202015004868U1 (en) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | Topical skin composition and its use |
EP3909562A2 (en) | 2014-07-11 | 2021-11-17 | Mary Kay Inc. | Cosmetic compositions for the lip |
DE202015009366U1 (en) | 2014-07-11 | 2017-04-10 | Mary Kay Inc. | Pore minimizer |
DE202015004867U1 (en) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | lipstick composition |
DE202015004872U1 (en) | 2014-07-11 | 2015-12-23 | Mary Kay Inc. | Topical skin composition and its use |
WO2016018732A1 (en) | 2014-07-29 | 2016-02-04 | The Procter & Gamble Company | A multi-step regimen for improving the appearance and feel of human skin |
US10206859B2 (en) | 2014-07-29 | 2019-02-19 | The Procter & Gamble Company | Cosmetic composition |
US10407649B2 (en) | 2014-08-06 | 2019-09-10 | S.P.C.P. Sa | Use in detergent compositions of polymers obtained by low-concentration reverse emulsion polymerization with a low content of neutralized monomers |
WO2016049392A1 (en) | 2014-09-26 | 2016-03-31 | The Procter & Gamble Company | Methods for smoothing wrinkles and skin texture imperfections |
EP3000459A1 (en) | 2014-09-29 | 2016-03-30 | Johnson & Johnson Consumer Inc. | Antiperspirant compositions |
DE202015008361U1 (en) | 2014-12-03 | 2016-04-21 | Mary Kay Inc. | Cosmetic compositions |
DE202015009461U1 (en) | 2014-12-03 | 2017-09-15 | Mary Kay Inc. | Cosmetic composition and use thereof |
WO2016090145A2 (en) | 2014-12-03 | 2016-06-09 | Mary Kay Inc. | Cosmetic compositions |
US11446218B2 (en) | 2014-12-04 | 2022-09-20 | Mary Kay Inc. | Cosmetic compositions |
US10272028B2 (en) | 2014-12-04 | 2019-04-30 | Mary Kay Inc. | Cosmetic Compostions |
DE202015009464U1 (en) | 2014-12-04 | 2017-09-25 | Mary Kay Inc. | cosmetic compositions |
US10881699B2 (en) | 2014-12-04 | 2021-01-05 | Mary Kay Inc. | Cosmetic compositions |
US9814670B2 (en) | 2014-12-04 | 2017-11-14 | Mary Kay Inc. | Cosmetic compositions |
US12036296B2 (en) | 2014-12-04 | 2024-07-16 | Mary Kay Inc. | Cosmetic compositions |
WO2016090252A1 (en) | 2014-12-04 | 2016-06-09 | Mary Kay Inc. | Topical skin care composition comprising trifluoroacetyl tripeptide-2 |
WO2016100477A1 (en) | 2014-12-16 | 2016-06-23 | The Procter & Gamble Company | Compositions providing delayed release of actives |
EP3034131A1 (en) | 2014-12-19 | 2016-06-22 | Johnson & Johnson Consumer Inc. | Antiperspirant composition |
US11856955B2 (en) | 2015-03-25 | 2024-01-02 | Vanderbilt University | Binary compositions as disruptors of Orco-mediated odorant sensing |
US10791739B2 (en) | 2015-03-25 | 2020-10-06 | Vanderbilt University | Binary compositions as disruptors of orco-mediated odorant sensing |
WO2016178944A1 (en) | 2015-05-01 | 2016-11-10 | The Procter & Gamble Company | Method of improving the appearance of skin and compositions therefor using nicotinamide riboside |
WO2016178945A1 (en) | 2015-05-01 | 2016-11-10 | The Procter & Gamble Company | Method of improving the appearance of skin and compositions therefor using nicotinamide riboside |
US10881598B2 (en) | 2015-05-06 | 2021-01-05 | Abs Materials, Inc. | Method of using personal and home care compositions containing a sol-gel derived material |
WO2016191442A1 (en) | 2015-05-28 | 2016-12-01 | The Procter & Gamble Company | Multi-component products and multi-step regimens for improving the appearance or feel of human skin |
US10285926B2 (en) | 2015-06-29 | 2019-05-14 | The Procter & Gamble Company | Superabsorbent polymers and starch powders for use in skin care compositions |
WO2017004108A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Superabsorbent polymers and starch powders for use in skin care compositions |
WO2017004101A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Skin care compositions comprising particles with nicotinamide riboside and methods of using the same |
WO2017004102A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container |
WO2017004340A1 (en) | 2015-06-30 | 2017-01-05 | The Procter & Gamble Company | Methods for making compositions containing multiple populations of microcapsules |
WO2017004338A1 (en) | 2015-06-30 | 2017-01-05 | The Procter & Gamble Company | Compositions containing multiple populations of microcapsules |
US9687442B2 (en) | 2015-07-27 | 2017-06-27 | Mary Kay Inc. | Topical skin formulations |
US11911635B2 (en) | 2015-07-27 | 2024-02-27 | Mary Kay Inc. | Topical skin formulations |
US10869821B2 (en) | 2015-07-27 | 2020-12-22 | Mary Kay Inc. | Topical skin formulations |
US10052278B2 (en) | 2015-07-27 | 2018-08-21 | Mary Kay Inc. | Topical skin formulations |
US10201495B2 (en) | 2015-07-27 | 2019-02-12 | Mary Kay Inc. | Topical skin formulations |
US11577099B2 (en) | 2015-07-27 | 2023-02-14 | Mary Kay Inc. | Topical skin formulations |
EP4289412A2 (en) | 2015-07-28 | 2023-12-13 | Mary Kay, Inc. | Topical skin formulations |
US9974729B2 (en) | 2015-07-28 | 2018-05-22 | Mary Kay Inc. | Topical skin formulations |
US10071033B1 (en) | 2015-07-28 | 2018-09-11 | Mary Kay Inc. | Topical skin formulations |
EP3851093A1 (en) | 2015-08-10 | 2021-07-21 | Mary Kay Inc. | Topical compositions |
WO2017025963A1 (en) | 2015-08-10 | 2017-02-16 | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | Methods and pharmaceutical compositions for improving wound healing using cd24 |
US10722436B2 (en) | 2015-08-10 | 2020-07-28 | Mary Kay Inc. | Topical compositions |
US11179305B2 (en) | 2015-08-10 | 2021-11-23 | Mary Kay Inc. | Topical compositions |
EP3175888A1 (en) | 2015-12-02 | 2017-06-07 | Johnson & Johnson Consumer Inc. | Compositions containing polymeric sulfur and uses thereof |
US10238685B2 (en) | 2015-12-02 | 2019-03-26 | Johnson & Johnson Consumer Inc. | Compositions containing polymeric sulfur and uses thereof |
US10300009B2 (en) | 2015-12-18 | 2019-05-28 | Mary Kay Inc. | Topical cosmetic compositions |
US11690798B2 (en) | 2015-12-18 | 2023-07-04 | Mary Kay Inc. | Topical cosmetic compositions |
US10870022B2 (en) | 2015-12-18 | 2020-12-22 | Mary Kay Inc. | Topical cosmetic compositions |
EP4282476A2 (en) | 2015-12-18 | 2023-11-29 | Mary Kay Inc. | Topical cosmetic compositions |
US11419815B2 (en) | 2015-12-18 | 2022-08-23 | Mary Kay Inc. | Topical cosmetic compositions |
DE202016008641U1 (en) | 2015-12-18 | 2018-10-15 | Mary Kay Inc. | Topical cosmetic compositions |
US11684568B2 (en) | 2015-12-18 | 2023-06-27 | Mary Kay Inc. | Topical cosmetic compositions |
WO2017115280A1 (en) | 2015-12-30 | 2017-07-06 | Mary Kay Inc. | Topical compositions |
US11642289B2 (en) | 2015-12-30 | 2023-05-09 | Mary Kay Inc. | Topical compositions |
US11925700B2 (en) | 2015-12-30 | 2024-03-12 | Mary Kay Inc. | Topical compositions |
US10206868B2 (en) | 2015-12-30 | 2019-02-19 | Mary Kay Inc. | Topical compositions |
US10952948B2 (en) | 2015-12-30 | 2021-03-23 | Mary Kay Inc. | Topical compositions |
WO2017123512A1 (en) | 2016-01-11 | 2017-07-20 | The Procter & Gamble Company | Method of treating a skin condition and compositions therefor |
WO2017124075A1 (en) | 2016-01-15 | 2017-07-20 | Isp Investments Llc | Bioactive compositions from ginseng plant (panax spp.) and methods for their production and use |
US12030919B2 (en) | 2016-02-11 | 2024-07-09 | Seevix Material Sciences Ltd. | Composite materials comprising synthetic dragline spider silk |
US10912956B2 (en) | 2016-03-23 | 2021-02-09 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
US11918833B2 (en) | 2016-03-23 | 2024-03-05 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
US11344751B2 (en) | 2016-03-23 | 2022-05-31 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
WO2017180797A1 (en) | 2016-04-14 | 2017-10-19 | The Procter & Gamble Company | Products and methods for treating periorbital dyschromia |
WO2017180798A1 (en) | 2016-04-14 | 2017-10-19 | The Procter & Gamble Company | Products and methods for treating periorbital dyschromia |
WO2017196818A1 (en) | 2016-05-09 | 2017-11-16 | The Procter & Gamble Company | Method of identifying cosmetic agents for moisturizing skin |
WO2018053188A1 (en) | 2016-09-14 | 2018-03-22 | Yong Zhu | Cosmetic tensioning composition |
US10493009B2 (en) | 2016-12-13 | 2019-12-03 | The Procter & Gamble Company | Stable personal care compositions containing a retinoid |
WO2018111952A1 (en) | 2016-12-13 | 2018-06-21 | The Procter & Gamble Company | Stable personal care compositions containing a retinoid |
WO2018125743A1 (en) | 2016-12-29 | 2018-07-05 | Mary Kay Inc. | Cosmetic compositions comprising shea butter |
US11723856B2 (en) | 2017-03-16 | 2023-08-15 | Coast Southwest Inc. | Use of UV resistant active materials on hair |
WO2018170439A1 (en) | 2017-03-16 | 2018-09-20 | Coast Southwest, Inc. | Use of uv resistant active materials on hair |
US10835481B2 (en) | 2017-03-16 | 2020-11-17 | Coast Southwest, Inc. | Use of UV resistant active materials on hair |
WO2018170355A1 (en) | 2017-03-17 | 2018-09-20 | Mary Kay Inc. | Cosmetic compositions and methods |
US10660847B2 (en) | 2017-03-17 | 2020-05-26 | Mary Kay Inc. | Cosmetic compositions and methods |
US10881604B2 (en) | 2017-03-17 | 2021-01-05 | Mary Kay Inc. | Cosmetic compositions and methods |
US10463585B2 (en) | 2017-04-11 | 2019-11-05 | The Procter & Gamble Company | Cosmetic compositions |
WO2018191106A1 (en) | 2017-04-11 | 2018-10-18 | The Procter & Gamble Company | Cosmetic compositions |
US10813858B2 (en) | 2017-04-11 | 2020-10-27 | The Procter & Gamble Company | Cosmetic compositions |
DE202018006387U1 (en) | 2017-06-13 | 2020-03-20 | Mary Kay, Inc. | Cosmetic compositions and their use to tighten the skin |
US11389392B2 (en) | 2017-06-13 | 2022-07-19 | Mary Kay Inc. | Cosmetic compositions and methods for their use in firming skin |
US11110049B2 (en) | 2017-06-23 | 2021-09-07 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
WO2018237218A1 (en) | 2017-06-23 | 2018-12-27 | The Procter & Gamble Company | Composition and method for improving the appearance of skin |
US11534589B2 (en) | 2017-09-12 | 2022-12-27 | Lts Lohmann Therapie-Systeme Ag | Iontophoretic microneedle device |
WO2019053051A1 (en) | 2017-09-12 | 2019-03-21 | Lts Lohmann Therapie-Systeme Ag | Lontophoretic microneedle device |
US12097279B2 (en) | 2017-09-18 | 2024-09-24 | Mary Kay Inc. | Cosmetic compositions and methods |
WO2019087084A1 (en) | 2017-11-02 | 2019-05-09 | Eman Biodiscoveries Sd. Bhd. | Extract of orthosiphon stamineus, formulations, and uses thereof |
WO2019148080A1 (en) | 2018-01-29 | 2019-08-01 | Mary Kay Inc. | Topical compositions |
WO2019226722A1 (en) | 2018-05-22 | 2019-11-28 | The Procter & Gamble Company | System and method for identifying connections between perturbagens and genes associated with a skin condition |
WO2019236935A1 (en) | 2018-06-08 | 2019-12-12 | The Procter & Gamble Company | Topical skincare compositions comprising centella asiatica selected triterpenes |
WO2019245944A1 (en) | 2018-06-18 | 2019-12-26 | The Procter & Gamble Company | Method for degrading bilirubin in skin |
WO2020010036A1 (en) | 2018-07-03 | 2020-01-09 | The Procter & Gamble Company | Method of treating a skin condition |
US11622963B2 (en) | 2018-07-03 | 2023-04-11 | The Procter & Gamble Company | Method of treating a skin condition |
US11547734B2 (en) | 2018-07-03 | 2023-01-10 | Mary Kay Inc. | Topical muscle relaxation compositions and methods |
US12048724B2 (en) | 2018-07-03 | 2024-07-30 | Mary Kay Inc. | Topical muscle relaxation compositions and methods |
WO2020026241A1 (en) | 2018-07-31 | 2020-02-06 | Collplant Ltd. | Tobacco transgenic event and methods for detection and use thereof |
DE202019005695U1 (en) | 2018-09-18 | 2021-07-01 | Mary Kay, Inc. | Plant extracts to reduce the appearance of hyperpigmented skin or to lighten the skin |
WO2020061184A1 (en) | 2018-09-18 | 2020-03-26 | Mary Kay Inc. | Plant extracts to reduce the appearance of hyperpigmented skin or to lighten skin |
US11883523B2 (en) | 2018-09-18 | 2024-01-30 | Mary Kay Inc. | Plant extracts to reduce the appearance of hyperpigmented skin or to lighten skin |
FR3087119A1 (en) | 2018-10-12 | 2020-04-17 | Laboratoires Clarins | COSMETIC COMPOSITION FOR SKIN CARE AND RADIANCE AND PROCESS FOR PREPARING THE SAME |
WO2020074395A1 (en) | 2018-10-12 | 2020-04-16 | Laboratoires Clarins | Cosmetic composition for skin care and radiance, and method for preparing same |
US11883524B2 (en) | 2018-12-14 | 2024-01-30 | Mary Kay Inc. | Cosmetic compositions |
US11612559B2 (en) | 2018-12-14 | 2023-03-28 | Mary Kay Inc. | Cosmetic compositions |
US11185492B2 (en) | 2018-12-14 | 2021-11-30 | Mary Kay Inc. | Cosmetic compositions |
WO2020123306A1 (en) | 2018-12-14 | 2020-06-18 | Mary Kay Inc. | Cosmetic compositions |
DE202019005710U1 (en) | 2018-12-14 | 2021-07-20 | Mary Kay Inc. | Cosmetic compositions |
DE202019005739U1 (en) | 2018-12-20 | 2021-09-28 | Mary Kay Inc. | Cosmetic compositions |
WO2020131477A2 (en) | 2018-12-20 | 2020-06-25 | Mary Kay Inc. | Cosmetic compositions |
DE202020005611U1 (en) | 2019-02-18 | 2021-10-25 | Mary Kay Inc. | Topical skin composition used to treat rosacea and redness of the skin |
WO2020172101A1 (en) | 2019-02-18 | 2020-08-27 | Mary Kay Inc. | Topical skin compositions for treating rosacea and skin redness |
US11304987B2 (en) | 2019-03-05 | 2022-04-19 | Fre Skincare Ltd | Argan extracts for the treatment of dermatological conditions |
WO2020219478A1 (en) | 2019-04-22 | 2020-10-29 | Elc Management Llc | Topical delivery system containing cellulose nanofibers |
WO2020264568A1 (en) | 2019-06-28 | 2020-12-30 | The Procter & Gamble Company | Method of inhibiting par2 activation and compositions therefor |
WO2020264567A1 (en) | 2019-06-28 | 2020-12-30 | The Procter & Gamble Company | Skin care composition |
WO2021010953A1 (en) | 2019-07-15 | 2021-01-21 | The Procter & Gamble Company | Topical skincare compositions comprising centella asiatica |
WO2021026565A1 (en) | 2019-08-07 | 2021-02-11 | Mary Kay Inc. | Dissolvable vitamin c and retinol film |
WO2021119664A1 (en) | 2019-12-10 | 2021-06-17 | Mary Kay Inc. | Herbal cosmetic composition for treating skin |
US11571379B2 (en) | 2020-01-24 | 2023-02-07 | The Procter & Gamble Company | Skin care composition |
WO2021150807A1 (en) | 2020-01-24 | 2021-07-29 | The Procter & Gamble Company | Skin care composition |
WO2021155398A1 (en) | 2020-01-28 | 2021-08-05 | Mary Kay Inc. | Lip composition |
WO2021168474A1 (en) | 2020-02-17 | 2021-08-26 | Mary Kay Inc. | Topical cosmetic compositions |
EP3871765A1 (en) | 2020-02-26 | 2021-09-01 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
EP3871764A1 (en) | 2020-02-26 | 2021-09-01 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
EP3871766A1 (en) | 2020-02-26 | 2021-09-01 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
KR20220166842A (en) | 2020-04-09 | 2022-12-19 | 버텔러스 홀딩스 엘엘씨 | Crosslinking composition and use thereof |
EP3900697A1 (en) | 2020-04-21 | 2021-10-27 | Takasago International Corporation | Fragrance composition |
WO2021214628A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified polymers |
DE202021004226U1 (en) | 2020-04-23 | 2023-03-21 | Mary Kay, Inc. | topical cosmetic compositions |
WO2021214626A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols |
WO2021217176A1 (en) | 2020-04-23 | 2021-10-28 | Mary Kay Inc. | Topical cosmetic compositions |
US11690869B2 (en) | 2020-04-23 | 2023-07-04 | Johnson & Johnson Consumer Inc. | Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers |
WO2021214627A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified polymers |
WO2021217186A1 (en) | 2020-04-23 | 2021-10-28 | Mary Kay Inc. | Topical cosmetic compositions |
US12076414B2 (en) | 2020-04-23 | 2024-09-03 | Johnson & Johnson Consumer Inc. | Methods and compositions inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers |
WO2021214625A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers |
WO2021214624A1 (en) | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers |
WO2021222933A1 (en) | 2020-04-29 | 2021-11-04 | Mary Kay Inc. | Cosmetic compositions and methods comprising plumeria alba flower extract |
WO2021226632A1 (en) | 2020-05-06 | 2021-11-11 | Mary Kay Inc. | Cosmetic composition comprising gluconolactone and glycolic acid |
WO2021232040A1 (en) | 2020-05-11 | 2021-11-18 | Mary Kay Inc. | Brightening booster technology and brightening ampule |
WO2021243359A1 (en) | 2020-05-27 | 2021-12-02 | Mary Kay Inc. | Topical compositions and methods |
WO2021247495A1 (en) | 2020-06-01 | 2021-12-09 | The Procter & Gamble Company | LOW-pH SKIN CARE COMPOSITION AND METHODS OF USING THE SAME |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
WO2021247496A1 (en) | 2020-06-01 | 2021-12-09 | The Procter & Gamble Company | Method of improving penetration of a vitamin b3 compound into skin |
EP3957296A1 (en) | 2020-06-01 | 2022-02-23 | The Procter & Gamble Company | Low ph skin care composition and methods of using the same |
US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
US11911498B2 (en) | 2020-06-01 | 2024-02-27 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
WO2021253053A1 (en) | 2020-06-12 | 2021-12-16 | Mary Kay Inc. | Topical compositions and methods |
DE202021004246U1 (en) | 2020-06-12 | 2023-04-25 | Mary Kay Inc. | Topical composition |
WO2021258099A1 (en) | 2020-06-16 | 2021-12-23 | Mary Kay Inc. | Cosmetic composition |
WO2022094595A1 (en) | 2020-10-30 | 2022-05-05 | Mary Kay Inc. | Instant effect eye cream |
WO2022132518A1 (en) | 2020-12-14 | 2022-06-23 | The Procter & Gamble Company | Method of manufacturing cosmetic compositions comprising sucrose esters and solvents |
WO2022132519A1 (en) | 2020-12-14 | 2022-06-23 | The Procter & Gamble Company | Cosmetic compositions comprising sucrose esters and solvents |
US12036302B2 (en) | 2020-12-14 | 2024-07-16 | The Procter & Gamble Company | Method of treating oxidative stress in skin and compositions therefor |
US11850299B2 (en) | 2021-01-22 | 2023-12-26 | The Procter & Gamble Company | Skin care composition and method of using the same |
WO2022159967A1 (en) | 2021-01-22 | 2022-07-28 | The Procter & Gamble Company | Skin care composition comprising vitamin b3 combined with two peptides |
US11571378B2 (en) | 2021-01-22 | 2023-02-07 | The Procter & Gamble Company | Skin care composition and method of using the same |
WO2022159705A1 (en) | 2021-01-22 | 2022-07-28 | Prolacta Bioscience, Inc. | Topical human milk formulations |
WO2022159968A1 (en) | 2021-01-22 | 2022-07-28 | The Procter & Gamble Company | Skin care composition comprising a combination of peptides |
US11771637B2 (en) | 2021-01-22 | 2023-10-03 | The Procter & Gamble Company | Skin care composition and method of using the same |
US12109194B2 (en) | 2021-02-05 | 2024-10-08 | Biojiva Llc | Synergistic combination therapy for treating ALS |
US11510889B2 (en) | 2021-02-05 | 2022-11-29 | Retrotope, Inc. | Methods for inhibiting the progression of neurodegenerative diseases |
US11491130B2 (en) | 2021-02-05 | 2022-11-08 | Retrotope, Inc. | Methods of treating amyotrophic lateral sclerosis |
WO2022192882A1 (en) | 2021-03-09 | 2022-09-15 | Mary Kay Inc. | Topical compositions for uv protection |
WO2022249052A1 (en) | 2021-05-27 | 2022-12-01 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
EP4094827A1 (en) | 2021-05-27 | 2022-11-30 | Takasago International Corporation | Aqueous dispersion of microcapsules, and uses thereof |
WO2022251874A1 (en) | 2021-05-28 | 2022-12-01 | Mary Kay Inc. | Barrier guard technology |
WO2022256208A1 (en) | 2021-05-30 | 2022-12-08 | The Procter & Gamble Company | Cosmetic product comprising a cosmetic composition contained in an applicator |
WO2023279086A1 (en) | 2021-07-01 | 2023-01-05 | Mary Kay Inc. | Topical composition against fine lines and wrinkles |
WO2023023397A1 (en) * | 2021-08-20 | 2023-02-23 | Retrotope, Inc | Methods for inhibiting the progression of neurodegenerative diseases |
WO2023081670A1 (en) | 2021-11-03 | 2023-05-11 | The Procter & Gamble Company | Cosmetic product comprising oil discontinuous phase and method of use thereof |
WO2023081671A1 (en) | 2021-11-03 | 2023-05-11 | The Procter & Gamble Company | Cosmetic composition comprising oil discontinuous phase |
WO2023097321A1 (en) | 2021-11-29 | 2023-06-01 | The Procter & Gamble Company | Skin care composition comprising a hydroxycinnamic acid |
WO2023097320A1 (en) | 2021-11-29 | 2023-06-01 | The Procter & Gamble Company | Method of improving the appearance of skin |
WO2023097326A1 (en) | 2021-11-29 | 2023-06-01 | The Procter & Gamble Company | Method for treating post-acne marks |
WO2023097322A2 (en) | 2021-11-29 | 2023-06-01 | The Procter & Gamble Company | Skin care composition |
WO2023122467A1 (en) | 2021-12-21 | 2023-06-29 | The Procter & Gamble Company | Cosmetic composition comprising vitamin b3 compound and lauroyl lysine |
WO2023122465A2 (en) | 2021-12-21 | 2023-06-29 | The Procter & Gamble Company | Cosmetic composition comprising mica and lauroyl lysine |
WO2023122466A2 (en) | 2021-12-21 | 2023-06-29 | The Procter & Gamble Company | Cosmetic composition comprising sucrose ester and lauroyl lysine |
WO2023154791A1 (en) | 2022-02-10 | 2023-08-17 | The Procter & Gamble Company | Topical skin care with colloidal oatmeal |
WO2023192538A1 (en) | 2022-03-31 | 2023-10-05 | Galderma Holding SA | Personal care compositions for sensitive skin and methods of use |
WO2024081034A1 (en) | 2022-10-12 | 2024-04-18 | The Procter & Gamble Company | Cosmetic composition comprising polyacrylate crosspolymer-6, and silica and/or lauroyl lysine |
WO2024081035A1 (en) | 2022-10-12 | 2024-04-18 | The Procter & Gamble Company | Cosmetic composition comprising silica and lauroyl lysine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3755560A (en) | Nongreasy cosmetic lotions | |
DE69519123T2 (en) | Cosmetics for nails | |
DE69121976T2 (en) | Hair cleaners | |
DE69414462T2 (en) | Cosmetic composition with a pseudo latex with remanent properties | |
US4663157A (en) | Sunscreen compositions | |
US4478853A (en) | Skin conditioning composition | |
DE69204978T2 (en) | OILY COSMETIC COMPOSITION CONTAINING LIKE THICKENING AGENTS A COMBINATION OF TWO COPOLYMERS AND RHEOLOGICAL MODIFIERS. | |
DE60020098T2 (en) | Liquid polymer dispersions, their preparation and their use | |
EP2814456B1 (en) | Water resistant polymers for personal care | |
DE69901524T2 (en) | Cosmetic composition containing an anionic polymer and an acrylic terpolymer and use of this composition for the treatment of keratin fibers | |
JP2000516571A (en) | Improved water resistant sunscreen insect repellent composition | |
DE60221112T2 (en) | FILM COMPOSITION FOR LOCAL APPLICATION AND USE FOR THE RELEASE OF ACTIVE SUBSTANCES | |
DE69700324T2 (en) | Cosmetic composition containing a specific copolymer and use of this copolymer in cosmetics | |
DE69600057T2 (en) | Cosmetic compositions for sun protection of the skin and / or hair based on a synergistic mixture of filters and uses | |
CA1091161A (en) | Oil in water emulsion film forming sunscreen compositions | |
AU666641B2 (en) | Gel type compositions having improved oil control | |
DE60001232T2 (en) | Skin cleanser | |
DE69500027T2 (en) | Gel-like cosmetic and / or dermatological composition containing hollow particles and a large amount of solvent | |
JPS6126764B2 (en) | ||
JP2000063261A (en) | Reparation for external use for skin | |
DE602004000983T2 (en) | Homogeneous powder of a self-dispersing inverse latex and a powder for cosmetic or pharmacological use, and its use as a texturizing agent | |
DE69111466T2 (en) | FACIAL SKIN CARE EMULSION. | |
JPS609692B2 (en) | Make-up cosmetics | |
JP2003507399A (en) | Aqueous cosmetic composition | |
DE69005989T2 (en) | Sunscreen with an improved effect. |